TW202012390A - Novel substituted pyrazole derivatives - Google Patents

Novel substituted pyrazole derivatives Download PDF

Info

Publication number
TW202012390A
TW202012390A TW108122910A TW108122910A TW202012390A TW 202012390 A TW202012390 A TW 202012390A TW 108122910 A TW108122910 A TW 108122910A TW 108122910 A TW108122910 A TW 108122910A TW 202012390 A TW202012390 A TW 202012390A
Authority
TW
Taiwan
Prior art keywords
substituted
unsubstituted
alkyl
salt
group
Prior art date
Application number
TW108122910A
Other languages
Chinese (zh)
Inventor
蘇倫德拉K 庫瑪瓦
沙拉巴A 科荷里
基蘭S 巴巴爾
馬尼什K 亞達夫
拉維K 夏阿瑪
納德K 阿羅拉
Original Assignee
日商日本歐愛特農業科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日本歐愛特農業科技股份有限公司 filed Critical 日商日本歐愛特農業科技股份有限公司
Publication of TW202012390A publication Critical patent/TW202012390A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

An object of the present disclosure is to provide a novel substituted pyrazole compound or a salt thereof as represented by formula (1) that controls pests: wherein, Q represents an oxygen atom or a sulfur atom, or the like; R represents substituted or unsubstituted aryl, C1-C12 alkyl, or the like; R1 represents hydrogen, substituted or unsubstituted C1-C12 alkylcarbonyl, substituted or unsubstituted C1-C12 alkoxycarbonyl, or the like; R2 and R3 each independently represent hydrogen, substituted or unsubstituted C1-C12 alkyl, or the like; R4 and R5 each independently represent hydrogen, substituted or unsubstituted C1-C12 alkyl, or the like; and X1, X2 and X3 represent C-R8, C-R9 and C-R10, respectively, wherein R8, R9 and R10 each independently represent hydrogen, halogen, methyl, ethyl or the like.

Description

新穎之經取代吡唑衍生物Novel substituted pyrazole derivatives

發明領域 本揭示有關於新穎的吡唑化合物(pyrazole compounds)以及用於製備該等化合物的製程。再者,本揭示提供一種包含有本揭示的化合物的農業和園藝殺蟲劑(insecticide)與殺真菌劑(fungicide)組成物。Field of invention The present disclosure relates to novel pyrazole compounds and processes for preparing these compounds. Furthermore, the present disclosure provides an agricultural and horticultural insecticide and fungicide composition containing the compound of the present disclosure.

發明背景 近年來,已被觀察到的是:由於慣常殺蟲劑和殺真菌劑的長期和大量使用,各種不同的昆蟲和真菌已獲得對此的抗性。因此,這些已知的殺害蟲劑(pesticides)現在不能有效地控制這些害蟲。為了克服這個情況,有一持續的需要用於發展可控制各種不同的化學-敏感性以及化學-抗性的昆蟲和真菌的新型的殺害蟲劑。Background of the invention In recent years, it has been observed that due to the long-term and large-scale use of conventional insecticides and fungicides, various insects and fungi have acquired resistance to this. Therefore, these known pesticides (pesticides) cannot now effectively control these pests. To overcome this situation, there is an ongoing need to develop new insecticides that can control various chemical-sensitive and chemical-resistant insects and fungi.

帶有害蟲控制活性的各種不同的化合物先前已被發展。例如,WO 2007/088978 (專利文獻(PTL) 1)揭示具有殺真菌活性的喹啉衍生物(quinoline derivatives),但是沒有關於殺蟲活性的描述。再者,WO 2006/013896 (專利文獻(PTL) 2)、JP 2008-110953 (專利文獻(PTL) 3)、JP 2633377 (專利文獻(PTL) 4)以及US 4168311 (專利文獻(PTL) 5)揭示具有一殺蟲活性的喹啉衍生物。Various compounds with pest control activity have been previously developed. For example, WO 2007/088978 (Patent Literature (PTL) 1) discloses quinoline derivatives having fungicidal activity, but there is no description about insecticidal activity. Furthermore, WO 2006/013896 (Patent Literature (PTL) 2), JP 2008-110953 (Patent Literature (PTL) 3), JP 2633377 (Patent Literature (PTL) 4) and US 4168311 (Patent Literature (PTL) 5) A quinoline derivative with an insecticidal activity is revealed.

PTL 1和PTL 2揭示由下列化學式(A )所代表的化合物:

Figure 02_image004
其中, Z代表一氧原子、一硫原子、SO、SO2 、CO或Q等等, 其中Q是一C1-4 烷撐基團(C1-4 alkylene group)(該C1-4 烷撐基團可被取代以一鹵素原子或一氰基基團); R1 、R2 和R3 代表氫、C1-4 烷基基團、C1-4 鹵烷基基團、C1-4 烷基氧基基團、C1-4 鹵烷氧基基團、烷基氧基羰基基團、硝基基團、氰基基團、甲醯基基團、乙醯基基團、乙醯基乙氧基基團等等; R2 和R3 一起代表一個(CH2 )m ,其中m代表3或4; X1 、X2 和X3 各個獨立地代表一氫原子、一鹵素原子、一可被取代以一鹵素原子的C1-4 烷基基團或一C1-4 烷基氧基基團、一C1-4 烷基氧基羰基基團、一可被取代以一鹵素原子的C1-4 烷基氧基基團,或一可被取代以一鹵素原子的C1-4 烷基氧基羰基基團,有條件的是:X1 、X2 和X3 不同時地代表氫原子; W1 代表一氮原子或CY1 , W2 代表一氮原子或CY2 ,和 W3 代表一氮原子或CY3 , 有條件的是:當W1 代表一氮原子時,W2 和W3 分別地代表CY2 和CY3 ,當W2 代表一氮原子時,W1 和W3 分別地代表CY1 和CY3 ,以及當W3 代表一氮原子時,W1 和W2 分別地代表CY1 和CY2 ;以及 Y1 、Y2 和Y3 各個獨立地代表一氫原子、A,或 B, 其中A代表一C1-8 烷基基團、C1-8 烷基氧基基團、C2-8 烯基基團、C2-8 烯基氧基基團、C1-8 烷基氧基羰基基團、C2-8 烯基硫基基團、C1-8 烷基亞磺醯基基團、C2-8 烯基亞磺醯基基團、C1-8 烷基磺醯基基團、C2-8 烯基磺醯基基團、苯基基團,或苯氧基基團,其中所有這些取代基可進一步被取代以各種不同的基團(諸如鹵素、C1-4 烷基基團等等),以及 B代表一鹵素原子,或一C1-4 烷基基團。PTL 1 and PTL 2 reveal the compounds represented by the following chemical formula ( A ):
Figure 02_image004
Wherein, Z represents an oxygen atom, a sulfur atom, SO, SO 2, CO, etc., or Q, wherein Q is a C 1-4 alkylene group (C 1-4 alkylene group) (wherein the C 1-4 alkyl The propylene group may be substituted with a halogen atom or a cyano group); R 1 , R 2 and R 3 represent hydrogen, C 1-4 alkyl group, C 1-4 haloalkyl group, C 1 -4 alkyloxy group, C 1-4 haloalkoxy group, alkyloxycarbonyl group, nitro group, cyano group, methyl group, acetyl group, Acetyl ethoxy groups, etc.; R 2 and R 3 together represent a (CH 2 ) m , where m represents 3 or 4; X 1 , X 2 and X 3 each independently represent a hydrogen atom, a halogen Atom, a C 1-4 alkyl group which may be substituted with a halogen atom or a C 1-4 alkyloxy group, a C 1-4 alkyloxycarbonyl group, a a halogen atom C 1-4 alkyl radical, which may be substituted, or a halogen atom to a C 1-4 alkyloxycarbonyl group, the conditions are: X 1, X 2 and X 3 Differently represent hydrogen atoms; W 1 represents a nitrogen atom or CY 1 , W 2 represents a nitrogen atom or CY 2 , and W 3 represents a nitrogen atom or CY 3 , conditionally: when W 1 represents a nitrogen atom , W 2 and W 3 represent CY 2 and CY 3 respectively , when W 2 represents a nitrogen atom, W 1 and W 3 represent CY 1 and CY 3 respectively , and when W 3 represents a nitrogen atom, W 1 and W 2 represent CY 1 and CY 2 respectively ; and Y 1 , Y 2 and Y 3 each independently represent a hydrogen atom, A, or B, where A represents a C 1-8 alkyl group, C 1 -8 alkyloxy group, C 2-8 alkenyl group, C 2-8 alkenyloxy group, C 1-8 alkyloxycarbonyl group, C 2-8 alkenylthio group Group, C 1-8 alkylsulfinyl group, C 2-8 alkenylsulfinyl group, C 1-8 alkylsulfinyl group, C 2-8 alkenylsulfonyl group Group, phenyl group, or phenoxy group, where all of these substituents can be further substituted with various groups (such as halogen, C 1-4 alkyl groups, etc.), and B represents a halogen Atom, or a C 1-4 alkyl group.

該等刊物亦提到:為了農業和園藝的目的,由化學式(A )所代表的化合物是有用的作為殺真菌劑和殺蟲劑以控制害蟲。然而,這些刊物沒有任何地方包括本揭示的化合物。引用列表 專利文獻These publications also mention that for agricultural and horticultural purposes, the compound represented by the chemical formula ( A ) is useful as a fungicide and insecticide to control pests. However, these publications do not include the compounds of the present disclosure anywhere. Citation List Patent Literature

PTL 1:WO 2007/088978A1 PTL 2:WO 2006/013896A1 PTL 3:JP 2008-110953 PTL 4:JP 2633377 PTL 5:US 4168311PTL 1: WO 2007/088978A1 PTL 2: WO 2006/013896A1 PTL 3: JP 2008-110953 PTL 4: JP 2633377 PTL 5: US 4168311

發明概要問題的解決方案 本揭示提供新穎之經取代的吡唑化合物或它的鹽類,其展現高的殺蟲和殺真菌活性對抗藥物抗性昆蟲和真菌以及藥物敏感性昆蟲和真菌。 Solution to Problem of the Invention The present disclosure provides novel substituted pyrazole compounds or salts thereof that exhibit high insecticidal and fungicidal activity against drug-resistant insects and fungi and drug-sensitive insects and fungi.

本揭示亦提供一種用於製備該等新穎之經取代的吡唑化合物或它的鹽類的製程。The present disclosure also provides a process for preparing these novel substituted pyrazole compounds or its salts.

本揭示進一步提供一種新型的農業和園藝組合物,其包含有一經取代的吡唑化合物或它的一鹽類作為一活性成分,其展現一對抗化學-抗性以及化學-敏感性昆蟲和真菌的顯著殺蟲和殺真菌效用。The present disclosure further provides a novel agricultural and horticultural composition comprising a substituted pyrazole compound or a salt thereof as an active ingredient, which exhibits a resistance to chemical-resistant and chemical-sensitive insects and fungi Significant insecticidal and fungicidal effects.

特別地,本發明人進行廣泛的研究,並且成功合成一種已顯示優異的殺蟲和殺真菌活性的由下列化學式(1 )所代表的化合物或它的一鹽類。本發明人根據上面的發現已進行進一步的研究。In particular, the present inventors conducted extensive research and successfully synthesized a compound represented by the following chemical formula ( 1 ) or a salt thereof which has shown excellent insecticidal and fungicidal activity. The inventors have conducted further studies based on the above findings.

作為廣泛研究的結果,本發明人已發現:一由下列通式(1 )所代表的化合物或它的一鹽類展現優異的殺蟲和殺真菌活性。As a result of extensive research, the present inventors have discovered that a compound represented by the following general formula ( 1 ) or a salt thereof exhibits excellent insecticidal and fungicidal activity.

因此,本揭示有關於由下列通式(1 )所代表的新穎之經取代的吡唑化合物或它們的鹽類。Therefore, the present disclosure relates to novel substituted pyrazole compounds represented by the following general formula ( 1 ) or their salts.

更特別地,本揭示包括下列具體例: 具體例A1:More specifically, the present disclosure includes the following specific examples: Specific example A1:

一種由下列化學式(1 )所代表的經取代的吡唑化合物、或它的一鹽類:

Figure 02_image006
其中, Q代表一氧原子、一硫原子、CR6 R7 或直接鍵; R6 和R7 各個獨立地代表氫、鹵素、氰基、C1 -C12 烷基、C1 -C12 鹵烷基、C1 -C12 烷氧基、C1 -C12 鹵烷氧基、C1 -C12 氰基烷氧基、C1 -C12 烷基硫基、C1 -C12 鹵烷基硫基、C1 -C12 烷氧基、C1 -C12 烷基、C1 -C12 鹵烷氧基、C2 -C12 烯基、C2 -C12 鹵烯基、C2 -C12 烯基氧基、C2 -C12 鹵烯基氧基、C2 -C12 炔基、C2 -C12 鹵炔基、C2 -C12 炔基氧基、C2 -C12 鹵炔基氧基、C1 -C12 烷基亞磺醯基、C1 -C12 烷基磺醯基、C1 -C12 鹵烷基亞磺醯基、C1 -C12 鹵烷基磺醯基、C3 -C12 環烷基、C1 -C12 烷基羰基、C1 -C12 烷氧基羰基、C1 -C12 鹵烷基羰基、C1 -C12 鹵烷氧基羰基、C1 -C12 烷基羰基胺基、C1 -C12 烷基磺醯基氧基、C1 -C12 烷基亞磺醯基氧基、經取代的或未經取代的芳基、經取代的或未經取代的雜芳基或者經取代的或未經取代的飽和雜環; R代表經取代的或未經取代的芳基、經取代的或未經取代的雜芳基、經取代的或未經取代的芳基C1 -C12 烷基、經取代的或未經取代的雜芳基C1 -C12 烷基、C1 -C12 烷基、C1 -C12 鹵烷基、C1 -C12 氰基烷基、C1 -C12 烷氧基C1 -C12 烷基、C1 -C12 烷基硫基C1 -C12 烷基、、C1 -C12 鹵烷氧基C1 -C12 烷基、C2 -C12 烯基、C2 -C12 炔基、C2 -C12 鹵烯基、C2 -C12 鹵炔基、C1 -C12 烷基亞磺醯基、C1 -C12 烷基磺醯基、C1 -C12 鹵烷基亞磺醯基、C1 -C12 鹵烷基磺醯基、C1 -C12 烷基羰基、C1 -C12 鹵烷基羰基、C1 -C12 烷氧基羰基、C1 -C12 鹵烷氧基羰基、C3 -C12 環烷基,或者飽和雜環; R1 代表氫、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C3 -C12 環烷基、經取代的或未經取代的芳基C1 -C12 烷基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C1 -C12 鹵烷基羰基、經取代的或未經取代的C1 -C12 鹵烷氧基羰基、經取代的或未經取代的C2 -C12 烯基羰基、經取代的或未經取代的C2 -C12 炔基羰基、經取代的或未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的芳基氧基羰基、經取代的或未經取代的芳基C1 -C12 烷氧基羰基、經取代的或未經取代的雜芳基氧基羰基、經取代的或未經取代的雜芳基C1 -C12 烷氧基羰基、經取代的或未經取代的芳基羰基、經取代的或未經取代的芳基C1 -C12 烷基羰基、經取代的或未經取代的雜芳基羰基、經取代的或未經取代的雜芳基C1 -C12 烷基羰基、經取代的或未經取代的雜環羰基、經取代的或未經取代的雜環C1 -C12 烷基羰基、經取代的或未經取代的C3 -C12 環烷基C1 -C12 烷基羰基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的C1 -C12 鹵烷基亞磺醯基、經取代的或未經取代的C1 -C12 鹵烷基磺醯基、經取代的或未經取代的芳基亞磺醯基、經取代的或未經取代的雜芳基亞磺醯基、經取代的或未經取代的芳基磺醯基,或者經取代的或未經取代的雜芳基磺醯基; R2 代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 鹵烷基、經取代的或未經取代的C1 -C12 烷氧基,或者經取代的或未經取代的C1 -C12 鹵烷氧基; R3 代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 鹵烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C1 -C12 鹵烷氧基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C3 -C12 環烷基、經取代的或未經取代的芳基、經取代的或未經取代的雜芳基,或者經取代的或未經取代的雜環; R4 和R5 各個獨立地代表氫、鹵素、氰基、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 鹵烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C1 -C12 烷基硫基,或者經取代的或未經取代的芳基; X1 代表C-R8 或N, X2 代表C-R9 或N,和 X3 代表C-R10 或N, 有條件的是:當X1 代表一氮原子時,X2 和X3 分別地代表C-R9 和C-R10 ,當X2 代表一氮原子時,X1 和X3 分別地代表C-R8 和C-R10 ,以及當X3 代表一氮原子時,X1 和X2 分別地代表C-R8 和C-R9 ; R8 、R9 和R10 各個獨立地代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 鹵烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C1 -C12 鹵烷氧基、經取代的或未經取代的C1 -C12 烷基硫基、經取代的或未經取代的C1 -C12 鹵烷基硫基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的C1 -C12 鹵烷氧基羰基、氰基、硝基或者經取代的或未經取代的胺基。 具體例A2:A substituted pyrazole compound represented by the following chemical formula ( 1 ), or a salt thereof:
Figure 02_image006
Among them, Q represents an oxygen atom, a sulfur atom, CR 6 R 7 or a direct bond; R 6 and R 7 each independently represent hydrogen, halogen, cyano, C 1 -C 12 alkyl, C 1 -C 12 halogen Alkyl, C 1 -C 12 alkoxy, C 1 -C 12 haloalkoxy, C 1 -C 12 cyanoalkoxy, C 1 -C 12 alkylthio, C 1 -C 12 haloalkane Thio, C 1 -C 12 alkoxy, C 1 -C 12 alkyl, C 1 -C 12 haloalkoxy, C 2 -C 12 alkenyl, C 2 -C 12 haloalkenyl, C 2 -C 12 alkenyloxy, C 2 -C 12 haloalkenyloxy, C 2 -C 12 alkynyl, C 2 -C 12 haloalkynyl, C 2 -C 12 alkynyloxy, C 2 -C 12 haloalkynyloxy, C 1 -C 12 alkylsulfinyl, C 1 -C 12 alkylsulfinyl, C 1 -C 12 haloalkylsulfinyl, C 1 -C 12 haloalkane Sulfosulfonyl, C 3 -C 12 cycloalkyl, C 1 -C 12 alkylcarbonyl, C 1 -C 12 alkoxycarbonyl, C 1 -C 12 haloalkylcarbonyl, C 1 -C 12 haloalkane Oxycarbonyl, C 1 -C 12 alkylcarbonylamino, C 1 -C 12 alkylsulfonyloxy, C 1 -C 12 alkylsulfinyloxy, substituted or unsubstituted Aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted saturated heterocycle; R represents substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl Group, substituted or unsubstituted aryl C 1 -C 12 alkyl, substituted or unsubstituted heteroaryl C 1 -C 12 alkyl, C 1 -C 12 alkyl, C 1- C 12 haloalkyl, C 1 -C 12 cyanoalkyl, C 1 -C 12 alkoxy C 1 -C 12 alkyl, C 1 -C 12 alkylthio C 1 -C 12 alkyl, C 1 -C 12 haloalkoxy C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 2 -C 12 haloalkenyl, C 2 -C 12 haloalkynyl , C 1 -C 12 alkylsulfinyl, C 1 -C 12 alkylsulfinyl, C 1 -C 12 haloalkylsulfinyl, C 1 -C 12 haloalkylsulfinyl, C 1 -C 12 alkylcarbonyl, C 1 -C 12 haloalkylcarbonyl, C 1 -C 12 alkoxycarbonyl, C 1 -C 12 haloalkoxycarbonyl, C 3 -C 12 cycloalkyl, or saturated Heterocycle; R 1 represents hydrogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, substituted or unsubstituted aryl C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 1 -C 12 haloalkylcarbonyl, substituted or unsubstituted C 1 -C 12 haloalkoxycarbonyl, substituted or unsubstituted C 2 -C 12 alkenylcarbonyl, substituted Or unsubstituted C 2 -C 12 alkynylcarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, Substituted or unsubstituted aryloxycarbonyl, substituted or unsubstituted aryl C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted heteroaryloxycarbonyl, Substituted or unsubstituted heteroaryl C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted arylcarbonyl, substituted or unsubstituted aryl C 1 -C 12 alkylcarbonyl , Substituted or unsubstituted heteroarylcarbonyl, substituted or unsubstituted heteroaryl C 1 -C 12 alkylcarbonyl, substituted or unsubstituted heterocyclic carbonyl, substituted or Unsubstituted heterocyclic C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkyl C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted C 1 -C 12 haloalkylsulfinyl, Substituted or unsubstituted C 1 -C 12 haloalkylsulfonyl, substituted or unsubstituted arylsulfinyl, substituted or unsubstituted heteroarylsulfinyl , Substituted or unsubstituted arylsulfonyl, or substituted or unsubstituted heteroarylsulfonyl; R 2 represents hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, substituted or unsubstituted C 1 -C 12 alkoxy, or substituted or unsubstituted C 1- C 12 haloalkoxy; R 3 represents hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, substituted Or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 haloalkoxy, substituted or unsubstituted C 2 -C 12 alkenyl, substituted Or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted Heteroaryl, or substituted or unsubstituted heterocycle; R 4 and R 5 each independently represent hydrogen, halogen, cyano, substituted or unsubstituted C 1 -C 12 alkyl, substituted of Or unsubstituted C 1 -C 12 haloalkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, or Substituted or unsubstituted aryl; X 1 represents CR 8 or N, X 2 represents CR 9 or N, and X 3 represents CR 10 or N, with the proviso that when X 1 represents a nitrogen atom, X 2 and X 3 represent CR 9 and CR 10 respectively , when X 2 represents a nitrogen atom, X 1 and X 3 represent CR 8 and CR 10 respectively , and when X 3 represents a nitrogen atom, X 1 and X 2 represents CR 8 and CR 9 respectively ; R 8 , R 9 and R 10 each independently represent hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 haloalkoxy, substituted or unsubstituted Substituted C 1 -C 12 alkylthio, substituted or unsubstituted C 1 -C 12 haloalkylthio, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, Substituted or unsubstituted C 1 -C 12 haloalkoxycarbonyl, cyano, nitro or substituted or unsubstituted amine. Specific example A2:

依據具體例A1的經取代的吡唑化合物或它的一鹽類,其中Q代表一氧原子,或一硫原子。 具體例A3:The substituted pyrazole compound or a salt thereof according to the specific example A1, wherein Q represents an oxygen atom or a sulfur atom. Specific example A3:

依據具體例A1或A2中任一者的經取代的吡唑化合物或它的一鹽類,其中R代表經取代的或未經取代的芳基、經取代的或未經取代的雜芳基或C1 -C12 烷基。 具體例A4:A substituted pyrazole compound or a salt thereof according to any one of the specific examples A1 or A2, wherein R represents a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group or C 1 -C 12 alkyl. Specific example A4:

依據具體例A1至A3中任一者的經取代的吡唑化合物或它的一鹽類,其中R1 代表氫、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的芳基羰基、經取代的或未經取代的芳基氧基羰基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的芳基亞磺醯基,或者經取代的或未經取代的芳基磺醯基。 具體例A5:A substituted pyrazole compound or a salt thereof according to any one of the specific examples A1 to A3, wherein R 1 represents hydrogen, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or Unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted Or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted arylcarbonyl, substituted or unsubstituted aryloxycarbonyl, substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted arylsulfinyl, or substituted or Unsubstituted arylsulfonyl. Specific example A5:

依據具體例A1至A4中任一者的經取代的吡唑化合物或它的一鹽類,其中R2 代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基,或者經取代的或未經取代的C1 -C12 鹵烷基。 具體例A6:A substituted pyrazole compound or a salt thereof according to any one of the specific examples A1 to A4, wherein R 2 represents hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, or Substituted or unsubstituted C 1 -C 12 haloalkyl. Specific example A6:

依據具體例A1至A5中任一者的經取代的吡唑化合物或它的一鹽類,其中R3 代表經取代的或未經取代的C1 -C12 烷基,或者經取代的或未經取代的C1 -C12 鹵烷基。 具體例A7:A substituted pyrazole compound or a salt thereof according to any one of the specific examples A1 to A5, wherein R 3 represents a substituted or unsubstituted C 1 -C 12 alkyl group, or a substituted or unsubstituted Substituted C 1 -C 12 haloalkyl. Specific example A7:

依據具體例A1至A6中任一者的經取代的吡唑化合物或它的一鹽類,其中R4 和R5 各個獨立地代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基,或者經取代的或未經取代的C1 -C12 鹵烷基。 具體例A8:A substituted pyrazole compound or a salt thereof according to any one of the specific examples A1 to A6, wherein R 4 and R 5 each independently represent hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, or substituted or unsubstituted C 1 -C 12 haloalkyl. Specific example A8:

依據具體例A1至A7中任一者的經取代的吡唑化合物或它的一鹽類 ,其中X1 代表C-R8 ,X2 代表C-R9 ,以及X3 代表C-R10 ,其中R8 、R9 和R10 彼此獨立地是氫、鹵素、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 鹵烷基,或者經取代的或未經取代的C1 -C12 烷氧基。 具體例A9:A substituted pyrazole compound or a salt thereof according to any one of the specific examples A1 to A7, wherein X 1 represents CR 8 , X 2 represents CR 9 , and X 3 represents CR 10 , where R 8 and R 9 And R 10 are independently of each other hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 haloalkyl, or substituted or unsubstituted Substituted C 1 -C 12 alkoxy. Specific example A9:

一種害蟲控制劑,其包含有依據具體例A1至A8中任一者的經取代的吡唑化合物或它的一鹽類作為一活性成分。 具體例A10:A pest control agent comprising a substituted pyrazole compound according to any one of Specific Examples A1 to A8 or a salt thereof as an active ingredient. Specific example A10:

一種使用依據具體例A1至A8中任一者的經取代的吡唑化合物或它的一鹽類的方法,其用於控制害蟲。 具體例A11:A method of using a substituted pyrazole compound or a salt thereof according to any one of Specific Examples A1 to A8 for controlling pests. Specific example A11:

一種用於控制害蟲的方法,其包含有施加依據具體例A1至A8中任一者的經取代的吡唑化合物或它的一鹽類至一植物或它的附近,或者一植物被栽培的土壤。 具體例A12:A method for controlling pests, which comprises applying a substituted pyrazole compound or a salt thereof according to any one of Specific Examples A1 to A8 to a plant or its vicinity, or a soil where a plant is cultivated . Specific example A12:

一種用於控制害蟲的方法,其包含有施加一有效量的依據具體例A1至A8中任一者的經取代的吡唑化合物或它的一鹽類至害蟲、害蟲的一棲地,或者一預測棲息的地點。 再者特別地,本揭示包括下列具體例: 具體例1:A method for controlling pests, which comprises applying an effective amount of the substituted pyrazole compound according to any one of the specific examples A1 to A8 or a salt thereof to the pest, the pest's habitat, or a Predict where to live. Furthermore, the present disclosure includes the following specific examples: Specific example 1:

一種由下列化學式(1 )所代表的經取代的吡唑化合物、或它的一鹽類:

Figure 02_image006
其中, Q代表一氧原子、一硫原子、CR6 R7 或直接鍵; R6 和R7 各個獨立地代表氫、鹵素、氰基、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C1 -C12 烷基硫基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 烯基氧基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C2 -C12 炔基氧基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的C3 -C12 環烷基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的C1 -C12 烷基羰基胺基、經取代的或未經取代的C1 -C12 烷基磺醯基氧基、經取代的或未經取代的C1 -C12 烷基亞磺醯基氧基、經取代的或未經取代的芳基、經取代的或未經取代的雜芳基或者經取代的或未經取代的飽和雜環; R代表氫、經取代的或未經取代的芳基、經取代的或未經取代的雜芳基、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的C3 -C12 環烷基,或者經取代的或未經取代的飽和雜環; R1 代表氫、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C3 -C12 環烷基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C2 -C12 烯基羰基、經取代的或未經取代的C2 -C12 炔基羰基、經取代的或未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的芳基氧基羰基、經取代的或未經取代的雜芳基氧基羰基、經取代的或未經取代的芳基羰基、經取代的或未經取代的雜芳基羰基、經取代的或未經取代的雜環羰基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的芳基亞磺醯基、經取代的或未經取代的雜芳基亞磺醯基、經取代的或未經取代的芳基磺醯基、經取代的或未經取代的雜芳基磺醯基; R2 和R3 各個獨立地代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C3 -C12 環烷基、經取代的或未經取代的芳基、經取代的或未經取代的雜芳基,或者經取代的或未經取代的雜環; R4 和R5 各個獨立地代表氫、鹵素、氰基、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C1 -C12 烷基硫基或者經取代的或未經取代的芳基; X1 代表C-R8 或N, X2 代表C-R9 或N,和 X3 代表C-R10 或N, 有條件的是:當X1 代表一氮原子時,X2 和X3 分別地代表C-R9 和C-R10 ,當X2 代表一氮原子時,X1 和X3 分別地代表C-R8 和C-R10 ,和當X3 代表一氮原子時,X1 和X2 分別地代表C-R8 和C-R9 ;以及 R8 、R9 和R10 各個獨立地代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C1 -C12 烷基硫基、經取代的或未經取代的C1 -C12 烷氧基羰基、氰基、硝基,或者經取代的或未經取代的胺基。 具體例1a:A substituted pyrazole compound represented by the following chemical formula ( 1 ), or a salt thereof:
Figure 02_image006
Where Q represents an oxygen atom, a sulfur atom, CR 6 R 7 or a direct bond; R 6 and R 7 each independently represent hydrogen, halogen, cyano, substituted or unsubstituted C 1 -C 12 alkane Group, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, substituted or unsubstituted C 2 -C 12 Alkenyl, substituted or unsubstituted C 2 -C 12 alkenyloxy, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 2 -C 12 Alkynyloxy, substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted Substituted C 3 -C 12 cycloalkyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or Unsubstituted C 1 -C 12 alkylcarbonylamino, substituted or unsubstituted C 1 -C 12 alkylsulfonyloxy, substituted or unsubstituted C 1 -C 12 alkyl Sulfenyloxy, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted saturated heterocyclic ring; R represents hydrogen, substituted Or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 2 -C 12 alkene Group, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, or substituted or unsubstituted saturated heterocycle; R 1 represents hydrogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 2 -C 12 alkenylcarbonyl, substituted or unsubstituted C 2 -C 12 alkynylcarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted aryloxycarbonyl, substituted or unsubstituted Heteroaryloxycarbonyl, substituted or unsubstituted arylcarbonyl, substituted or unsubstituted heteroarylcarbonyl, substituted or unsubstituted heterocyclic carbonyl, Substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted arylsulfinyl Sulfonyl, substituted or unsubstituted heteroarylsulfinyl, substituted or unsubstituted arylsulfonyl, substituted or unsubstituted heteroarylsulfonyl; R 2 and R 3 each independently represent hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted Substituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, substituted or unsubstituted Substituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocycle; R 4 and R 5 each independently represent hydrogen, halogen, cyano, substituted or unsubstituted Substituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, or substituted or Unsubstituted aryl; X 1 represents CR 8 or N, X 2 represents CR 9 or N, and X 3 represents CR 10 or N, conditionally: when X 1 represents a nitrogen atom, X 2 and X 3 represents CR 9 and CR 10 respectively , when X 2 represents a nitrogen atom, X 1 and X 3 represent CR 8 and CR 10 respectively , and when X 3 represents a nitrogen atom, X 1 and X 2 respectively Stands for CR 8 and CR 9 ; and R 8 , R 9 and R 10 each independently represent hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, cyano, nitro, or Substituted or unsubstituted amine groups. Specific example 1a:

依據具體例1的經取代的吡唑化合物或它的一鹽類,其中,在R6 和R7 中, 該經取代的或未經取代的C1 -C12 烷基是選自於由C1 -C12 烷基、C1 -C12 鹵烷基、C1 -C12 烷氧基C1 -C12 烷基,以及C1 -C12 鹵烷氧基C1 -C12 烷基所構成的群組; 該經取代的或未經取代的C1 -C12 烷氧基是選自於由C1 -C12 烷氧基、C1 -C12 鹵烷氧基,以及C1 -C12 氰基烷氧基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基硫基是選自於由C1 -C12 烷基硫基和C1 -C12 鹵烷基硫基所構成的群組; 該經取代的或未經取代的C2 -C12 烯基是選自於由C2 -C12 烯基和C2 -C12 鹵烯基所構成的群組; 該經取代的或未經取代的C2 -C12 烯基氧基是選自於由C2 -C12 烯基氧基和C2 -C12 鹵烯基氧基所構成的群組; 該經取代的或未經取代的C2 -C12 炔基是選自於由C2 -C12 炔基和C2 -C12 鹵炔基所構成的群組; 該經取代的或未經取代的C2 -C12 炔基氧基是選自於由C2 -C12 炔基氧基和C2 -C12 鹵炔基氧基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基亞磺醯基是選自於由C1 -C12 烷基亞磺醯基和C1 -C12 鹵烷基亞磺醯基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基磺醯基是選自於由C1 -C12 烷基磺醯基和C1 -C12 鹵烷基磺醯基所構成的群組; 該經取代的或未經取代的C3 -C12 環烷基是C3 -C12 環烷基; 該經取代的或未經取代的C1 -C12 烷基羰基是選自於由C1 -C12 烷基羰基和C1 -C12 鹵烷基羰基所構成的群組; 該經取代的或未經取代的C1 -C12 烷氧基羰基是選自於由C1 -C12 烷氧基羰基和C1 -C12 鹵烷氧基羰基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基羰基胺基是C1 -C12 烷基羰基胺基; 該經取代的或未經取代的C1 -C12 烷基磺醯基氧基是C1 -C12 烷基磺醯基氧基;和/或 該經取代的或未經取代的C1 -C12 烷基亞磺醯基氧基是C1 -C12 烷基亞磺醯基氧基。 具體例1b:The substituted pyrazole compound or a salt thereof according to the specific example 1, wherein in R 6 and R 7 , the substituted or unsubstituted C 1 -C 12 alkyl group is selected from C 1 -C 12 alkyl, C 1 -C 12 haloalkyl, C 1 -C 12 alkoxy C 1 -C 12 alkyl, and C 1 -C 12 haloalkoxy C 1 -C 12 alkyl The group consisting of; the substituted or unsubstituted C 1 -C 12 alkoxy is selected from the group consisting of C 1 -C 12 alkoxy, C 1 -C 12 haloalkoxy, and C 1- C 12 cyanoalkoxy group; the substituted or unsubstituted C 1 -C 12 alkylthio group is selected from C 1 -C 12 alkylthio group and C 1 -C 12 haloalkylthio groups; the substituted or unsubstituted C 2 -C 12 alkenyl group is selected from the group consisting of C 2 -C 12 alkenyl and C 2 -C 12 haloalkenyl The group consisting of; the substituted or unsubstituted C 2 -C 12 alkenyloxy is selected from the group consisting of C 2 -C 12 alkenyloxy and C 2 -C 12 haloalkenyloxy The group of the substituted or unsubstituted C 2 -C 12 alkynyl is selected from the group consisting of C 2 -C 12 alkynyl and C 2 -C 12 haloalkynyl; the substituted Or unsubstituted C 2 -C 12 alkynyloxy is selected from the group consisting of C 2 -C 12 alkynyloxy and C 2 -C 12 haloalkynyloxy; the substituted Or unsubstituted C 1 -C 12 alkylsulfinyl group is selected from the group consisting of C 1 -C 12 alkylsulfinyl group and C 1 -C 12 haloalkylsulfinyl group ; The substituted or unsubstituted C 1 -C 12 alkylsulfonyl group is selected from the group consisting of C 1 -C 12 alkylsulfonyl group and C 1 -C 12 haloalkylsulfonyl group The group; the substituted or unsubstituted C 3 -C 12 cycloalkyl is C 3 -C 12 cycloalkyl; the substituted or unsubstituted C 1 -C 12 alkylcarbonyl is selected from In the group consisting of C 1 -C 12 alkylcarbonyl and C 1 -C 12 haloalkylcarbonyl; the substituted or unsubstituted C 1 -C 12 alkoxycarbonyl is selected from the group consisting of 1 -C 12 alkoxycarbonyl group and C 1 -C 12 haloalkoxycarbonyl group; the substituted or unsubstituted C 1 -C 12 alkylcarbonylamino group is C 1 -C 12 Alkylcarbonylamino; the substituted or unsubstituted C 1 -C 12 alkylsulfonyloxy is C 1 -C 12 alkylsulfonyloxy; and/or the substituted or unsubstituted The substituted C 1 -C 12 alkylsulfinyloxy is C 1 -C 12 alkylsulfinyloxy. Specific example 1b:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中,在R中, 該經取代的或未經取代的C1 -C12 烷基是選自於由C1 -C12 烷基、C1 -C12 鹵烷基、C1 -C12 氰基烷基、C1 -C12 烷氧基C1 -C12 烷基、C1 -C12 烷基硫基C1 -C12 烷基、C1 -C12 鹵烷氧基C1 -C12 烷基、經取代的或未經取代的芳基C1 -C12 烷基,以及經取代的或未經取代的雜芳基芳基C1 -C12 烷基所構成的群組; 該經取代的或未經取代的C2 -C12 烯基是選自於由C2 -C12 烯基和C2 -C12 鹵烯基所構成的群組; 該經取代的或未經取代的C2 -C12 炔基是選自於由C2 -C12 炔基和C2 -C12 鹵炔基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基亞磺醯基是選自於由C1 -C12 烷基亞磺醯基和C1 -C12 鹵烷基亞磺醯基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基磺醯基是選自於由C1 -C12 烷基磺醯基和C1 -C12 鹵烷基磺醯基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基羰基是選自於由C1 -C12 烷基羰基C1 -C12 鹵烷基羰基所構成的群組; 該經取代的或未經取代的C1 -C12 烷氧基羰基是選自於由C1 -C12 烷氧基羰基和C1 -C12 鹵烷氧基羰基所構成的群組;和/或 該經取代的或未經取代的飽和雜環是飽和雜環。 具體例1c:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein in R, the substituted or unsubstituted C 1 -C 12 alkyl group is selected from the group consisting of 1 -C 12 alkyl, C 1 -C 12 haloalkyl, C 1 -C 12 cyanoalkyl, C 1 -C 12 alkoxy C 1 -C 12 alkyl, C 1 -C 12 alkyl sulfur Group C 1 -C 12 alkyl, C 1 -C 12 haloalkoxy C 1 -C 12 alkyl, substituted or unsubstituted aryl C 1 -C 12 alkyl, and substituted or unsubstituted Substituted heteroaryl aryl C 1 -C 12 alkyl group; the substituted or unsubstituted C 2 -C 12 alkenyl group is selected from C 2 -C 12 alkenyl and C 2 -C 12 haloalkenyl group; the substituted or unsubstituted C 2 -C 12 alkynyl group is selected from C 2 -C 12 alkynyl and C 2 -C 12 haloalkyn Group consisting of groups; the substituted or unsubstituted C 1 -C 12 alkylsulfinyl group is selected from the group consisting of C 1 -C 12 alkylsulfinyl group and C 1 -C 12 halo The group consisting of alkylsulfinyl; the substituted or unsubstituted C 1 -C 12 alkylsulfonyl is selected from C 1 -C 12 alkylsulfonyl and C 1- C 12 haloalkyl sulfonyl group; the substituted or unsubstituted C 1 -C 12 alkylcarbonyl group is selected from C 1 -C 12 alkylcarbonyl C 1 -C 12 halo The group consisting of alkylcarbonyl; the substituted or unsubstituted C 1 -C 12 alkoxycarbonyl is selected from the group consisting of C 1 -C 12 alkoxycarbonyl and C 1 -C 12 haloalkoxy Group consisting of carbonyl; and/or the substituted or unsubstituted saturated heterocycle is a saturated heterocycle. Specific example 1c:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中,在R1 中, 該經取代的或未經取代的C1 -C12 烷基是選自於由經取代的或未經取代的C1 -C12 烷基以及經取代的或未經取代的芳基C1 -C12 烷基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基羰基是選自於由經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C1 -C12 鹵烷基羰基、經取代的或未經取代的芳基C1 -C12 烷基羰基、經取代的或未經取代的雜芳基C1 -C12 烷基羰基、經取代的或未經取代的雜環C1 -C12 烷基羰基,以及經取代的或未經取代的C3- C12 環烷基C1 -C12 烷基羰基所構成的群組; 該經取代的或未經取代的C1 -C12 烷氧基羰基是選自於由經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的芳基C1 -C12 烷氧基羰基,以及經取代的或未經取代的雜芳基C1 -C12 烷氧基羰基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基亞磺醯基是選自於由經取代的或未經取代的C1 -C12 烷基亞磺醯基,以及經取代的或未經取代的C1 -C12 鹵烷基亞磺醯基所構成的群組;和/或 該經取代的或未經取代的C1 -C12 烷基磺醯基是選自於由經取代的或未經取代的C1 -C12 烷基磺醯基,以及C1 -C12 鹵烷基磺醯基所構成的群組;以及 該等被提到作為R1 的基團亦可進一步藉由各種不同的取代基基團(諸如F、Cl、Br、I、CN、NO2 、CH3 、C(CH3 )3 、OCH3 、CO2 CH3 、CO2 CH2 CH3 、SO2 CH3 、OCH2 CF3 、CF3 ,或OCF3 )而被取代。 具體例1d:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein, in R 1 , the substituted or unsubstituted C 1 -C 12 alkyl group is selected from The group consisting of substituted or unsubstituted C 1 -C 12 alkyl and substituted or unsubstituted aryl C 1 -C 12 alkyl; the substituted or unsubstituted C 1 -C 12 alkylcarbonyl is selected from substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 1 -C 12 haloalkylcarbonyl, substituted or Unsubstituted aryl C 1 -C 12 alkylcarbonyl, substituted or unsubstituted heteroaryl C 1 -C 12 alkylcarbonyl, substituted or unsubstituted heterocyclic C 1 -C 12 alkylcarbonyl group and a substituted or unsubstituted C 3- C 12 cycloalkyl C 1 -C 12 alkylcarbonyl group consisting of; the substituted or unsubstituted C 1 -C 12 alkyl The oxycarbonyl group is selected from a substituted or unsubstituted C 1 -C 12 alkoxycarbonyl group, a substituted or unsubstituted aryl C 1 -C 12 alkoxycarbonyl group, and a substituted Or an unsubstituted heteroaryl C 1 -C 12 alkoxycarbonyl group; the substituted or unsubstituted C 1 -C 12 alkylsulfinyl group is selected from substituted Or unsubstituted C 1 -C 12 alkylsulfinyl and substituted or unsubstituted C 1 -C 12 haloalkylsulfinyl; and/or the Substituted or unsubstituted C 1 -C 12 alkylsulfonyl is selected from substituted or unsubstituted C 1 -C 12 alkylsulfonyl and C 1 -C 12 haloalkyl Sulfonyl groups; and the groups mentioned as R 1 can be further substituted by various substituent groups (such as F, Cl, Br, I, CN, NO 2 , CH 3 , C(CH 3 ) 3 , OCH 3 , CO 2 CH 3 , CO 2 CH 2 CH 3 , SO 2 CH 3 , OCH 2 CF 3 , CF 3 , or OCF 3 ) are replaced. Specific example 1d:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中,在R2 中, 該經取代的或未經取代的C1 -C12 烷基是選自於由經取代的或未經取代的C1 -C12 烷基,以及經取代的或未經取代的C1 -C12 鹵烷基所構成的群組;和/或 該經取代的或未經取代的C1 -C12 烷氧基是選自於由經取代的或未經取代的C1 -C12 烷氧基,以及經取代的或未經取代的C1 -C12 鹵烷氧基所構成的群組。 具體例1e:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein, in R 2 , the substituted or unsubstituted C 1 -C 12 alkyl group is selected from A group consisting of substituted or unsubstituted C 1 -C 12 alkyl, and substituted or unsubstituted C 1 -C 12 haloalkyl; and/or the substituted or unsubstituted The C 1 -C 12 alkoxy is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkoxy, and substituted or unsubstituted C 1 -C 12 haloalkoxy Formed group. Specific example 1e:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中,在R3 中, 該經取代的或未經取代的C1 -C12 烷基是選自於由經取代的或未經取代的C1 -C12 烷基,以及經取代的或未經取代的C1 -C12 鹵烷基所構成的群組;和/或 該經取代的或未經取代的C1 -C12 烷氧基是選自於由經取代的或未經取代的C1 -C12 烷氧基,以及經取代的或未經取代的C1 -C12 鹵烷氧基所構成的群組。 具體例1f:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein, in R 3 , the substituted or unsubstituted C 1 -C 12 alkyl group is selected from A group consisting of substituted or unsubstituted C 1 -C 12 alkyl, and substituted or unsubstituted C 1 -C 12 haloalkyl; and/or the substituted or unsubstituted The C 1 -C 12 alkoxy is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkoxy, and substituted or unsubstituted C 1 -C 12 haloalkoxy Formed group. Specific example 1f:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中,在R4 和R5 中, 該經取代的或未經取代的C1 -C12 烷基是選自於由經取代的或未經取代的C1 -C12 烷基,以及經取代的或未經取代的C1 -C12 鹵烷基所構成的群組。 具體例1g:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein, in R 4 and R 5 , the substituted or unsubstituted C 1 -C 12 alkyl group is selected From the group consisting of substituted or unsubstituted C 1 -C 12 alkyl, and substituted or unsubstituted C 1 -C 12 haloalkyl. Specific example 1g:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中,在R8 、R9 和R10 中, 該經取代的或未經取代的C1 -C12 烷基是選自於由經取代的或未經取代的C1 -C12 烷基,以及經取代的或未經取代的C1 -C12 鹵烷基所構成的群組; 該經取代的或未經取代的C1 -C12 烷氧基是選自於由經取代的或未經取代的C1 -C12 烷氧基,以及經取代的或未經取代的C1 -C12 鹵烷氧基所構成的群組; 該經取代的或未經取代的C1 -C12 烷基硫基是選自於由經取代的或未經取代的C1 -C12 烷基硫基,以及經取代的或未經取代的C1 -C12 鹵烷基硫基所構成的群組;和/或 該經取代的或未經取代的C1 -C12 烷氧基羰基是選自於由經取代的或未經取代的C1 -C12 烷氧基羰基,以及經取代的或未經取代的C1 -C12 鹵烷氧基羰基所構成的群組。 具體例1h:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein, in R 8 , R 9 and R 10 , the substituted or unsubstituted C 1 -C 12 alkyl The group is selected from the group consisting of substituted or unsubstituted C 1 -C 12 alkyl groups, and substituted or unsubstituted C 1 -C 12 haloalkyl groups; the substituted or Unsubstituted C 1 -C 12 alkoxy is selected from substituted or unsubstituted C 1 -C 12 alkoxy, and substituted or unsubstituted C 1 -C 12 haloalkanes Oxygen group; the substituted or unsubstituted C 1 -C 12 alkylthio group is selected from substituted or unsubstituted C 1 -C 12 alkylthio group, and Substituted or unsubstituted C 1 -C 12 haloalkylthio group; and/or the substituted or unsubstituted C 1 -C 12 alkoxycarbonyl group is selected from A group consisting of a substituted or unsubstituted C 1 -C 12 alkoxycarbonyl group, and a substituted or unsubstituted C 1 -C 12 haloalkoxycarbonyl group. Specific example 1h:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中 Q代表一氧原子或一硫原子; R代表經取代的或未經取代的芳基、經取代的或未經取代的C1 -C12 烷基, R1 代表氫、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的芳基氧基羰基、經取代的或未經取代的芳基羰基,或者經取代的或未經取代的C1 -C12 烷基磺醯基; R2 代表氫,或者經取代的或未經取代的C1 -C12 烷基; R3 代表經取代的或未經取代的C1 -C12 烷基; R4 和R5 各個獨立地代表氫、經取代的或未經取代的C1 -C12 烷基; X1 代表C-R8 或N, X2 代表C-R9 ,和 X3 代表C-R10 , 有條件的是:當X1 代表一氮原子時,X2 和X3 分別地代表C-R9 和C-R10 ,當X2 代表一氮原子時,X1 和X3 分別地代表C-R8 和C-R10 ,和當X3 代表一氮原子時,X1 和X2 分別地代表C-R8 和C-R9 ;以及 R8 、R9 和R10 各個獨立地代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基,或者經取代的或未經取代的C1 -C12 烷氧基。 具體例2:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein Q represents an oxygen atom or a sulfur atom; R represents a substituted or unsubstituted aryl group, substituted or Unsubstituted C 1 -C 12 alkyl, R 1 represents hydrogen, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, Substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxy Carbonyl, substituted or unsubstituted aryloxycarbonyl, substituted or unsubstituted arylcarbonyl, or substituted or unsubstituted C 1 -C 12 alkylsulfonyl; R 2 Represents hydrogen, or substituted or unsubstituted C 1 -C 12 alkyl; R 3 represents substituted or unsubstituted C 1 -C 12 alkyl; R 4 and R 5 each independently represent hydrogen, Substituted or unsubstituted C 1 -C 12 alkyl; X 1 represents CR 8 or N, X 2 represents CR 9 , and X 3 represents CR 10 , conditionally: when X 1 represents a nitrogen atom , X 2 and X 3 represent CR 9 and CR 10 respectively , when X 2 represents a nitrogen atom, X 1 and X 3 represent CR 8 and CR 10 respectively , and when X 3 represents a nitrogen atom, X 1 And X 2 represent CR 8 and CR 9 respectively ; and R 8 , R 9 and R 10 each independently represent hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, or substituted or Unsubstituted C 1 -C 12 alkoxy. Specific example 2:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中Q代表一氧原子,或一硫原子。 具體例3:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein Q represents an oxygen atom or a sulfur atom. Specific example 3:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R代表經取代的或未經取代的芳基、經取代的或未經取代的雜芳基,或者經取代的或未經取代的C1 -C12 烷基。 具體例4:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R represents a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, or Substituted or unsubstituted C 1 -C 12 alkyl. Specific example 4:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R代表經取代的或未經取代的C6 -C10 芳基,或者未經取代的C1 -C12 烷基。 具體例5:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R represents a substituted or unsubstituted C 6 -C 10 aryl group, or an unsubstituted C 1 -C 12 alkyl. Specific example 5:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R1 代表氫、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的芳基羰基、經取代的或未經取代的芳基氧基羰基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的芳基亞磺醯基,或者經取代的或未經取代的芳基磺醯基。 具體例6:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 1 represents hydrogen, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted Substituted C 2 -C 12 alkynyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted or unsubstituted Substituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted arylcarbonyl, substituted or unsubstituted aryloxycarbonyl, substituted or unsubstituted C 1- C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted arylsulfinyl, or substituted or unsubstituted Substituted arylsulfonyl. Specific example 6:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R1 代表氫、經取代的或未經取代的C2 -C12 烯基、未經取代的C2 -C12 炔基、未經取代的C1 -C12 烷基羰基、未經取代的C3 -C12 環烷基羰基、未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的C6 -C10 芳基羰基、未經取代的C6 -C10 芳基氧基羰基,或者未經取代的C6 -C10 芳基磺醯基。 具體例7:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 1 represents hydrogen, substituted or unsubstituted C 2 -C 12 alkenyl, unsubstituted C 2 -C 12 alkynyl, unsubstituted C 1 -C 12 alkylcarbonyl, unsubstituted C 3 -C 12 cycloalkylcarbonyl, unsubstituted C 1 -C 12 alkoxycarbonyl, substituted Or unsubstituted C 6 -C 10 arylcarbonyl, unsubstituted C 6 -C 10 aryloxycarbonyl, or unsubstituted C 6 -C 10 arylsulfonyl. Specific example 7:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R2 代表氫、鹵素,或者經取代的或未經取代的C1 -C12 烷基。 具體例8:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 2 represents hydrogen, halogen, or a substituted or unsubstituted C 1 -C 12 alkyl group. Specific example 8:

依據前述請求項中任一者的經取代的吡唑化合物或它的一鹽類,其中R2 代表氫,或者未經取代的C1 -C12 烷基。 具體例9:The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 2 represents hydrogen, or an unsubstituted C 1 -C 12 alkyl group. Specific example 9:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R3 代表經取代的或未經取代的C1 -C12 烷基。 具體例10:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 3 represents a substituted or unsubstituted C 1 -C 12 alkyl group. Specific example 10:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R4 和R5 各個獨立地代表氫、鹵素,或者經取代的或未經取代的C1 -C12 烷基。 具體例11:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 4 and R 5 each independently represent hydrogen, halogen, or substituted or unsubstituted C 1 -C 12 alkyl. Specific example 11:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R4 和R5 各個獨立地代表氫,或者未經取代的C1 -C12 烷基。 具體例12:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 4 and R 5 each independently represent hydrogen, or an unsubstituted C 1 -C 12 alkyl group. Specific example 12:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中X1 代表C-R8 ,X2 代表C-R9 ,X3 代表C-R10 ,以及R8 、R9 和R10 彼此獨立地是氫、鹵素、經取代的或未經取代的C1 -C12 烷基,或者經取代的或未經取代的C1 -C12 烷氧基。 具體例13:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein X 1 represents CR 8 , X 2 represents CR 9 , X 3 represents CR 10 , and R 8 , R 9 and R 10 Independent of each other are hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, or substituted or unsubstituted C 1 -C 12 alkoxy. Specific example 13:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中X1 代表C-R8 ,X2 代表C-R9 ,X3 代表C-R10 ,以及R8 、R9 和R10 彼此獨立地是氫、鹵素、經取代的或未經取代的C1 -C12 烷基,或者未經取代的C1 -C12 烷氧基。 具體例14:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein X 1 represents CR 8 , X 2 represents CR 9 , X 3 represents CR 10 , and R 8 , R 9 and R 10 Independent of each other are hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, or unsubstituted C 1 -C 12 alkoxy. Specific example 14:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中Q代表一氧原子。 具體例15:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein Q represents an oxygen atom. Specific example 15:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R代表經取代的或未經取代的C6 芳基。 具體例16:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R represents a substituted or unsubstituted C 6 aryl group. Specific example 16:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R1 代表氫、未經取代的C1 -C12 烷基羰基、未經取代的C3 -C12 環烷基羰基、未經取代的C1 -C12 烷氧基羰基,或者經取代的或未經取代的C 芳基羰基。 具體例17:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 1 represents hydrogen, unsubstituted C 1 -C 12 alkylcarbonyl, unsubstituted C 3 -C 12 Cycloalkylcarbonyl, unsubstituted C 1 -C 12 alkoxycarbonyl, or substituted or unsubstituted C 6 arylcarbonyl. Specific example 17:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R2 代表未經取代的C1 -C6 烷基。 具體例18:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 2 represents an unsubstituted C 1 -C 6 alkyl group. Specific example 18:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R3 代表未經取代的C1 -C6 烷基。 具體例19:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 3 represents an unsubstituted C 1 -C 6 alkyl group. Specific example 19:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中R4 和R5 各個獨立地代表氫,或者未經取代的C1 -C6 烷基。 具體例20:The substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein R 4 and R 5 each independently represent hydrogen, or an unsubstituted C 1 -C 6 alkyl group. Specific example 20:

依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類,其中X1 代表C-R8 ,X2 代表C-R9 ,X3 代表C-R10 ,以及R8 、R9 和R10 彼此獨立地是氫、鹵素、未經取代的C1 -C6 烷基,或者未經取代的C1 -C6 烷氧基。 具體例21:A substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples, wherein X 1 represents CR 8 , X 2 represents CR 9 , X 3 represents CR 10 , and R 8 , R 9 and R 10 Independent of each other is hydrogen, halogen, unsubstituted C 1 -C 6 alkyl, or unsubstituted C 1 -C 6 alkoxy. Specific example 21:

一種害蟲控制劑,其包含有依據前述具體例中任一者的經取代的吡唑化合物或它的一鹽類作為一活性成分。 具體例22:A pest control agent comprising a substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples as an active ingredient. Specific example 22:

一種使用依據前述具體例的任一者的經取代的吡唑化合物或它的一鹽類的方法,其用於控制害蟲。 具體例23:A method of using a substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples for controlling pests. Specific example 23:

一種用於控制害蟲的方法,其包含有施加依據前述具體例的任一者的經取代的吡唑化合物或它的一鹽類至一植物或它的附近,或者一植物被栽培的土壤。 具體例24:A method for controlling pests, which comprises applying a substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples to a plant or its vicinity, or a soil where a plant is cultivated. Specific example 24:

一種用於控制害蟲的方法,其包含有施加一有效量的依據前述具體例的任一者的經取代的吡唑化合物或它的一鹽類至害蟲、害蟲的一棲地,或者一預測棲息的地點。發明的有利效用 A method for controlling pests, which comprises applying an effective amount of a substituted pyrazole compound or a salt thereof according to any one of the foregoing specific examples to a pest, a pest's habitat, or a predicted habitat Location. Beneficial effect of invention

依據本揭示的一種新穎經取代的吡唑化合物或它的一鹽類達到一優異的殺蟲和殺真菌效用。此外,依據本揭示的吡唑化合物或它的一鹽類是有用的作為一新型的殺蟲劑和殺真菌劑,其展現優異的殺蟲和殺真菌效用,不僅對抗化學-敏感性真菌而且對抗化學-抗性真菌。A novel substituted pyrazole compound or a salt thereof according to the present disclosure achieves an excellent insecticidal and fungicidal effect. In addition, the pyrazole compound or a salt thereof according to the present disclosure is useful as a novel insecticide and fungicide, which exhibits excellent insecticidal and fungicidal effects, not only against chemical-sensitive fungi but also against Chemical-resistant fungus.

較佳實施例之詳細說明具體例的描述 本揭示被描述在下文中。遍及整個說明書,除非另有特別地註釋,一單數措辭應被瞭解為包含呈複數形式的概念。因此,除非另有特別地註釋,單數冠詞(例如,在英語的情況下“一(a) ”、“一(an) ”、“該(the)”和類似之物)亦應該被瞭解為包含呈複數形式的概念。進一步,除非另有特別地註釋,在此所使用的術語應該被瞭解為以在本技藝中被慣常地使用的意義而被使用。因此,除非另有定義,在此所使用的所有術語和科學技術術語具有與由那些熟習本揭示所屬技藝者所慣常地瞭解的術語相同的意義。 在一矛盾的情況下,本說明書(包括定義)優先。 1. 經取代的吡唑化合物或它的一鹽類Detailed Description of the Preferred Embodiments Description of Specific Examples This disclosure is described below. Throughout the entire specification, unless specifically noted otherwise, a singular word should be understood to include concepts in the plural. Therefore, unless otherwise noted, singular articles (for example, in the case of English "一(a)", "一(an)", "the (the)" and similar) should also be understood to include The concept in the plural. Further, unless specifically noted otherwise, the terminology used herein should be understood to be used in the meaning conventionally used in the art. Therefore, unless otherwise defined, all terms and scientific and technical terms used herein have the same meaning as those terms conventionally understood by those skilled in the art of the disclosure of the disclosure. In case of a contradiction, this specification (including definitions) takes precedence. 1. Substituted pyrazole compound or one of its salts

本揭示是針對一種由下列化學式(1)所代表的化合物:

Figure 02_image006
或它的一鹽類(在下文中有時被意指為“本揭示的化合物(1)”或“化合物(1)”), 其中R、R1 、R2 、R3 、R4 、R5 、X1 、X2 、X3 ,以及Q是如上面所定義的。This disclosure is directed to a compound represented by the following chemical formula (1):
Figure 02_image006
Or a salt thereof (sometimes hereinafter referred to as "compound (1) of the present disclosure" or "compound (1)"), wherein R, R 1 , R 2 , R 3 , R 4 , R 5 , X 1 , X 2 , X 3 , and Q are as defined above.

接著,在本說明書的術語被描述在下面。Next, the terms in this specification are described below.

在本說明書中,一由“取代的”所定義的基團的取代基的數目沒有特別地被限制若它是可取代的,並且是一個或複數的。此外,除非另有指示,當該基團是在其他基團上的一部分或一取代基時,關於各個基團的描述亦適用。In this specification, the number of substituents of a group defined by "substituted" is not particularly limited if it is substitutable, and is one or plural. In addition, unless otherwise indicated, when the group is a part or a substituent on other groups, the description about each group also applies.

“C1 -C12 烷基”意指一具有1至12個碳原子的直鏈或支鏈飽和烴基團。“C1 -C6 烷基”或“C1 -C3 烷基”分別地意指一具有1至6個或1至3個碳原子的直鏈或支鏈飽和烴基團。"C 1 -C 12 alkyl" means a linear or branched saturated hydrocarbon group having 1 to 12 carbon atoms. "C 1 -C 6 alkyl" or "C 1 -C 3 alkyl" means a linear or branched saturated hydrocarbon group having 1 to 6 or 1 to 3 carbon atoms, respectively.

“C2 -C12 烯基”意指一具有2至12個碳原子並且含有1至3個雙鍵的直鏈或支鏈不飽和烴基團。"C 2 -C 12 alkenyl" means a straight or branched chain unsaturated hydrocarbon group having 2 to 12 carbon atoms and containing 1 to 3 double bonds.

“C2 -C12 炔基”意指一具有2至12個碳原子並且含有1個三鍵的直鏈或支鏈不飽和烴基團。"C 2 -C 12 alkynyl" means a linear or branched unsaturated hydrocarbon group having 2 to 12 carbon atoms and containing 1 triple bond.

“C3 -C12 環烷基”意指一具有3至12個碳原子的環狀烷基,並且包括那些具有一部分地橋聯結構的環狀烷基。“C3 -C6 環烷基”意指一具有3至6個碳原子的環狀烷基。"C 3 -C 12 cycloalkyl" means a cyclic alkyl group having 3 to 12 carbon atoms, and includes those having a partial bridge structure. "C 3 -C 6 cycloalkyl" means a cyclic alkyl group having 3 to 6 carbon atoms.

“C1 -C12 烷氧基”意指一“C1 -C12 烷基氧基基團”,其中“C1 -C12 烷基”部分被定義與上面所描述的“C1 -C12 烷基”相同。"C 1 -C 12 alkoxy" means a "C 1 -C 12 alkyloxy group", where the "C 1 -C 12 alkyl" portion is defined as described above for "C 1 -C "12 alkyl" is the same.

“芳基”意指一單環或多環芳族烴。"Aryl" means a monocyclic or polycyclic aromatic hydrocarbon.

“C6 -C10 芳基”意指一具有6至10個碳原子的如在此所定義的芳基基團。“C6 芳基”意指一具有6個碳原子的如在此所定義的芳基基團。"C 6 -C 10 aryl" means an aryl group having 6 to 10 carbon atoms as defined herein. "C 6 aryl" means an aryl group having 6 carbon atoms as defined herein.

“雜環(heterocyclic)”意指一飽和的、不飽和的或芳族雜環基團,其具有氮、氧、磷和/或硫原子的至少一者在環中並且可以在任何可取代的位置被鍵結。“雜環”可被意指為“雜環(heterocycle)”或"雜環基(heterocyclyl) ”。"Heterocyclic" means a saturated, unsaturated or aromatic heterocyclic group having at least one of nitrogen, oxygen, phosphorus and/or sulfur atoms in the ring and may be substituted in any The location is bonded. "Heterocycle" may mean "heterocycle" or "heterocyclyl".

“雜芳基”意指一芳族雜環基團,其具有氮、氧和/或硫原子的至少一者在環中並且可以在任何可取代的位置被鍵結,其中雜芳基的環成員原子除了碳原子以外包括1、2、3或4個選自於N、O和S的雜原子。"Heteroaryl" means an aromatic heterocyclic group having at least one of nitrogen, oxygen, and/or sulfur atoms in the ring and may be bonded at any substitutable position, wherein the ring of heteroaryl The member atoms include 1, 2, 3, or 4 heteroatoms selected from N, O, and S in addition to carbon atoms.

下列顯示如在這個說明書所使用的各個基團的特別實例。The following shows specific examples of each group as used in this specification.

鹵素的實例包括,但不特別地限於,氟、氯、溴、碘,以及類似之物。Examples of halogen include, but are not particularly limited to, fluorine, chlorine, bromine, iodine, and the like.

C1 -C12 烷基的實例包括,但不特別地限於,C1 -C12 直鏈或支鏈烷基,諸如甲基、乙基、n-丙基、異丙基、n-丁基、異丁基、二級-丁基、三級-丁基、n-戊基、異戊基、新戊基、1,1-二甲基丙-1-基、n-己基、1-乙基戊基、2-乙基己基,以及類似之物。Examples of C 1 -C 12 alkyl groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkyl groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl , Isobutyl, secondary-butyl, tertiary-butyl, n-pentyl, isopentyl, neopentyl, 1,1-dimethylprop-1-yl, n-hexyl, 1-ethyl Amylpentyl, 2-ethylhexyl, and the like.

C1 -C12 鹵烷基的實例包括,但不特別地限於,被取代以1至9個、較佳地1至8個鹵素原子的C1 -C12 直鏈或支鏈烷基,諸如氟甲基、氯甲基、溴甲基、碘甲基、二氟甲基、2,2-二氟乙基、三氟甲基、2,2,2-三氟乙基、五氟乙基、3,3,3-三氟丙基、七氟異丙基、4,4,4-三氟丁基、七氟異丁基,以及類似之物。Examples of C 1 -C 12 haloalkyl groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkyl groups substituted with 1 to 9, preferably 1 to 8 halogen atoms, such as Fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, 2,2-difluoroethyl, trifluoromethyl, 2,2,2-trifluoroethyl, pentafluoroethyl , 3,3,3-trifluoropropyl, heptafluoroisopropyl, 4,4,4-trifluorobutyl, heptafluoroisobutyl, and the like.

C1 -C12 烷氧基的實例包括,但不特別地限於,C1 -C12 直鏈或支鏈烷氧基,諸如甲氧基、乙氧基、n-丙氧基、異丙氧基、n-丁氧基、異丁氧基、二級-丁氧基、三級-丁氧基、n-戊基氧基、異戊基氧基、新戊基氧基、1,1-二甲基丙-1-基氧基、n-己基氧基、1-乙基戊基氧基、2-乙基己基氧基,以及類似之物。Examples of C 1 -C 12 alkoxy groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkoxy groups, such as methoxy, ethoxy, n-propoxy, isopropoxy Group, n-butoxy, isobutoxy, secondary-butoxy, tertiary-butoxy, n-pentyloxy, isopentyloxy, neopentyloxy, 1,1- Dimethylprop-1-yloxy, n-hexyloxy, 1-ethylpentyloxy, 2-ethylhexyloxy, and the like.

C1 -C12 鹵烷氧基的實例包括,但不特別地限於,被取代以1至9個、較佳地1至8個鹵素原子的C1 -C12 直鏈或支鏈烷氧基,諸如氟甲氧基、氯甲氧基、溴甲氧基、碘甲氧基、二氟甲氧基、2,2-二氟乙氧基、三氟甲氧基、2,2,2-三氟乙氧基、五氟乙氧基、3,3,3-三氟丙氧基、七氟異丙氧基、4,4,4-三氟丁氧基、七氟異丁氧基,以及類似之物。Examples of C 1 -C 12 haloalkoxy groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkoxy groups substituted with 1 to 9, preferably 1 to 8 halogen atoms , Such as fluoromethoxy, chloromethoxy, bromomethoxy, iodomethoxy, difluoromethoxy, 2,2-difluoroethoxy, trifluoromethoxy, 2,2,2- Trifluoroethoxy, pentafluoroethoxy, 3,3,3-trifluoropropoxy, heptafluoroisopropoxy, 4,4,4-trifluorobutoxy, heptafluoroisobutoxy, And the like.

C1 -C12 烷氧基C1 -C12 烷基的實例包括,但不特別地限於,其中C1 -C12 直鏈或支鏈烷基被取代以一C1 -C12 直鏈或支鏈烷氧基的烷氧基烷基,諸如甲氧基甲基、乙氧基甲基、n-丙氧基甲基、異丙氧基甲基、n-丁氧基甲基、異丁氧基甲基、二級-丁氧基甲基、三級-丁氧基甲基、甲氧基乙基、乙氧基乙基、甲氧基-n-丙基、甲氧基-n-丁基,以及類似之物。Examples of C 1 -C 12 alkoxy C 1 -C 12 alkyl include, but are not particularly limited to, wherein C 1 -C 12 linear or branched alkyl is substituted with a C 1 -C 12 linear or Branched-chain alkoxyalkyl groups such as methoxymethyl, ethoxymethyl, n-propoxymethyl, isopropoxymethyl, n-butoxymethyl, isobutyl Oxymethyl, secondary-butoxymethyl, tertiary-butoxymethyl, methoxyethyl, ethoxyethyl, methoxy-n-propyl, methoxy-n- Butyl, and the like.

C1 -C12 鹵烷氧基C1 -C12 烷基的實例包括,但不特別地限於,被取代以1至9個、較佳地1至8個鹵素原子的直鏈或支鏈烷氧基烷基,諸如氟甲氧基甲基、氯甲氧基甲基、溴甲氧基甲基、碘甲氧基甲基、二氟甲氧基甲基、三氟甲氧基甲基、2,2,2-三氟乙氧基甲基,以及類似之物。Examples of the C 1 -C 12 haloalkoxy group C 1 -C 12 alkyl group include, but are not particularly limited to, linear or branched alkane substituted with 1 to 9, preferably 1 to 8 halogen atoms Oxyalkyl, such as fluoromethoxymethyl, chloromethoxymethyl, bromomethoxymethyl, iodomethoxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, 2,2,2-trifluoroethoxymethyl, and the like.

C3 -C12 環烷基的實例包括,但不特別地限於,環丙基、環丁基、環戊基、環己基、環庚基、環辛基,以及類似之物。Examples of C 3 -C 12 cycloalkyl include, but are not particularly limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, and the like.

C3 -C12 環烷基羰基的實例包括,但不特別地限於,環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基以及類似之物。Examples of the C 3 -C 12 cycloalkylcarbonyl group include, but are not particularly limited to, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, and the like.

C1 -C12 烷基羰基的實例包括,但不特別地限於,C1 -C12 直鏈或支鏈烷基羰基基團,諸如甲基羰基(乙醯基)、乙基羰基(丙醯基)、n-丙基羰基(丁醯基)、異丙基羰基(異丁醯基)、n-丁基羰基(戊醯基)、異丁基羰基(異戊醯基)、二級-丁基羰基、三級-丁基羰基、n-戊基羰基、異戊基羰基、新戊基羰基、(1,1-二甲基丙-1-基)羰基、(1-乙基戊基)羰基、(2-乙基己基)羰基,以及類似之物。Examples of C 1 -C 12 alkylcarbonyl groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkylcarbonyl groups, such as methylcarbonyl (acetyl), ethylcarbonyl (propyl) ), n-propylcarbonyl (butylamide), isopropylcarbonyl (isobutylamide), n-butylcarbonyl (pentylamide), isobutylcarbonyl (isopentylamide), secondary-butylcarbonyl, Tertiary-butylcarbonyl, n-pentylcarbonyl, isopentylcarbonyl, neopentylcarbonyl, (1,1-dimethylprop-1-yl)carbonyl, (1-ethylpentyl)carbonyl, ( 2-ethylhexyl)carbonyl, and the like.

C1 -C12 鹵烷基羰基的實例包括,但不特別地限於,被取代以1至9個、較佳地1至5個鹵素原子的C1 -C12 直鏈或支鏈烷基羰基,諸如氟甲基羰基、氯甲基羰基、溴甲基羰基、碘甲基羰基、二氯甲基羰基、三氯甲基羰基、二氟甲基羰基、三氟甲基羰基、氯二氟甲基羰基、溴二氟甲基羰基、二氯氟甲基羰基、2,2,2-三氯乙基羰基、2,2,2-三氟乙基羰基、五氟乙基羰基,以及類似之物。Examples of C 1 -C 12 haloalkylcarbonyl groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkylcarbonyl groups substituted with 1 to 9, preferably 1 to 5 halogen atoms , Such as fluoromethylcarbonyl, chloromethylcarbonyl, bromomethylcarbonyl, iodomethylcarbonyl, dichloromethylcarbonyl, trichloromethylcarbonyl, difluoromethylcarbonyl, trifluoromethylcarbonyl, chlorodifluoromethyl Carbonyl, bromodifluoromethylcarbonyl, dichlorofluoromethylcarbonyl, 2,2,2-trichloroethylcarbonyl, 2,2,2-trifluoroethylcarbonyl, pentafluoroethylcarbonyl, and the like Thing.

C1 -C12 烷氧基羰基的實例包括,但不特別地限於,C1 -C12 直鏈或支鏈烷氧基羰基,諸如甲氧基羰基、乙氧基羰基、n-丙氧基羰基、異丙氧基羰基、n-丁氧基羰基、異丁氧基羰基、二級-丁氧基羰基、三級-丁氧基羰基、n-戊基氧基羰基、異戊基氧基羰基、新戊基氧基羰基、(1,1-二甲基丙-1-基氧基)羰基、n-己基氧基羰基、(1-乙基戊基氧基)羰基、(2-乙基己基氧基)羰基,以及類似之物。Examples of C 1 -C 12 alkoxycarbonyl groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkoxycarbonyl groups, such as methoxycarbonyl, ethoxycarbonyl, n-propoxy Carbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, secondary-butoxycarbonyl, tertiary-butoxycarbonyl, n-pentyloxycarbonyl, isopentyloxy Carbonyl, neopentyloxycarbonyl, (1,1-dimethylprop-1-yloxy)carbonyl, n-hexyloxycarbonyl, (1-ethylpentyloxy)carbonyl, (2-ethyl Hexyloxy)carbonyl, and the like.

C1 -C12 鹵烷氧基羰基的實例包括,但不特別地限於,被取代以1至9個、較佳地1至5個鹵素原子的C1 -C12 直鏈或支鏈烷氧基羰基,諸如氟甲氧基羰基、氯甲氧基羰基、溴甲氧基羰基、碘甲氧基羰基、二氯甲氧基羰基、三氯甲氧基羰基、二氟甲氧基羰基、三氟甲氧基羰基、2,2,2-三氟乙氧基甲基、五氟乙氧基羰基、3,3,3-三氟丙氧基羰基、4,4,4-三氟丁氧基羰基、七氟異丙氧基羰基,以及類似之物。Examples of C 1 -C 12 haloalkoxycarbonyl groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkoxy groups substituted with 1 to 9, preferably 1 to 5 halogen atoms Carbonyl, such as fluoromethoxycarbonyl, chloromethoxycarbonyl, bromomethoxycarbonyl, iodomethoxycarbonyl, dichloromethoxycarbonyl, trichloromethoxycarbonyl, difluoromethoxycarbonyl, tri Fluoromethoxycarbonyl, 2,2,2-trifluoroethoxymethyl, pentafluoroethoxycarbonyl, 3,3,3-trifluoropropoxycarbonyl, 4,4,4-trifluorobutoxy Carbonyl, heptafluoroisopropoxycarbonyl, and the like.

C1 -C12 氰基烷基的實例包括,但不特別地限於,被取代以一氰基基團的C1 -C12 直鏈或支鏈烷基,諸如氰基甲基、氰基乙基、氰基-n-丙基、氰基-異丙基、氰基-n-丁基、氰基-異丁基、氰基-二級-丁基、氰基-三級-丁基、氰基-n-己基,以及類似之物。Examples of C 1 -C 12 cyanoalkyl include, but are not particularly limited to, C 1 -C 12 linear or branched alkyl substituted with a cyano group, such as cyanomethyl, cyanoethyl Group, cyano-n-propyl, cyano-isopropyl, cyano-n-butyl, cyano-isobutyl, cyano-secondary-butyl, cyano-tertiary-butyl, Cyano-n-hexyl, and the like.

C1 -C12 氰基烷氧基的實例包括,但不特別地限於,被取代以一氰基基團的C1 -C12 直鏈或支鏈烷氧基,諸如氰基甲氧基、氰基乙氧基、氰基-n-丙氧基、氰基-異丙氧基、氰基-n-丁氧基、氰基-異-丁氧基、氰基-二級-丁氧基、氰基-三級-丁氧基、氰基-己基氧基,以及類似之物。Examples of C 1 -C 12 cyanoalkoxy include, but are not particularly limited to, C 1 -C 12 linear or branched alkoxy substituted with a cyano group, such as cyanomethoxy, Cyanoethoxy, cyano-n-propoxy, cyano-isopropoxy, cyano-n-butoxy, cyano-iso-butoxy, cyano-secondary-butoxy , Cyano-tertiary-butoxy, cyano-hexyloxy, and the like.

C2 -C12 烯基的實例包括,但不特別地限於,乙烯基、丙烯基、2-丁烯基、3-丁烯基、1-甲基丙烯基,以及類似之物。Examples of C 2 -C 12 alkenyl groups include, but are not particularly limited to, vinyl, propenyl, 2-butenyl, 3-butenyl, 1-methylpropenyl, and the like.

C2 -C12 鹵烯基的實例包括,但不特別地限於,2,2-二氯乙烯基、2,2-二溴乙烯基、2,2-二氟乙烯基、3,3-二氟-2-丙烯基、4,4-二氟-3-丁烯基、4,4,4-三氟-2-丁烯基,以及類似之物。Examples of C 2 -C 12 haloalkenyl groups include, but are not particularly limited to, 2,2-dichlorovinyl, 2,2-dibromovinyl, 2,2-difluorovinyl, 3,3-di Fluoro-2-propenyl, 4,4-difluoro-3-butenyl, 4,4,4-trifluoro-2-butenyl, and the like.

C2 -C12 炔基的實例包括,但不特別地限於,乙炔基、2-丙炔基(炔丙基)、1-甲基-2-丙炔基、1-丁炔基、2-丁炔基、3-丁炔基,以及類似之物。Examples of C 2 -C 12 alkynyl groups include, but are not particularly limited to, ethynyl, 2-propynyl (propargyl), 1-methyl-2-propynyl, 1-butynyl, 2- Butynyl, 3-butynyl, and the like.

C2 -C12 鹵炔基的實例包括,但不特別地限於,氟乙炔基、溴乙炔基、氯乙炔基、碘乙炔基、3,3,3-三氟-1-丙炔基,以及類似之物。Examples of C 2 -C 12 haloalkynyl groups include, but are not particularly limited to, fluoroethynyl, bromoethynyl, chloroethynyl, iodoethynyl, 3,3,3-trifluoro-1-propynyl, and Something similar.

C1 -C12 烷基亞磺醯基的實例包括,但不特別地限於,C1 -C12 直鏈或支鏈烷基亞磺醯基, 諸如甲基亞磺醯基、乙基亞磺醯基、n-丙基亞磺醯基、異丙基亞磺醯基、n-丁基亞磺醯基、異丁基亞磺醯基、二級-丁基亞磺醯基、三級-丁基亞磺醯基,以及類似之物。Examples of C 1 -C 12 alkylsulfinyl groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkyl sulfinyl groups, such as methylsulfinyl, ethylsulfinyl Acyl, n-propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, second-butylsulfinyl, tertiary- Butylsulfinyl, and the like.

C1 -C12 鹵烷基亞磺醯基的實例包括,但不特別地限於,被取代以1至9個、較佳地1至5個鹵素原子的C1 -C12 直鏈或支鏈烷基亞磺醯基,諸如氟甲基亞磺醯基、氯甲基亞磺醯基、溴甲基亞磺醯基、碘甲基亞磺醯基、二氯甲基亞磺醯基、三氯甲基亞磺醯基、二氟甲基亞磺醯基、 三氟甲基亞磺醯基、氯二氟甲基亞磺醯基、溴二氟甲基亞磺醯基、二氯氟甲基亞磺醯基、2,2,2-三氯乙基亞磺醯基、2,2,2-三氟乙基亞磺醯基、五氟乙基亞磺醯基,以及類似之物。Examples of the C 1 -C 12 haloalkylsulfinyl group include, but are not particularly limited to, C 1 -C 12 linear or branched chains substituted with 1 to 9, preferably 1 to 5 halogen atoms Alkylsulfinyl, such as fluoromethylsulfinyl, chloromethylsulfinyl, bromomethylsulfinyl, iodomethylsulfinyl, dichloromethylsulfinyl, tris Chloromethylsulfinyl, difluoromethylsulfinyl, trifluoromethylsulfinyl, chlorodifluoromethylsulfinyl, bromodifluoromethylsulfinyl, dichlorofluoromethane Sulfenyl, 2,2,2-trichloroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, pentafluoroethylsulfinyl, and the like.

C1 -C12 烷基磺醯基的實例包括,但不特別地限於,C1 -C12 直鏈或支鏈烷基磺醯基基團,諸如甲基磺醯基、乙基磺醯基、n-丙基磺醯基、異丙基磺醯基、n-丁基磺醯基、異丁基磺醯基、二級-丁基磺醯基、三級-丁基磺醯基,以及類似之物。Examples of C 1 -C 12 alkylsulfonyl groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkylsulfonyl groups, such as methylsulfonyl, ethylsulfonyl , N-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, secondary-butylsulfonyl, tertiary-butylsulfonyl, and Something similar.

C1 -C12 鹵烷基磺醯基的實例包括,但不特別地限於,被取代以1至9個、較佳地1至5個鹵素原子的C1 -C12 直鏈或支鏈烷基磺醯基,諸如氟甲基磺醯基、氯甲基磺醯基、溴甲基磺醯基、碘甲基磺醯基、二氯甲基磺醯基、三氯甲基磺醯基、二氟甲基磺醯基、三氟甲基磺醯基、氯二氟甲基磺醯基、溴二氟甲基磺醯基、二氯氟甲基磺醯基、2,2,2-三氯乙基磺醯基、2,2,2-三氟乙基磺醯基、五氟乙基磺醯基,以及類似之物。Examples of the C 1 -C 12 haloalkylsulfonyl group include, but are not particularly limited to, C 1 -C 12 linear or branched alkane substituted with 1 to 9, preferably 1 to 5 halogen atoms Sulfosulfonyl, such as fluoromethylsulfonyl, chloromethylsulfonyl, bromomethylsulfonyl, iodomethylsulfonyl, dichloromethylsulfonyl, trichloromethylsulfonyl, Difluoromethylsulfonyl, trifluoromethylsulfonyl, chlorodifluoromethylsulfonyl, bromodifluoromethylsulfonyl, dichlorofluoromethylsulfonyl, 2,2,2-tris Chloroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, pentafluoroethylsulfonyl, and the like.

C1 -C12 烷基硫基的實例包括,但不特別地限於,C1 -C12 直鏈或支鏈烷基硫基、 諸如甲基硫基、乙基硫基、n-丙基硫基、異丙基硫基、n-丁基硫基、異丁基硫基、二級-丁基硫基、三級-丁基硫基,以及類似之物。Examples of C 1 -C 12 alkylthio groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkylthio groups, such as methylthio, ethylthio, n-propylthio Group, isopropylsulfanyl group, n-butylsulfanyl group, isobutylsulfanyl group, secondary-butylsulfanyl group, tertiary-butylsulfanyl group, and the like.

C1 -C12 鹵烷基硫基的實例包括,但不特別地限於,被取代以1至9個、較佳地1至5個鹵素原子的C1 -C12 直鏈或支鏈烷基硫基,諸如氟甲基硫基、氯甲基硫基、溴甲基硫基、碘甲基硫基、二氯甲基硫基、三氯甲基硫基、二氟甲基硫基、三氟甲基硫基、氯二氟甲基硫基、溴二氟甲基硫基、二氯氟甲基硫基、2,2,2-三氯乙基硫基、2,2,2-三氟乙基硫基、五氟乙基硫基,以及類似之物。Examples of C 1 -C 12 haloalkylthio groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkyl groups substituted with 1 to 9, preferably 1 to 5 halogen atoms Thio, such as fluoromethylthio, chloromethylthio, bromomethylthio, iodomethylthio, dichloromethylthio, trichloromethylthio, difluoromethylthio, tri Fluoromethylthio, chlorodifluoromethylthio, bromodifluoromethylthio, dichlorofluoromethylthio, 2,2,2-trichloroethylthio, 2,2,2-tri Fluoroethylthio, pentafluoroethylthio, and the like.

C2 -C12 烯基氧基的實例包括,但不特別地限於,乙烯基氧基、1-丙烯基氧基、異丙烯基氧基、丙烯基氧基、2-丁烯基氧基、3-丁烯基氧基、1-甲基丙烯基氧基,以及類似之物。Examples of C 2 -C 12 alkenyloxy include, but are not particularly limited to, vinyloxy, 1-propenyloxy, isopropenyloxy, propenyloxy, 2-butenyloxy, 3-butenyloxy, 1-methylpropenyloxy, and the like.

C2 -C12 鹵烯基氧基的實例包括,但不特別地限於,2,2-二氯乙烯基氧基、2,2-二溴乙烯基氧基、2,2-二氟乙烯基氧基、3,3-二氟-2-丙烯基氧基、4,4-二氟-3-丁烯基氧基、4,4,4-三氟-2-丁烯基氧基,以及類似之物。Examples of C 2 -C 12 haloalkenyloxy include, but are not particularly limited to, 2,2-dichlorovinyloxy, 2,2-dibromovinyloxy, 2,2-difluorovinyl Oxy, 3,3-difluoro-2-propenyloxy, 4,4-difluoro-3-butenyloxy, 4,4,4-trifluoro-2-butenyloxy, and Something similar.

C2 -C12 炔基氧基的實例包括,但不特別地限於,乙炔基氧基、2-丙炔基氧基、1-甲基-2-丙炔基氧基、1,1-二甲基-2-丙炔基氧基、1-丁炔基氧基、2-丁炔基氧基、3-丁炔基氧基,以及類似之物。Examples of C 2 -C 12 alkynyloxy include, but are not particularly limited to, ethynyloxy, 2-propynyloxy, 1-methyl-2-propynyloxy, 1,1-di Methyl-2-propynyloxy, 1-butynyloxy, 2-butynyloxy, 3-butynyloxy, and the like.

C2 -C12 鹵炔基氧基的實例包括,但不特別地限於,氟乙炔基氧基、溴乙炔基氧基、氯乙炔基氧基、碘乙炔基氧基、3,3,3-三氟-1-丙炔基氧基,以及類似之物。Examples of C 2 -C 12 haloalkynyloxy include, but are not particularly limited to, fluoroethynyloxy, bromoethynyloxy, chloroethynyloxy, iodoethynyloxy, 3,3,3- Trifluoro-1-propynyloxy, and the like.

C1 -C12 烷基磺醯基氧基的實例包括,但不特別地限於,C1 -C12 直鏈或支鏈烷基磺醯基基團,諸如甲基磺醯基氧基、乙基磺醯基氧基、n-丙基磺醯基氧基、異丙基磺醯基氧基、n-丁基磺醯基氧基、異丁基磺醯基氧基、二級-丁基磺醯基氧基、三級-丁基磺醯基氧基,以及類似之物。Examples of C 1 -C 12 alkylsulfonyloxy groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkylsulfonyl groups, such as methylsulfonyloxy, ethyl Sulfonyloxy, n-propylsulfonyloxy, isopropylsulfonyloxy, n-butylsulfonyloxy, isobutylsulfonyloxy, secondary-butyl Sulfonyloxy, tertiary-butylsulfonyloxy, and the like.

C1 -C12 烷基亞磺醯基氧基的實例包括,但不特別地限於,C1 -C12 直鏈或支鏈烷基亞磺醯基氧基基團,諸如甲基亞磺醯基氧基、乙基亞磺醯基氧基、n-丙基亞磺醯基氧基、異丙基亞磺醯基氧基、n-丁基亞磺醯基氧基、異丁基亞磺醯基氧基、二級-丁基亞磺醯基氧基、三級-丁基亞磺醯基氧基,以及類似之物。Examples of C 1 -C 12 alkylsulfinyloxy groups include, but are not particularly limited to, C 1 -C 12 linear or branched alkylsulfinyloxy groups, such as methylsulfinyloxy Yloxy, ethylsulfinyloxy, n-propylsulfinyloxy, isopropylsulfinyloxy, n-butylsulfinyloxy, isobutylsulfinyl Acyloxy, secondary-butylsulfinyloxy, tertiary-butylsulfinyloxy, and the like.

經取代的或未經取代的胺基的實例包括,但不特別地限於,胺基、單烷基胺基、二烷基胺基、單醯基胺基,以及類似之物。烷基的實例包括上面所提到的C1 -C12 烷基,以及類似之物。醯基的實例包括上面所提到的C1 -C12 烷氧基羰基、鹵烷氧基羰基、芳基羰基,以及類似之物。Examples of substituted or unsubstituted amine groups include, but are not particularly limited to, amine groups, monoalkylamine groups, dialkylamine groups, monoacylamino groups, and the like. Examples of the alkyl group include the C 1 -C 12 alkyl group mentioned above, and the like. Examples of the acyl group include the above-mentioned C 1 -C 12 alkoxycarbonyl group, haloalkoxycarbonyl group, arylcarbonyl group, and the like.

芳基的實例包括,但不特別地限於,苯基、1-萘基、2-萘基,以及類似之物。Examples of aryl groups include, but are not particularly limited to, phenyl, 1-naphthyl, 2-naphthyl, and the like.

芳基C1 -C12 烷基的實例包括,但不特別地限於,苄基、苯基乙基、苯基-n-丙基以及類似之物。這些芳基C1 -C12 烷基可進一步在烷基部分或芳基部分或這兩者而被取代。Examples of aryl C 1 -C 12 alkyl groups include, but are not particularly limited to, benzyl, phenylethyl, phenyl-n-propyl, and the like. These aryl C 1 -C 12 alkyl groups may be further substituted in the alkyl portion or the aryl portion or both.

芳基氧基的實例包括,但不特別地限於,苯氧基、1-萘基氧基、2-萘基氧基,以及類似之物。Examples of aryloxy groups include, but are not particularly limited to, phenoxy, 1-naphthyloxy, 2-naphthyloxy, and the like.

芳基C1 -C12 烷氧基的實例包括,但不特別地限於,苄基氧基、苯基乙氧基、苯基-n-丙氧基、苯基-n-丁氧基、1-萘基甲氧基、2-萘基甲氧基,以及類似之物。Examples of aryl C 1 -C 12 alkoxy groups include, but are not particularly limited to, benzyloxy, phenylethoxy, phenyl-n-propoxy, phenyl-n-butoxy, 1 -Naphthylmethoxy, 2-naphthylmethoxy, and the like.

雜芳基氧基的實例包括,但不特別地限於,吡啶基氧基(pyridinyloxy)、嘧啶基氧基(pyrimidinyloxy)、吡唑基氧基(pyrazolyloxy),以及類似之物。Examples of heteroaryloxy groups include, but are not particularly limited to, pyridinyloxy, pyrimidinyloxy, pyrazolyloxy, and the like.

雜芳基C1 -C12 烷氧基的實例包括,但不特別地限於,吡啶基甲氧基、吡啶基乙氧基、嘧啶基乙氧基、吡唑基甲氧基,以及類似之物。Examples of heteroaryl C 1 -C 12 alkoxy groups include, but are not particularly limited to, pyridyl methoxy, pyridyl ethoxy, pyrimidinyl ethoxy, pyrazolyl methoxy, and the like .

芳基磺醯基的實例包括,但不特別地限於,苯基磺醯基、1-萘基磺醯基、2-萘基磺醯基,以及類似之物。Examples of arylsulfonyl include, but are not particularly limited to, phenylsulfonyl, 1-naphthylsulfonyl, 2-naphthylsulfonyl, and the like.

芳基亞磺醯基的實例包括,但不特別地限於,苯基亞磺醯基、1-萘基亞磺醯基、2-萘基亞磺醯基,以及類似之物。Examples of arylsulfinyl include, but are not particularly limited to, phenylsulfinyl, 1-naphthylsulfinyl, 2-naphthylsulfinyl, and the like.

雜芳基的實例包括,但不特別地限於,噻吩基(thienyl)、呋喃基(furyl)、吡咯基(pyrrolyl),㗁唑基(oxazolyl)、異㗁唑基(isoxazolyl)、噻唑基(thiazolyl)、異噻唑基(isothiazolyl)、吡唑基(pyrazolyl)、咪唑基(imidazolyl)、㗁二唑基(oxadiazolyl)、噻二唑基(thiadiazolyl)、三唑基(triazolyl)、四唑基(tetrazolyl)、吡啶基(pyridyl)、嗒嗪基(pyridazinyl)、嘧啶基(pyrimidinyl)、吡嗪基(pyrazinyl)、三嗪基(triazinyl)、四嗪基(tetrazinyl)、吲哚基(indolyl)、異吲哚基(isoindolyl)、吲唑基(indazolyl)、喹唑啉基(quinazolinyl)、咔唑基(carbazolyl)、苯并㗁唑基(benzoxazolyl)、苯并異㗁唑基(benzisoxazolyl)、苯并噻唑基(benzothiazolyl)、苯并異噻唑基(benzisothiazolyl)、苯并咪唑基(benzimidazolyl)、喹啉基(quinolinyl)、異喹啉基(isoquinolinyl)、吡啶並吲哚(pyridoindolyl)、噌啉基(cinnolinyl)、呔嗪基(phthalazinyl)、喹㗁啉基(quinoxalinyl)、嘌呤基(purinyl)、啡噻嗪基呋喃基(phenothiazinylfuranyl)、苯并呋喃基(benzofuranyl)、苯并二氫吡喃基(chromanyl)、苯并噻吩基(benzothienyl),以及類似之物。Examples of heteroaryl groups include, but are not particularly limited to, thienyl, furyl, pyrrolyl, oxazolyl, isoxazolyl, thiazolyl ), isothiazolyl, isoazolazolyl, pyrazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, triazolyl, tetrazolyl ), pyridyl (pyridyl), pyridazinyl (pyridazinyl), pyrimidinyl (pyrimidinyl), pyrazinyl (pyrazinyl), triazinyl (triazinyl), tetrazinyl (tetrazinyl), indolyl (indolyl), iso Isoindolyl, indazolyl, quinazolinyl, carbazolyl, benzoxazolyl, benzisoxazolyl, benzoxazolyl Benzothiazolyl, benzisothiazolyl, benzimidazolyl, quinolinyl, quinolinyl, isoquinolinyl, pyridoindolyl, cinnoline (pyridoindolyl) cinnolinyl), phthalazinyl, quinoxalinyl, purinyl, purinyl, phenothiazinylfuranyl, benzofuranyl, benzofuranyl ( chromanyl), benzothienyl, and the like.

上面所提到的所有芳基和雜芳基可選擇性地進一步被取代。取代基的數目的實例包括,但不特別地限於,1至20個(較佳地1至10個,以及更佳地1至5個)。All the aryl and heteroaryl groups mentioned above can be optionally further substituted. Examples of the number of substituents include, but are not particularly limited to, 1 to 20 (preferably 1 to 10, and more preferably 1 to 5).

一雜環基團的實例包括,但不特別地限於,噻吩基、呋喃基、四氫呋喃基、二氧戊環基(dioxolanyl)、二㗁烷基(dioxanyl)、吡咯基、吡咯啉基(pyrrolinyl)、吡咯啶基(pyrrolidinyl)、㗁唑基、異㗁唑基、㗁唑啉基(oxazolinyl)、㗁唑啶基(oxazolidinyl)、異㗁唑啉基(isoxazolinyl)、噻唑基、異噻唑基、噻唑啉基(thiazolinyl)、噻唑啶基(thiazolidinyl)、異噻唑啉基(isothiazolinyl)、吡唑基、吡唑啶基(pyrazolidinyl)、咪唑基、咪唑啉基(imidazolinyl)、咪唑啶基(imidazolidinyl)、㗁二唑基、㗁二唑啉基(oxadiazolinyl)、噻二唑啉基(thiadiazolinyl)、三唑基、三唑啉基(triazolinyl)、三唑啶基(triazolidinyl)、四唑基、四唑啉基(tetrazolinyl)、吡啶基、二氫吡啶基(dihydropyridyl)、四氫吡啶基(tetrahydropyridyl)、哌啶基(piperidyl)、㗁嗪基(oxazinyl)、二氫㗁嗪基(dihydroxazinyl)、嗎福林並(morpholino)、噻嗪基(thiazinyl)、二氫噻嗪基(dihydrothiazinyl)、(thiamorpholino)、嗒嗪基、二氫嗒嗪基(dihydropyridazinyl)、四氫嗒嗪基(tetrahydropyridazinyl)、六氫嗒嗪基(hexahydropyridazinyl)、㗁二嗪基(oxadiazinyl)、二氫㗁二嗪基(dihydrooxadiazinyl)、四氫㗁二嗪基(tetrahydrooxadiazinyl)、噻二唑基、噻二嗪基(thiadiazinyl)、二氫噻二嗪基(dihydrothiadiazinyl)、四氫噻二嗪基(tetrahydrothiadiazinyl)、嘧啶基、二氫嘧啶基、四氫嘧啶基、六氫嘧啶基、吡嗪基(pyrazinyl)、二氫吡嗪基(dihydropyrazinyl)、四氫吡嗪基(tetrahydropyrazinyl)、哌嗪基(piperazinyl)、三嗪基、二氫三嗪基(dihydrotriazinyl)、四氫三嗪基(tetrahydrotriazinyl)、六氫三嗪基(hexahydrotriazinyl)、四嗪基、二氫四嗪基(dihydrotetrazinyl)、吲哚基、吲哚啉基(indolinyl)、異吲哚基、吲唑基、喹唑啉基、二氫喹唑啉基(dihydroquinazolyl)、四氫喹唑啉基(tetrahydroquinazolyl)、咔唑基、苯并㗁唑基、苯并㗁唑啉基(benzoxazolinyl)、苯并異㗁唑基、苯并異㗁唑啉基(benzisoxazolinyl)、苯并噻唑基、苯并異噻唑基、苯并異噻唑啉基(benzisothiazolinyl)、苯并咪唑基、吲唑啉基(indazolinyl)、喹啉基、二氫喹啉基(dihydroquinolinyl)、四氫喹啉基(tetrahydroquinolinyl)、異喹啉基、二氫異喹啉基(dihydroisoquinolinyl)、四氫異喹啉基(tetrahydroisoquinolinyl)、吡啶並吲哚基、二氫苯并㗁嗪基(dihydrobenzoxazinyl)、噌啉基、二氫噌啉基(dihydrocinnolinyl)、四氫噌啉基(tetrahydrocinnolinyl)、呔嗪基(phthalazinyl)、二氫呔嗪基(dihydrophthalazinyl)、四氫呔嗪基(tetrahydrophthalazinyl)、喹㗁啉基、二氫喹㗁啉基(dihydroquinoxalinyl)、四氫喹㗁啉基(tetrahydroquinoxalinyl)、嘌呤基、二氫苯并三嗪基(dihydrobenzotriazinyl)、二氫苯并四嗪基(dihydrobenzotetrazinyl)、啡噻嗪基呋喃基、苯并呋喃基、苯并二氫吡喃基、苯并噻吩基,以及類似之物。Examples of a heterocyclic group include, but are not particularly limited to, thienyl, furyl, tetrahydrofuranyl, dioxolanyl, dioxanyl, pyrrolyl, pyrrolinyl , Pyrrolidinyl, pyrazolidinyl, isoazolidinyl, oxazolinyl, oxazolidinyl, isoxazolinyl, thiazolyl, isothiazolyl, thiazole Thiazolinyl, thiazolidinyl, isothiazolinyl, pyrazolyl, pyrazolidinyl, imidazolyl, imidazolinyl, imidazolidinyl, Oxadiazolinyl, oxadiazolinyl, thiadiazolinyl, triazolyl, triazolinyl, triazolidinyl, tetrazolyl, tetrazolyl Tetrazolinyl, pyridyl, dihydropyridyl, tetrahydropyridyl, tetrahydropyridyl, piperidyl, oxazinyl, dihydroxazinyl, morpholin Morpholino, thiazinyl, dihydrothiazinyl, (thiamorpholino), thiazinyl, dihydropyridazinyl, dihydropyridazinyl, tetrahydropyridazinyl, hexahydropyridazinyl Hexahydropyridazinyl, oxadiazinyl, oxadiazinyl, dihydrooxadiazinyl, tetrahydrooxadiazinyl, thiadiazinyl, thiadiazinyl, thiadiazinyl, dihydrothiadiazinyl Dihydrothiadiazinyl, tetrahydrothiadiazinyl, pyrimidinyl, dihydropyrimidinyl, tetrahydropyrimidinyl, hexahydropyrimidinyl, pyrazinyl, dihydropyrazinyl , Tetrahydropyrazinyl (tetrahydropyrazinyl), piperazinyl (piperazinyl), triazinyl, dihydrotriazinyl (dihydrotriazinyl), tetrahydrotriazinyl (tetrahydrotriazinyl) , Hexahydrotriazinyl, tetrazinyl, dihydrotetrazinyl, indolyl, indolinyl, isoindolyl, indazolyl, quinazolinyl, di Dihydroquinazolyl, tetrahydroquinazolyl, carbazolyl, benzoxazolyl, benzoxazolinyl, benzoxazolinyl, benzoisoazolyl, benzoisoazolyl Benzisoxazolinyl, benzthiazolyl, benzisothiazolyl, benzisothiazolinyl, benzimidazolyl, indazolinyl, quinolinyl, dihydroquinolinyl (dihydroquinolinyl), tetrahydroquinolinyl, isoquinolinyl, dihydroisoquinolinyl, tetrahydroisoquinolinyl, tetrahydroisoquinolinyl, pyridoindolyl, dihydrobenzoxazine (Dihydrobenzoxazinyl), cinnoline, dihydrocinnolinyl, tetrahydrocinnolinyl, tetrahydrocinnolinyl, phthalazinyl, dihydrophthalazinyl, tetrahydrophthalazinyl ), quinoline group, dihydroquinoxalinyl group, dihydroquinoxalinyl group, tetrahydroquinoxalinyl group, purine group, dihydrobenzotriazinyl group, dihydrobenzotriazinyl group, dihydrobenzotetrazinyl group ), phenothiazinylfuranyl, benzofuranyl, chromanyl, benzothienyl, and the like.

這些雜環基團包括在任何可取代的位置被取代以一側氧基(oxo)或硫酮基團(thioketone group)的那些。These heterocyclic groups include those substituted with a pendant oxo or thioketone group at any substitutable position.

上面所提到的所有雜環可選擇性地進一步被取代。取代基的數目的實例包括,但不特別地限於,1至20個(較佳地1至10個,以及更佳地1至5個)。All the heterocycles mentioned above can be optionally further substituted. Examples of the number of substituents include, but are not particularly limited to, 1 to 20 (preferably 1 to 10, and more preferably 1 to 5).

呈“取代的”的一取代基或取代基的實例包括:但不特別地限於,鹵素、硝基、氰基、羥基、甲醯基、C1 -C12 烷基、C1 -C12 鹵烷基、C1 -C12 烷氧基、C1 -C12 鹵烷氧基、C1 -C12 烷氧基C1 -C12 烷基、C1 -C12 鹵烷氧基C1 -C12 烷基、C3 -C12 環烷基、C3 -C12 環烷基C1 -C12 烷基、C1 -C12 烷基羰基、C1 -C12 鹵烷基羰基、芳基羰基、芳基氧基羰基、C1 -C12 烷氧基羰基、C1 -C12 鹵烷氧基羰基、C1 -C12 氰基烷基、C1 -C12 氰基烷氧基、C2 -C12 烯基、C2 -C12 鹵烯基、C2 -C12 炔基、C2 -C12 鹵炔基、C1 -C12 烷基磺醯基、C1 -C12 鹵烷基磺醯基、C1 -C12 烷基亞磺醯基、C1 -C12 鹵烷基亞磺醯基、C1 -C12 烷基硫基、C1 -C12 鹵烷基硫基、C3 -C12 環烷基磺醯基、C3 -C12 環烷基亞磺醯基、C3 -C12 環烷基硫基、C3 -C122 環烷基C1 -C12 烷基磺醯基、C3 -C12 環烷基C1 -C12 烷基亞磺醯基、C3 -C12 環烷基C1 -C12 烷基硫基、C1 -C12 烷氧基C1 -C12 烷基磺醯基、C1 -C12 烷氧基C1 -C12 烷基亞磺醯基、C1 -C12 烷氧基C1 -C12 烷基硫基、C2 -C12 烯基氧基、C2 -C12 鹵烯基氧基、C2 -C12 炔基氧基、C2 -C12 鹵炔基氧基、C1 -C12 烷基磺醯基氧基、C1 -C12 鹵烷基磺醯基氧基、C1 -C12 烷基亞磺醯基氧基、C1 -C12 鹵烷基亞磺醯基氧基、OCN、SCN、SF5 、經取代的或未經取代的胺基、芳基、芳基C1 -C12 烷基、芳基氧基、芳基C1 -C12 烷氧基、芳基磺醯基、芳基亞磺醯基、芳基硫基、芳基C1 -C12 烷基磺醯基、芳基C1 -C12 烷基亞磺醯基、芳基C1 -C12 烷基硫基、雜環、雜環C1 -C12 烷基、雜環氧基,以及類似之物。Examples of a substituent or substituents that are "substituted" include, but are not particularly limited to, halogen, nitro, cyano, hydroxy, formyl, C 1 -C 12 alkyl, C 1 -C 12 halo Alkyl, C 1 -C 12 alkoxy, C 1 -C 12 haloalkoxy, C 1 -C 12 alkoxy C 1 -C 12 alkyl, C 1 -C 12 haloalkoxy C 1- C 12 alkyl, C 3 -C 12 cycloalkyl, C 3 -C 12 cycloalkyl C 1 -C 12 alkyl, C 1 -C 12 alkylcarbonyl, C 1 -C 12 haloalkylcarbonyl, aromatic Carbonyl, aryloxycarbonyl, C 1 -C 12 alkoxycarbonyl, C 1 -C 12 haloalkoxycarbonyl, C 1 -C 12 cyanoalkyl, C 1 -C 12 cyanoalkoxy , C 2 -C 12 alkenyl, C 2 -C 12 haloalkenyl, C 2 -C 12 alkynyl, C 2 -C 12 haloalkynyl, C 1 -C 12 alkylsulfonyl, C 1 -C 12 haloalkylsulfonyl, C 1 -C 12 alkylsulfinyl, C 1 -C 12 haloalkylsulfinyl, C 1 -C 12 alkylthio, C 1 -C 12 halo Thio, C 3 -C 12 cycloalkylsulfonyl, C 3 -C 12 cycloalkylsulfinyl, C 3 -C 12 cycloalkylsulfanyl, C 3 -C 122 cycloalkyl C 1 -C 12 alkylsulfonyl, C 3 -C 12 cycloalkyl C 1 -C 12 alkylsulfinyl, C 3 -C 12 cycloalkyl C 1 -C 12 alkylthio, C 1- C 12 alkoxy C 1 -C 12 alkylsulfonyl, C 1 -C 12 alkoxy C 1 -C 12 alkylsulfinyl, C 1 -C 12 alkoxy C 1 -C 12 alkyl Thio, C 2 -C 12 alkenyloxy, C 2 -C 12 haloalkenyloxy, C 2 -C 12 alkynyloxy, C 2 -C 12 haloalkynyloxy, C 1 -C 12 alkylsulfonyloxy, C 1 -C 12 haloalkylsulfonyloxy, C 1 -C 12 alkylsulfinyloxy, C 1 -C 12 haloalkylsulfinyloxy Group, OCN, SCN, SF 5 , substituted or unsubstituted amine group, aryl group, aryl C 1 -C 12 alkyl group, aryloxy group, aryl C 1 -C 12 alkoxy group, aryl Sulfosulfonyl, arylsulfinyl, arylthio, aryl C 1 -C 12 alkylsulfonyl, aryl C 1 -C 12 alkylsulfinyl, aryl C 1 -C 12 alkylthio, heterocyclic, heterocyclic C 1 -C 12 alkyl, heterocyclic oxy, and the like.

這些之中,較佳的取代基是鹵素、硝基、氰基、C1 -C12 烷基、C1 -C12 鹵烷基、C1 -C12 烷氧基、C1 -C12 鹵烷氧基、C1 -C12 烷基磺醯基、C1 -C12 烷氧基羰基、C1 -C12 鹵烷基磺醯基、C1 -C12 烷基亞磺醯基、C1 -C12 鹵烷基亞磺醯基、C1 -C12 烷基硫基、C1 -C12 鹵烷基硫基、經取代的或未經取代的胺基、芳基,和雜環,以及更佳的取代基是氟、氯、溴、碘、氰基、硝基、甲基、乙基、C(CH3 )3 、三氟甲基、甲氧基、乙氧基、三氟甲氧基、OCH2 CF3 、CO2 CH3 、CO2 CH2 CH3 ,或SO2 CH3Among these, preferred substituents are halogen, nitro, cyano, C 1 -C 12 alkyl, C 1 -C 12 haloalkyl, C 1 -C 12 alkoxy, C 1 -C 12 halo Alkoxy, C 1 -C 12 alkylsulfonyl, C 1 -C 12 alkoxycarbonyl, C 1 -C 12 haloalkylsulfonyl, C 1 -C 12 alkylsulfinyl, C 1 -C 12 haloalkylsulfinyl, C 1 -C 12 alkylthio, C 1 -C 12 haloalkylthio, substituted or unsubstituted amine, aryl, and heterocyclic , And better substituents are fluorine, chlorine, bromine, iodine, cyano, nitro, methyl, ethyl, C(CH 3 ) 3 , trifluoromethyl, methoxy, ethoxy, trifluoro Methoxy, OCH 2 CF 3 , CO 2 CH 3 , CO 2 CH 2 CH 3 , or SO 2 CH 3 .

較佳的經取代的芳基基團是鹵素-取代的芳基、二鹵素-取代的芳基、C1 -C12 烷基-取代的芳基、C1 -C12 鹵烷基-取代的芳基、鹵素和C1 -C12 鹵烷基-取代的芳基、C1 -C12 烷氧基-取代的芳基、C1 -C12 鹵烷氧基-取代的芳基,以及C1 -C12 烷基硫基-取代的芳基。更佳的經取代的芳基基團是氯-取代的芳基、二氯-取代的芳基、氟-取代的芳基、二氟-取代的芳基、三氟甲基-取代的芳基、甲基-取代的芳基、氯-和三氟甲基-取代的芳基、三氟甲氧基-取代的芳基、甲氧基-取代的芳基、三氟甲氧基-取代的芳基,以及甲基硫基-取代的芳基。Preferred substituted aryl groups are halogen-substituted aryl, dihalogen-substituted aryl, C 1 -C 12 alkyl-substituted aryl, C 1 -C 12 haloalkyl-substituted Aryl, halogen and C 1 -C 12 haloalkyl-substituted aryl, C 1 -C 12 alkoxy-substituted aryl, C 1 -C 12 haloalkoxy-substituted aryl, and C 1 -C 12 alkylthio-substituted aryl. More preferred substituted aryl groups are chloro-substituted aryl, dichloro-substituted aryl, fluoro-substituted aryl, difluoro-substituted aryl, trifluoromethyl-substituted aryl , Methyl-substituted aryl, chloro- and trifluoromethyl-substituted aryl, trifluoromethoxy-substituted aryl, methoxy-substituted aryl, trifluoromethoxy-substituted Aryl, and methylthio-substituted aryl.

較佳的經取代的雜芳基基團是鹵素-取代的雜芳基、C1 -C12 烷基-取代的雜芳基、C1 -C12 鹵烷基-取代的雜芳基、鹵素和C1 -C12 鹵烷基-取代的雜芳基、C1 -C12 烷氧基-取代的雜芳基、C1 -C12 鹵烷氧基-取代的雜芳基,以及C1 -C12 烷基硫基-取代的雜芳基。更佳的經取代的雜芳基基團是氯-取代的雜芳基、氟-取代的雜芳基、三氟甲基-取代的雜芳基、氯-和三氟甲基-取代的雜芳基、三氟甲氧基-取代的雜芳基,和甲氧基-取代的雜芳基,以及甲基硫基-取代的雜芳基。Preferred substituted heteroaryl groups are halogen-substituted heteroaryl, C 1 -C 12 alkyl-substituted heteroaryl, C 1 -C 12 haloalkyl-substituted heteroaryl, halogen And C 1 -C 12 haloalkyl-substituted heteroaryl, C 1 -C 12 alkoxy-substituted heteroaryl, C 1 -C 12 haloalkoxy-substituted heteroaryl, and C 1 -C 12 alkylthio-substituted heteroaryl. More preferred substituted heteroaryl groups are chloro-substituted heteroaryl, fluoro-substituted heteroaryl, trifluoromethyl-substituted heteroaryl, chloro- and trifluoromethyl-substituted heteroaryl Aryl, trifluoromethoxy-substituted heteroaryl, and methoxy-substituted heteroaryl, and methylthio-substituted heteroaryl.

較佳的經取代的雜環基團是鹵素-取代的雜環、C1 -C12 烷基-取代的雜環、C1 -C12 烷基-經取代的雜環、C1 -C12 烷氧基-取代的雜環、C1 -C12 鹵烷氧基-取代的雜環,以及C1 -C12 烷基硫基-取代的雜環。更佳的經取代的雜環基團是氯-取代的雜環、氟-取代的雜環、三氟甲基-取代的雜環、三氟甲氧基-取代的雜環、甲氧基-取代的雜環,以及甲基硫基-取代的雜環。Preferred substituted heterocyclic groups are halogen-substituted heterocycles, C 1 -C 12 alkyl-substituted heterocycles, C 1 -C 12 alkyl-substituted heterocycles, C 1 -C 12 Alkoxy-substituted heterocycles, C 1 -C 12 haloalkoxy-substituted heterocycles, and C 1 -C 12 alkylthio-substituted heterocycles. More preferred substituted heterocyclic groups are chlorine-substituted heterocycles, fluorine-substituted heterocycles, trifluoromethyl-substituted heterocycles, trifluoromethoxy-substituted heterocycles, methoxy- Substituted heterocycles, and methylthio-substituted heterocycles.

由化學式(1)所代表的化合物的鹽類可以是任何類型的鹽類,只要它們是農業上可接受的。該等鹽類的實例包括無機酸鹽,諸如一鹽酸鹽、一硫酸鹽、一硝酸鹽,和類似之物;有機酸鹽,諸如一乙酸鹽、一甲磺酸鹽,和類似之物;鹼金屬鹽,諸如一鈉鹽、一鉀鹽,和類似之物;鹼土金屬鹽,諸如一鎂鹽、一鈣鹽,和類似之物;四級銨鹽,諸如二甲基銨、三乙基銨,和類似之物;以及類似之物。The salts of the compound represented by the chemical formula (1) may be any type of salts as long as they are agriculturally acceptable. Examples of such salts include inorganic acid salts, such as monohydrochloride, monosulfate, mononitrate, and the like; organic acid salts, such as monoacetate, monomethanesulfonate, and the like; Alkali metal salts, such as monosodium, potassium, and the like; alkaline earth metal salts, such as monomagnesium, monocalcium, and the like; quaternary ammonium salts, such as dimethylammonium, triethyl Ammonium, and the like; and similar.

X1 代表C-R8 或N,X2 代表C-R9 或N,X3 代表C-R10 或N。然而,當X1 代表一氮原子時,X2 和X3 分別地代表C-R9 和C-R10 ;當X2 代表一氮原子時,X1 和X3 分別地代表C-R8 和C-R10 ;以及當X3 代表一氮原子時,X1 和X2 分別地代表C-R8 和C-R9X 1 represents CR 8 or N, X 2 represents CR 9 or N, and X 3 represents CR 10 or N. However, when X 1 represents a nitrogen atom, X 2 and X 3 represent CR 9 and CR 10 respectively ; when X 2 represents a nitrogen atom, X 1 and X 3 represent CR 8 and CR 10 respectively ; and when When X 3 represents a nitrogen atom, X 1 and X 2 represent CR 8 and CR 9, respectively .

在本揭示的化合物(1)之中,一較佳的化合物是一種其中Q代表一氧原子或一硫原子的化合物,以及一更佳的化合物(1)是一種其中Q代表一氧原子的化合物。Among the compounds (1) of the present disclosure, a preferred compound is a compound in which Q represents an oxygen atom or a sulfur atom, and a more preferred compound (1) is a compound in which Q represents an oxygen atom .

在本揭示的化合物(1)之中,一較佳的化合物是一種其中R6 和R7 各個獨立地代表氫、鹵素,或C1 -C12 烷基的化合物,以及一更佳的化合物(1)是一種其中R6 和R7 各個獨立地代表氫、氯,或甲基的化合物。Among the compounds (1) of the present disclosure, a preferred compound is a compound in which R 6 and R 7 each independently represent hydrogen, halogen, or C 1 -C 12 alkyl, and a more preferred compound ( 1) is a compound in which R 6 and R 7 each independently represent hydrogen, chlorine, or methyl.

在本揭示的化合物(1)之中,一較佳的化合物是一種其中R代表經取代的或未經取代的芳基或C1 -C12 烷基的化合物,以及一更佳的化合物(1)是一種其中R代表鹵素、烷基、鹵烷基、烷氧基,或鹵烷氧基-取代的芳基、未經取代的芳基或甲基的化合物。Among the compounds (1) of the present disclosure, a preferred compound is a compound in which R represents a substituted or unsubstituted aryl group or a C 1 -C 12 alkyl group, and a better compound (1 ) Is a compound in which R represents halogen, alkyl, haloalkyl, alkoxy, or haloalkoxy-substituted aryl, unsubstituted aryl or methyl.

在本揭示的化合物(1)之中,一較佳的化合物是一種其中R1 代表氫、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的芳基氧基羰基,或者經取代的或未經取代的芳基羰基的化合物,以及一更佳的化合物(1)是一種其中R1 代表氫、未經取代的C2 -C12 烯基、未經取代的C2 -C12 炔基、未經取代的C1 -C12 烷基羰基、未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、未經取代的芳基氧基羰基,或者經取代的或未經取代的芳基羰基的化合物。Among the compounds (1) of the present disclosure, a preferred compound is one in which R 1 represents hydrogen, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted aryloxycarbonyl, or substituted or unsubstituted arylcarbonyl compounds, and a better compound (1) is one of them R 1 represents hydrogen, unsubstituted C 2 -C 12 alkenyl, unsubstituted C 2 -C 12 alkynyl, unsubstituted C 1 -C 12 alkylcarbonyl, unsubstituted C 3 -C Compounds of 12 cycloalkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, unsubstituted aryloxycarbonyl, or substituted or unsubstituted arylcarbonyl.

在本揭示的化合物(1)之中,一較佳的化合物是一種其中R2 代表氫、經取代的或未經取代的C1 -C12 烷基的化合物,以及一更佳的化合物(1)是一種其中R2 代表氫、甲基或乙基的化合物。Among the compounds (1) of the present disclosure, a preferred compound is a compound in which R 2 represents hydrogen, a substituted or unsubstituted C 1 -C 12 alkyl group, and a better compound (1 ) Is a compound in which R 2 represents hydrogen, methyl or ethyl.

在本揭示的化合物(1)之中,一較佳的化合物是一種其中R3 代表經取代的或未經取代的C1 -C12 烷基的化合物,以及一更佳的化合物(1)是一種其中R3 代表甲基、乙基或三氟甲基的化合物。Among the compounds (1) of the present disclosure, a preferred compound is a compound in which R 3 represents a substituted or unsubstituted C 1 -C 12 alkyl group, and a more preferred compound (1) is A compound in which R 3 represents methyl, ethyl or trifluoromethyl.

在本揭示的化合物(1)之中,一較佳的化合物是一種其中R4 和R5 各個獨立地代表氫、經取代的或未經取代的C1 -C12 烷基的化合物,以及一更佳的化合物(1)是一種其中R4 和R5 各個獨立地代表氫或甲基的化合物。Among the compounds (1) of the present disclosure, a preferred compound is a compound in which R 4 and R 5 each independently represent hydrogen, a substituted or unsubstituted C 1 -C 12 alkyl group, and a A more preferable compound (1) is a compound in which R 4 and R 5 each independently represent hydrogen or methyl.

在本揭示的化合物(1)之中,一較佳的化合物是一種其中X1 、X2 和X3 各個獨立地代表C-R8 、C-R9 、C-R10 ,或者N的化合物,以及一更佳的化合物(1)是一種其中X1 、X2 和X3 各個獨立地代表C-R8 、C-R9 ,以及C-R10 的化合物。然而,當X1 代表一氮原子時,X2 和X3 分別地代表C-R9 和C-R10 。當X2 代表一氮原子時,X1 和X3 分別地代表C-R8 和C-R10 。當X3 代表一氮原子時,X1 和X2 分別地代表C-R8 和C-R9Among the compounds (1) of the present disclosure, a preferred compound is a compound in which X 1 , X 2 and X 3 each independently represent CR 8 , CR 9 , CR 10 , or N, and a more preferred Compound (1) is a compound in which X 1 , X 2 and X 3 each independently represent CR 8 , CR 9 , and CR 10 . However, when X 1 represents a nitrogen atom, X 2 and X 3 respectively represent CR 9 and CR 10 . When X 2 represents a nitrogen atom, X 1 and X 3 respectively represent CR 8 and CR 10 . When X 3 represents a nitrogen atom, X 1 and X 2 represent CR 8 and CR 9, respectively .

在本揭示的化合物(1)之中,一較佳的化合物是一種其中R8 、R9 和R10 各個獨立地代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基的化合物,以及一更佳的化合物(1)是一種其中R8 、R9 和R10 彼此獨立地代表氫、氯、甲基或乙基的化合物。Among the compounds (1) of the present disclosure, a preferred compound is one in which R 8 , R 9 and R 10 each independently represent hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl Compound, and a more preferred compound (1) is a compound in which R 8 , R 9 and R 10 independently of each other represent hydrogen, chlorine, methyl or ethyl.

這些之中,本揭示的一更佳的化合物是一化合物或它的一鹽類,其中 Q代表一氧原子; R是鹵素-、烷基-、鹵烷基-、烷氧基-或鹵烷氧基-取代的芳基;未經取代的芳基;或甲基; R1 是氫、未經取代的C2 -C12 烯基、未經取代的C2 -C12 炔基、未經取代的C1 -C12 烷基羰基、未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、未經取代的芳基氧基羰基,或者經取代的或未經取代的芳基羰基; R2 是氫,或者經取代的或未經取代的C1 -C12 烷基; R3 是經取代的或未經取代的C1 -C12 烷基; R4 是氫,或者經取代的或未經取代的C1 -C12 烷基; R5 是氫或甲基; X1 代表C-R8 或N; X2 代表C-R9 ; X3 代表C-R10 ; R8 是氫、C1 -C12 烷基或鹵素; R9 是氫、C1 -C12 烷基或鹵素; R10 是氫、C1 -C12 烷基或鹵素。Among these, a better compound of the present disclosure is a compound or a salt thereof, wherein Q represents an oxygen atom; R is halogen-, alkyl-, haloalkyl-, alkoxy- or haloalkane Oxy-substituted aryl; unsubstituted aryl; or methyl; R 1 is hydrogen, unsubstituted C 2 -C 12 alkenyl, unsubstituted C 2 -C 12 alkynyl, unsubstituted Substituted C 1 -C 12 alkylcarbonyl, unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, unsubstituted aryloxy Carbonyl, or substituted or unsubstituted arylcarbonyl; R 2 is hydrogen, or substituted or unsubstituted C 1 -C 12 alkyl; R 3 is substituted or unsubstituted C 1 -C 12 alkyl; R 4 is hydrogen, or substituted or unsubstituted C 1 -C 12 alkyl; R 5 is hydrogen or methyl; X 1 represents CR 8 or N; X 2 represents CR 9 ; X 3 represents CR 10 ; R 8 is hydrogen, C 1 -C 12 alkyl or halogen; R 9 is hydrogen, C 1 -C 12 alkyl or halogen; R 10 is hydrogen, C 1 -C 12 alkyl or halogen.

本揭示的一特別較佳的化合物是一化合物或它的一鹽類,其中 Q代表一氧原子; R6 是氫; R7 是氫; R是經取代的或未經取代的芳基,或者C1 -C12 烷基; R1 是氫、未經取代的C2 -C12 烯基、未經取代的C2 -C12 炔基、未經取代的C1 -C12 烷基羰基、未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、未經取代的芳基氧基羰基,或者經取代的或未經取代的芳基羰基; R2 是氫、甲基或乙基; R3 是甲基、乙基或三氟甲基; R4 是氫或甲基; R5 是氫,或者經取代的或未經取代的C1 -C12 烷基; X1 代表C-R8 或N; X2 代表C-R9 ; X3 代表C-R10 ; R8 是氫、氯、甲基或乙基; R9 是氫、氯、甲基或乙基; R10 是氫、 氯、甲基或乙基。A particularly preferred compound of the present disclosure is a compound or a salt thereof, wherein Q represents an oxygen atom; R 6 is hydrogen; R 7 is hydrogen; R is a substituted or unsubstituted aryl group, or C 1 -C 12 alkyl; R 1 is hydrogen, unsubstituted C 2 -C 12 alkenyl, unsubstituted C 2 -C 12 alkynyl, unsubstituted C 1 -C 12 alkylcarbonyl, Unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, unsubstituted aryloxycarbonyl, or substituted or unsubstituted Arylcarbonyl; R 2 is hydrogen, methyl or ethyl; R 3 is methyl, ethyl or trifluoromethyl; R 4 is hydrogen or methyl; R 5 is hydrogen, or substituted or unsubstituted Substituted C 1 -C 12 alkyl; X 1 represents CR 8 or N; X 2 represents CR 9 ; X 3 represents CR 10 ; R 8 is hydrogen, chlorine, methyl or ethyl; R 9 is hydrogen, chlorine, Methyl or ethyl; R 10 is hydrogen, chlorine, methyl or ethyl.

本揭示的另一個更佳化合物是一化合物或它的一鹽類,其中 Q代表一氧原子或一硫原子,較佳地一氧原子; R是被取代以鹵素、C1 -C6 烷基、C1 -C6 鹵烷基、C1 -C6 烷氧基、C1 -C6 鹵烷氧基,和/或C1 -C6 鹵烷基磺醯基的C6 芳基; R1 是氫、未經取代的C1 -C6 烷氧基羰基、未經取代的C1 -C6 烷基羰基、未經取代的C1 -C6 鹵烷基羰基、未經取代的C3 -C6 環烷基羰基,或未經取代的C6 芳基羰基,或者C1 -C6 鹵烷基-取代的C6 芳基羰基; R2 是C1 -C3 烷基; R3 是氫或C1 -C3 烷基; R4 是氫或C1 -C3 烷基; R5 是氫或C1 -C3 烷基; X1 代表C-R8 ; X2 代表C-R9 ; X3 代表C-R10 ; R8 是氫、C1 -C3 烷基,或氟; R9 是氫或C1 -C3 烷基; R10 是氫或C1 -C3 烷基。Another better compound of the present disclosure is a compound or a salt thereof, wherein Q represents an oxygen atom or a sulfur atom, preferably an oxygen atom; R is substituted with halogen, C 1 -C 6 alkyl , C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, and/or C 1 -C 6 haloalkylsulfonyl C 6 aryl; R 1 is hydrogen, unsubstituted C 1 -C 6 alkoxycarbonyl, unsubstituted C 1 -C 6 alkylcarbonyl, unsubstituted C 1 -C 6 haloalkylcarbonyl, unsubstituted C 3 -C 6 cycloalkylcarbonyl, or unsubstituted C 6 arylcarbonyl, or C 1 -C 6 haloalkyl-substituted C 6 arylcarbonyl; R 2 is C 1 -C 3 alkyl; R 3 is hydrogen or C 1 -C 3 alkyl; R 4 is hydrogen or C 1 -C 3 alkyl; R 5 is hydrogen or C 1 -C 3 alkyl; X 1 represents CR 8 ; X 2 represents CR 9 ; X 3 represents CR 10 ; R 8 is hydrogen, C 1 -C 3 alkyl, or fluorine; R 9 is hydrogen or C 1 -C 3 alkyl; R 10 is hydrogen or C 1 -C 3 alkyl.

本揭示的一特別地較佳的化合物是一化合物或它的一鹽類,其中 Q代表一氧原子或一硫原子,較佳地一氧原子; R是被取代以氟、氯、溴、C1 -C3 烷基、C1 -C3 鹵烷基,和/或C1 -C3 鹵烷氧基的C6 芳基; R1 是氫、未經取代的C1 -C6 烷氧基羰基、未經取代的C1 -C6 烷基羰基、未經取代的C1 -C6 鹵烷基羰基,或者未經取代的環丙基羰基; R2 是甲基; R3 是乙基; R4 是氫、甲基,或乙基; R5 是氫、甲基,或乙基; X1 代表C-R8 ; X2 代表C-R9 ; X3 代表C-R10 ; R8 是氫、甲基,或乙基; R9 是甲基; R10 是氫。A particularly preferred compound of the present disclosure is a compound or a salt thereof, wherein Q represents an oxygen atom or a sulfur atom, preferably an oxygen atom; R is substituted with fluorine, chlorine, bromine, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, and/or C 1 -C 3 haloalkoxy C 6 aryl; R 1 is hydrogen, unsubstituted C 1 -C 6 alkoxy Carbonyl, unsubstituted C 1 -C 6 alkylcarbonyl, unsubstituted C 1 -C 6 haloalkylcarbonyl, or unsubstituted cyclopropylcarbonyl; R 2 is methyl; R 3 is ethyl R 4 is hydrogen, methyl, or ethyl; R 5 is hydrogen, methyl, or ethyl; X 1 represents CR 8 ; X 2 represents CR 9 ; X 3 represents CR 10 ; R 8 is hydrogen, methyl Group, or ethyl; R 9 is methyl; R 10 is hydrogen.

本揭示亦併入如由化學式(1 )所代表的該等新穎之經取代的吡唑化合物或它們的一鹽類的製備。有各種不同的已知合成操作程序用於製備本揭示的化合物。在下文中,用於本揭示的一類型的化合物的合成操作程序將被描述和顯示在途徑 -1 。然而,該等新穎之經取代的吡唑化合物或它們的一鹽類的製備不限於這個方法。The present disclosure also incorporates the preparation of these novel substituted pyrazole compounds or their salts as represented by the chemical formula ( 1 ). There are various known synthetic synthetic procedures for preparing the compounds of the present disclosure. In the following, a synthetic procedure for a type of compound used in the present disclosure will be described and shown in Route -1 . However, the preparation of these novel substituted pyrazole compounds or their salts is not limited to this method.

途徑 -1

Figure 02_image009
其中R、R1 、R2 、R3 、X1 、X2 、X3 和Q是如上面所定義的,而LG和LG1 是已知離去基團的任一者。步驟 1-1 Path -1
Figure 02_image009
Where R, R 1 , R 2 , R 3 , X 1 , X 2 , X 3 and Q are as defined above, and LG and LG 1 are any of the known leaving groups. Step 1-1

這個步驟提供一種藉由化合物(I0 )與化合物(II )的反應而製備化合物(III)的方法。This step provides a method for preparing compound (III) by reacting compound ( I 0 ) with compound ( II ).

[反應途徑1-1]

Figure 02_image010
其中,R是如上面所定義的。[Reaction Path 1-1]
Figure 02_image010
Where R is as defined above.

上述的反應在一適當溶劑或沒有任何溶劑而被執行。當上述反應是在溶劑中被進行時,沒有限制被放在溶劑上,只要溶劑對於上述反應是不活性。此一溶劑的實例包括:脂肪酸或脂環烴-為基礎的溶劑(alicyclic hydrocarbon-based solvents),諸如n -己烷、環己烷、n -庚烷,和類似之物;芳族烴-為基礎的溶劑,諸如苯、氯苯、甲苯、二甲苯,和類似之物;鹵化烴-為基礎的溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿,和四氯化碳,和類似之物;酯溶劑,諸如二乙醚、四氫呋喃(THF)、1,4-二㗁烷,和類似之物;醯胺-為基礎的溶劑,諸如乙腈;N,N -二甲基甲醯胺(N,N -dimethylformamide, DMF)、N,N -二甲基乙醯胺、N -甲基-2-吡咯啶酮(N -methyl-2-pyrolidone)和類似之物;亞碸-為基礎的溶劑,諸如二甲亞碸、環丁砜(sulfolane)和類似之物;四氫呋喃、N,N -二甲基甲醯胺;以及質子性溶劑(protic solvents),像甲醇、乙醇、異丙醇、三級 - 丁醇或水等等。這些溶劑的任一者可被單獨使用或者當需要時它們的二或更多類型的一組合可被使用。The above reaction is performed in an appropriate solvent or without any solvent. When the above reaction is carried out in a solvent, there is no limitation to be placed on the solvent as long as the solvent is inactive to the above reaction. Examples of such a solvent include: fatty acid or alicyclic hydrocarbon-based solvents (alicyclic hydrocarbon-based solvents), such as n -hexane, cyclohexane, n -heptane, and the like; aromatic hydrocarbons- Basic solvents, such as benzene, chlorobenzene, toluene, xylene, and the like; halogenated hydrocarbon-based solvents, such as methylene chloride, 1,2-dichloroethane, chloroform, and carbon tetrachloride, And the like; ester solvents such as diethyl ether, tetrahydrofuran (THF), 1,4-dioxane, and the like; amide-based solvents such as acetonitrile; N,N -dimethylformamide Amine ( N,N- dimethylformamide, DMF), N,N -dimethylacetamide, N -methyl-2-pyrrolidone ( N- methyl-2-pyrolidone) and the like; Basic solvents, such as dimethylsulfoxide, sulfolane and the like; tetrahydrofuran, N,N -dimethylformamide; and protic solvents, such as methanol, ethanol, isopropanol, Tertiary - butanol or water, etc. Any of these solvents may be used alone or a combination of two or more types thereof may be used when needed.

要被使用的溶劑的量通常是每1莫耳的該化合物(I) 0.5至20公升,較佳地0.5至10公升。The amount of the solvent to be used is usually 0.5 to 20 liters per 1 mole of the compound (I), preferably 0.5 to 10 liters.

要被使用的化合物(II)的量通常是每1莫耳的該化合物(I) 1.0至10.0莫耳,較佳地1.0至1.5莫耳。The amount of the compound (II) to be used is generally 1.0 to 10.0 moles, preferably 1.0 to 1.5 moles per 1 mole of the compound (I).

反應溫度變化視起始化合物、試劑、溶劑和類似之物而定,但是它通常是自-40℃至在反應系統中的回流溫度,較佳地自0至100℃。The reaction temperature varies depending on the starting compound, reagents, solvents and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 0 to 100°C.

反應時間變化視化合物、試劑、溶劑和反應溫度以及類似之物而定,但是通常是自10分鐘至48小時,較佳地自60分鐘至10小時。步驟 1-2 The reaction time varies depending on the compound, reagents, solvent, reaction temperature and the like, but it is usually from 10 minutes to 48 hours, preferably from 60 minutes to 10 hours. Step 1-2

在這個步驟中,化合物(III)被甲醯化以產生化合物(IV)。In this step, compound (III) is methylated to produce compound (IV).

[反應途徑1-2]

Figure 02_image011
其中,R是如上面所定義的。[Reaction pathway 1-2]
Figure 02_image011
Where R is as defined above.

甲醯化可藉由任何已知的操作程序而被做出。甲醯化的一些實例包括,但不限於,使用POCl3 -DMF系統或使用六亞甲四胺(hexamethylenetetramine)。上述的反應在一適當溶劑或沒有任何溶劑而被執行。當上述反應是在溶劑中被進行時,沒有限制被放在溶劑上,只要溶劑對於上述反應是不活性。此一溶劑的實例包括:鹵化烴-為基礎的溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿、四氯化碳,和類似之物;醚-為基礎的溶劑,諸如四氫呋喃(THF)、1,4-二㗁烷,和類似之物;酯溶劑,諸如乙酸甲酯、乙酸乙酯,和類似之物;醯胺-為基礎的溶劑,諸如乙腈;N,N -二甲基甲醯胺(DMF)、N,N -二甲基乙醯胺、N -甲基-2-吡咯啶酮和類似之物;以及三氟乙酸、二甲亞碸、環丁碸等等。這些溶劑的任一者可被單獨使用或者當需要時它們的二或更多類型的一組合可被使用。Formulation can be done by any known operating procedures. Some examples of methylation include, but are not limited to, the use of POCl 3 -DMF system or the use of hexamethylenetetramine. The above reaction is performed in an appropriate solvent or without any solvent. When the above reaction is carried out in a solvent, there is no limitation to be placed on the solvent as long as the solvent is inactive to the above reaction. Examples of such a solvent include: halogenated hydrocarbon-based solvents such as methylene chloride, 1,2-dichloroethane, chloroform, carbon tetrachloride, and the like; ether-based solvents such as tetrahydrofuran (THF), 1,4-dioxane, and the like; ester solvents such as methyl acetate, ethyl acetate, and the like; amide-based solvents such as acetonitrile; N,N -di Methylformamide (DMF), N,N -dimethylacetamide, N -methyl-2-pyrrolidone, and the like; and trifluoroacetic acid, dimethylsulfoxide, cyclobutane, etc. . Any of these solvents may be used alone or a combination of two or more types thereof may be used when needed.

要被使用的溶劑的量通常是每1莫耳的該化合物(III) 1.0至20公升,較佳地1.0至10公升。The amount of the solvent to be used is usually 1.0 to 20 liters per 1 mole of the compound (III), preferably 1.0 to 10 liters.

要被使用的氧氯化磷(phosphorous oxychloride)的量通常是每1莫耳的該化合物(III) 1.0至20.0莫耳,較佳地1.0至10.0莫耳。相似地,要被使用的六亞甲四胺的量通常是每1莫耳的該化合物(III) 1.0至10.0莫耳,較佳地1.0至5.0莫耳。The amount of phosphorous oxychloride to be used is usually 1.0 to 20.0 mol per 1 mol of the compound (III), preferably 1.0 to 10.0 mol. Similarly, the amount of hexamethylenetetramine to be used is generally 1.0 to 10.0 moles per 1 mole of the compound (III), preferably 1.0 to 5.0 moles.

反應溫度變化視起始化合物、反應試劑、溶劑和類似之物而定,但是它通常是自-40℃至在反應系統中的回流溫度,較佳地自50至120℃。The reaction temperature varies depending on the starting compound, reaction reagents, solvent and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 50 to 120°C.

反應時間變化視化合物、反應試劑、溶劑和反應溫度以及類似之物而定,但是通常是自10分鐘至48小時,較佳地自1至10小時。步驟 1-3 The reaction time varies depending on the compound, reaction reagents, solvent, reaction temperature and the like, but it is usually from 10 minutes to 48 hours, preferably from 1 to 10 hours. Step 1-3

這個步驟由2個階段組成。在第一階段,化合物(IV)以一適合的過酸處理俾以產生一中間物。在第二階段,這個中間物被水解以產生化合物(V)。This step consists of 2 stages. In the first stage, compound (IV) is treated with a suitable peracid to produce an intermediate. In the second stage, this intermediate is hydrolyzed to produce compound (V).

[反應途徑1-3]

Figure 02_image012
其中,R和Q是如上面所定義的。[Reaction pathway 1-3]
Figure 02_image012
Among them, R and Q are as defined above.

在第一階段中,任何已知的過酸可被使用,實例包括但不限於,m -氯過氧苯甲酸(m -chloroperbenzoic acid)、過氧化氫、過乙酸等等。過酸的量通常是每1莫耳的該化合物(IV) 1.0至20.0莫耳,較佳地1.0至5.0莫耳。In the first stage, any known peracid may be used, examples include, but are not limited to, m - chloroperoxybenzoic acid (m -chloroperbenzoic acid), hydrogen peroxide, peracetic acid and the like. The amount of peracid is usually 1.0 to 20.0 moles per 1 mole of the compound (IV), preferably 1.0 to 5.0 moles.

上述的反應在一適當溶劑或沒有任何溶劑而被執行。當上述反應是在溶劑中被進行時,沒有限制被放在溶劑上,只要溶劑對於上述反應是不活性。此一溶劑的實例包括:鹵化烴-為基礎的溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿,和四氯化碳,以及類似之物;醚-為基礎的溶劑,諸如四氫呋喃(THF)、1,4-二㗁烷,和類似之物;酯溶劑,諸如乙酸甲酯、乙酸乙酯,和類似之物;醯胺-為基礎的溶劑,諸如乙腈;N,N -二甲基甲醯胺(DMF)、N,N -二甲基乙醯胺、N -甲基-2-吡咯啶酮和類似之物;以及二甲亞碸和環丁碸。這些溶劑的任一者可被單獨使用或者當需要時它們的二或更多類型的一組合可被使用。The above reaction is performed in an appropriate solvent or without any solvent. When the above reaction is carried out in a solvent, there is no limitation to be placed on the solvent as long as the solvent is inactive to the above reaction. Examples of such a solvent include: halogenated hydrocarbon-based solvents such as methylene chloride, 1,2-dichloroethane, chloroform, and carbon tetrachloride, and the like; ether-based solvents such as Tetrahydrofuran (THF), 1,4-dioxane, and the like; ester solvents such as methyl acetate, ethyl acetate, and the like; amide-based solvents such as acetonitrile; N,N- Dimethylformamide (DMF), N,N -dimethylacetamide, N -methyl-2-pyrrolidone, and the like; and dimethylsulfoxide and cyclobutane. Any of these solvents may be used alone or a combination of two or more types thereof may be used when needed.

要被使用的溶劑的量通常是每1莫耳的該化合物(IV) 1.0至20公升,較佳地1.0至10公升。The amount of the solvent to be used is usually 1.0 to 20 liters per 1 mole of the compound (IV), preferably 1.0 to 10 liters.

在第二階段中,中間物的水解可藉由任何已知的操作程序而被做出,實例包括,但不限於,在質子性溶劑中使用一酸,或者在適當溶劑中使用一鹼。對於酸性條件,任何熟知的酸(像鹽酸、硫酸等等)可被使用,而在鹼性條件下,任何已知的鹼(諸如像三乙胺的有機鹼或者像氫氧化鈉的無機鹼)可被使用。In the second stage, the hydrolysis of the intermediate can be made by any known procedures. Examples include, but are not limited to, the use of an acid in a protic solvent or a base in a suitable solvent. For acidic conditions, any well-known acids (like hydrochloric acid, sulfuric acid, etc.) can be used, while under alkaline conditions, any known bases (such as organic bases like triethylamine or inorganic bases like sodium hydroxide) Can be used.

要被使用的酸或鹼的量通常是每1莫耳的該化合物(IV) 1.0至20.0莫耳,較佳地1.0至5.0莫耳。The amount of acid or base to be used is usually 1.0 to 20.0 mol per 1 mol of the compound (IV), preferably 1.0 to 5.0 mol.

上述的反應在一適當溶劑或沒有任何溶劑而被執行。當上述反應是在溶劑中被進行時,沒有限制被放在溶劑上,只要溶劑對於上述反應是不活性。此一溶劑的實例包括:鹵化烴-為基礎的溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿,和四氯化碳,以及類似之物;醚-為基礎的溶劑,諸如四氫呋喃(THF)、1,4-二㗁烷,和類似之物;酯溶劑,諸如乙酸甲酯、乙酸乙酯,和類似之物;醯胺-為基礎的溶劑,諸如乙腈;N,N -二甲基甲醯胺(DMF)、N,N -二甲基乙醯胺、N -甲基-2-吡咯啶酮和類似之物;二甲亞碸或環丁碸;以及質子性溶劑,像甲醇、乙醇、水等等。這些溶劑的任一者可被單獨使用或者當需要時它們的二或更多類型的一組合可被使用。The above reaction is performed in an appropriate solvent or without any solvent. When the above reaction is carried out in a solvent, there is no limitation to be placed on the solvent as long as the solvent is inactive to the above reaction. Examples of such a solvent include: halogenated hydrocarbon-based solvents such as methylene chloride, 1,2-dichloroethane, chloroform, and carbon tetrachloride, and the like; ether-based solvents such as Tetrahydrofuran (THF), 1,4-dioxane, and the like; ester solvents such as methyl acetate, ethyl acetate, and the like; amide-based solvents such as acetonitrile; N,N- Dimethylformamide (DMF), N,N -dimethylacetamide, N -methyl-2-pyrrolidone, and the like; dimethylmethylene or cyclobutane; and protic solvents, Like methanol, ethanol, water, etc. Any of these solvents may be used alone or a combination of two or more types thereof may be used when needed.

要被使用的溶劑的量通常是每1莫耳的該化合物(IV) 1.0至20公升,較佳地1.0至10公升。The amount of the solvent to be used is usually 1.0 to 20 liters per 1 mole of the compound (IV), preferably 1.0 to 10 liters.

反應溫度變化視起始化合物、試劑、溶劑和類似之物而定,但是它通常是自-40℃至在反應系統中的回流溫度,較佳地自0至100℃。The reaction temperature varies depending on the starting compound, reagents, solvents and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 0 to 100°C.

反應時間變化視化合物、試劑、溶劑和反應溫度以及類似之物而定,但是通常是自10分鐘至48小時,較佳地自6小時至18小時。步驟 1-4 The reaction time varies depending on the compound, reagents, solvent, reaction temperature and the like, but it is usually from 10 minutes to 48 hours, preferably from 6 hours to 18 hours. Step 1-4

這個步驟由在一鹼和溶劑的存在下在化合物(V)與化合物(VI)之間的反應組成俾以產生化合物(VII)。This step consists of a reaction between compound (V) and compound (VI) in the presence of a base and a solvent to produce compound (VII).

[反應途徑1-4]

Figure 02_image013
其中,R、X1 、X2 、X3 和Q是如上面所定義的。LG代表任何適合的離去基團,諸如鹵素、O-甲磺酸鹽(O-mesylates)、O-磺酸鹽、O-甲苯磺酸鹽(O-tosylates)等等。[Reaction pathway 1-4]
Figure 02_image013
Among them, R, X 1 , X 2 , X 3 and Q are as defined above. LG represents any suitable leaving group such as halogen, O-mesylates, O-sulfonates, O-tosylates, etc.

被使用於上述反應的鹼沒有特別地被限制。至於該鹼,任何慣常地知曉的鹼可廣泛地被使用,並且鹼的實例包括:鹼金屬碳酸鹽,諸如碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉,和類似之物;鹼金屬氫氧化物,諸如氫氧化鈉、氫氧化鉀,和類似之物;無機鹼,包括鹼金屬氫化物,諸如氫化鈉和氫化鉀,和類似之物;鹼金屬烷氧化物(alkali metal alkoxides),諸如甲氧基鈉(sodium methoxide)、乙氧基鈉(sodium ethoxide)、三級 - 丁氧基鉀(potassiumtert -butoxide),和類似之物;有機鹼,諸如吡啶(pyridine)、三乙胺、二乙胺、二甲胺、甲胺、咪唑(imidazole)、苯并咪唑(benzimidazole)、二異丙基乙胺、4-二甲基胺吡啶、哌啶((piperidine),以及類似之物。這些鹼的任何分開的一者或者它們的二或更多類型的一組合可被使用。The base used in the above reaction is not particularly limited. As for the base, any conventionally known base can be widely used, and examples of the base include: alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and the like; Alkali metal hydroxides, such as sodium hydroxide, potassium hydroxide, and the like; inorganic bases, including alkali metal hydrides, such as sodium hydride and potassium hydride, and the like; alkali metal alkoxides ), such as sodium methoxide (sodium methoxide), sodium ethoxide (sodium ethoxide), three - butoxypotassium (potassium tert -butoxide), and the like of the composition; an organic base, such as pyridine (pyridine), three Ethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine (piperidine), and the like Any one of these bases or a combination of two or more types of them can be used.

要被使用的鹼的量通常是每1莫耳的該化合物(V) 1.0至5.0莫耳,較佳地1.0至1.5莫耳。The amount of the base to be used is usually 1.0 to 5.0 moles per 1 mole of the compound (V), preferably 1.0 to 1.5 moles.

上述的反應在一適當溶劑中被執行。沒有限制被放在溶劑上,只要溶劑對於上述反應是不活性。此一溶劑的實例包括:鹵化烴-為基礎的溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿,和四氯化碳,以及類似之物;醯胺-為基礎的溶劑,諸如四氫呋喃(THF)、1,4-二㗁烷;乙腈;N,N-二甲基甲醯胺(DMF)、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮和類似之物;以及二甲亞碸、環丁碸,和質子性溶劑,諸如甲醇、乙醇、水等等。這些溶劑的任一者可被單獨使用或者當需要時它們的二或更多類型的一組合可被使用。The above reaction is carried out in an appropriate solvent. There is no limit to being placed on the solvent as long as the solvent is inactive for the above reaction. Examples of such a solvent include: halogenated hydrocarbon-based solvents such as methylene chloride, 1,2-dichloroethane, chloroform, and carbon tetrachloride, and the like; amide-based solvents, Such as tetrahydrofuran (THF), 1,4-dioxane; acetonitrile; N,N-dimethylformamide (DMF), N,N-dimethylacetamide, N-methyl-2-pyrrolidine Ketones and the like; as well as dimethyl sulfonate, ciproin, and protic solvents such as methanol, ethanol, water, etc. Any of these solvents may be used alone or a combination of two or more types thereof may be used when needed.

要被使用的溶劑的量通常是每1莫耳的該化合物(V) 1.0至20公升,較佳地1.0至10公升。The amount of the solvent to be used is usually 1.0 to 20 liters per 1 mole of the compound (V), preferably 1.0 to 10 liters.

反應溫度變化視起始化合物、反應試劑、溶劑和類似之物而定,但是它通常是自-40℃至在反應系統中的回流溫度,較佳地自0至100℃。The reaction temperature varies depending on the starting compound, reaction reagents, solvent and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 0 to 100°C.

反應時間變化視化合物、試劑、溶劑和反應溫度以及類似之物而定,但是通常是自10分鐘至48小時,較佳地自60分鐘至12小時。步驟 1-5 The reaction time varies depending on the compound, reagents, solvent, reaction temperature and the like, but it is usually from 10 minutes to 48 hours, preferably from 60 minutes to 12 hours. Step 1-5

這個步驟涉及存在於化合物(VII)的硝基基團(NO2 )的還原俾以產生化合物(VIII)的胺基基團(NH2 )。This step involves the reduction of the nitro group (NO 2 ) present in compound (VII) to produce the amine group (NH 2 ) of compound (VIII).

[反應途徑1-5]

Figure 02_image014
其中,R、X1 、X2 、X3 和Q是如上面所定義的。[Reaction pathway 1-5]
Figure 02_image014
Among them, R, X 1 , X 2 , X 3 and Q are as defined above.

關於上述反應,各種不同的慣常方法被知曉並且可廣泛地被使用。該等方法的一些實例包括但不限於:鈀炭(Palladium Charcoal, Pd-C)在氫氛圍下在質子性溶劑(像甲醇、乙醇)中;雷氏鎳(Raney Nickel)(雷氏Ni)在氫氛圍下在質子性溶劑(像甲醇、乙醇)中;鐵粉在醋酸中;鋅粉(Zinc dust)在醋酸中;硫化鈉(Na2 S)在乙醇中;鋅粉、氯化銨和溶劑(像THF-MeOH、THF-EtOH)的一混合物;氯化亞錫(Stannous Chloride)在鹽酸中等等。Regarding the above reaction, various conventional methods are known and can be widely used. Some examples of such methods include, but are not limited to: Palladium Charcoal (Pd-C) in a protic solvent (like methanol, ethanol) under a hydrogen atmosphere; Raney Nickel (Raney Ni) in Under hydrogen atmosphere in protic solvents (like methanol, ethanol); iron powder in acetic acid; zinc powder (Zinc dust) in acetic acid; sodium sulfide (Na 2 S) in ethanol; zinc powder, ammonium chloride and solvents (Like THF-MeOH, THF-EtOH) a mixture; stannous chloride (Stannous Chloride) in hydrochloric acid and so on.

反應溫度變化視起始化合物、試劑、溶劑和類似之物而定,但是它通常是自-40℃至在反應系統中的回流溫度,較佳地自0至90℃。The reaction temperature varies depending on the starting compound, reagents, solvents and the like, but it is usually from -40°C to the reflux temperature in the reaction system, preferably from 0 to 90°C.

反應時間變化視化合物、試劑、溶劑和反應溫度以及類似之物而定,但是通常是自5分鐘至48小時,較佳地自60分鐘至6小時。步驟 1-6 The reaction time varies depending on the compound, reagents, solvent, reaction temperature and the like, but it is usually from 5 minutes to 48 hours, preferably from 60 minutes to 6 hours. Step 1-6

這個步驟是一種在一催化劑和一適合溶劑的存在下從化合物(VIII)和化合物(IX)的反應製備化合物(X)的方法。This step is a method for preparing compound (X) from the reaction of compound (VIII) and compound (IX) in the presence of a catalyst and a suitable solvent.

[反應途徑1-6]

Figure 02_image015
其中,R、R2 、R3 、X1 、X2 、X3 和Q是如上面所定義的。[Reaction pathway 1-6]
Figure 02_image015
Among them, R, R 2 , R 3 , X 1 , X 2 , X 3 and Q are as defined above.

上述的反應是在一適當溶劑或沒有任何溶劑而被執行。當上述反應是在溶劑中被進行時,沒有限制被放在溶劑上,只要溶劑對於上述反應是不活性。此一溶劑的實例包括:苯、氯苯、甲苯、二甲苯、1,2-二氯乙烷、二苯基醚、乙腈、N,N -二甲基甲醯胺(DMF)、N,N -二甲基乙醯胺、N -甲基-2-吡咯啶酮、多磷酸。這些溶劑的任一者可被單獨使用或者當需要時它們的二或更多類型的一組合可被使用。The above reaction is carried out in an appropriate solvent or without any solvent. When the above reaction is carried out in a solvent, there is no limitation to be placed on the solvent as long as the solvent is inactive to the above reaction. Examples of such a solvent include: benzene, chlorobenzene, toluene, xylene, 1,2-dichloroethane, diphenyl ether, acetonitrile, N,N -dimethylformamide (DMF), N,N -Dimethylacetamide, N -methyl-2-pyrrolidone, polyphosphoric acid. Any of these solvents may be used alone or a combination of two or more types thereof may be used when needed.

要被使用的溶劑的量通常是每1莫耳的由化學式(VIII)所代表的化合物 0.5至20公升,較佳地0.5至10公升。The amount of the solvent to be used is usually 0.5 to 20 liters, preferably 0.5 to 10 liters per 1 mole of the compound represented by the chemical formula (VIII).

上述反應可在一催化劑的存在下被執行。有可被使用於這個反應的各種不同的慣常催化劑並且這些催化劑的一些實例包括:三氟乙酸;鹽酸;硫酸;p -甲苯磺酸;三氟化硼合乙醚(boron trifluoride etherate, BF3 -Et2 O);氯化鋁(AlCl3 );氯化鐵(FeCl3 );氯化鈦(TiCl4 );氯化錫(SnCl4 )。The above reaction can be performed in the presence of a catalyst. There are various conventional catalysts that can be used in this reaction and some examples of these catalysts include: trifluoroacetic acid; hydrochloric acid; sulfuric acid; p -toluenesulfonic acid; boron trifluoride etherate (BF 3 -Et) 2 O); aluminum chloride (AlCl 3 ); iron chloride (FeCl 3 ); titanium chloride (TiCl 4 ); tin chloride (SnCl 4 ).

要被使用的酸的量通常是每1.5莫耳的該化合物(VIII) 1.0至5莫耳,較佳地0.05莫耳。The amount of acid to be used is usually 1.0 to 5 moles per 1.5 moles of the compound (VIII), preferably 0.05 moles.

要被使用的乙醯乙酸鹽(acetoacetate)(IX)的量通常是1.0至10.0莫耳,較佳地1.0至5.0莫耳的該化合物(VIII)。The amount of acetoacetate (IX) to be used is usually 1.0 to 10.0 moles, preferably 1.0 to 5.0 moles of the compound (VIII).

反應溫度變化視起始化合物的類型、試劑和溶劑而定,並且一般而言自0℃至200℃。The reaction temperature varies depending on the type of starting compound, reagents and solvent, and is generally from 0°C to 200°C.

反應時間變化視化合物、試劑、溶劑和反應溫度以及類似之物而定,但是通常是自10分鐘至48小時,較佳地自2小時至16小時。步驟 1-7 The reaction time varies depending on the compound, reagents, solvent, reaction temperature and the like, but it is usually from 10 minutes to 48 hours, preferably from 2 hours to 16 hours. Step 1-7

這個步驟藉由以化合物(XI)處理化合物(X)而產生化合物(1 )。This step produces compound ( 1 ) by treating compound (X) with compound (XI).

[反應途徑1-7]

Figure 02_image016
其中,R、R1 、R2 、R3 、R9 、R10 、X1 、X2 、X3 和Q是如上面所定義的。LG1 代表任何適合的離去基團,諸如鹵素、O -甲磺酸鹽、O -磺酸鹽、O -甲苯磺酸鹽等等。[Reaction pathway 1-7]
Figure 02_image016
Wherein, R, R 1 , R 2 , R 3 , R 9 , R 10 , X 1 , X 2 , X 3 and Q are as defined above. LG 1 represents any suitable leaving group, such as halogen, O -methanesulfonate, O -sulfonate, O -toluenesulfonate and the like.

上述的反應是在一適當溶劑或沒有任何溶劑而被執行。當上述反應是在溶劑中被進行時,沒有限制被放在溶劑上,只要溶劑對於上述反應是不活性。此一溶劑的實例包括:芳族烴-為基礎的溶劑,諸如苯、氯苯、甲苯、二甲苯,和類似之物;鹵化烴-為基礎的溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿,和四氯化碳,以及類似之物;醚-為基礎的溶劑,諸如二乙醚、四氫呋喃(THF)、1,4-二㗁烷,和類似之物;酯溶劑,諸如乙酸甲酯、乙酸乙酯,和類似之物;醯胺-為基礎的溶劑,諸如乙腈;N,N -二甲基甲醯胺(DMF)、N,N -二甲基乙醯胺、N -甲基-2-吡咯啶酮和類似之物;以及酮-為基礎的溶劑,諸如丙酮、甲乙酮、環己酮,和類似之物;以及二甲亞碸。這些溶劑的任一者可被單獨使用或者當需要時它們的二或更多類型的一組合可被使用。The above reaction is carried out in an appropriate solvent or without any solvent. When the above reaction is carried out in a solvent, there is no limitation to be placed on the solvent as long as the solvent is inactive to the above reaction. Examples of such a solvent include: aromatic hydrocarbon-based solvents such as benzene, chlorobenzene, toluene, xylene, and the like; halogenated hydrocarbon-based solvents such as dichloromethane, 1,2-bis Ethyl chloride, chloroform, and carbon tetrachloride, and the like; ether-based solvents, such as diethyl ether, tetrahydrofuran (THF), 1,4-dioxane, and the like; ester solvents, such as Methyl acetate, ethyl acetate, and the like; amide-based solvents, such as acetonitrile; N,N -dimethylformamide (DMF), N,N -dimethylacetamide, N -Methyl-2-pyrrolidone and the like; and ketone-based solvents such as acetone, methyl ethyl ketone, cyclohexanone, and the like; and dimethyl sulfoxide. Any of these solvents may be used alone or a combination of two or more types thereof may be used when needed.

要被使用的溶劑的量通常是每1莫耳的由化學式(X)所代表的化合物0.5至20公升,較佳地0.5至10公升。The amount of the solvent to be used is usually 0.5 to 20 liters per 1 mole of the compound represented by the chemical formula (X), preferably 0.5 to 10 liters.

一被使用於上述反應的鹼沒有特別地被限制。至於鹼,一慣常地知曉的鹼可廣泛地被使用,並且該鹼的實例包括:鹼金屬碳酸鹽,諸如碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉,和類似之物;鹼金屬氫氧化物,諸如氫氧化鈉、氫氧化鉀,和類似之物;無機鹼,包括鹼金屬氫化物,諸如氫化鈉和氫化鉀,和類似之物;鹼金屬烷氧化物,諸如甲氧基鈉、乙氧基鈉、三級 - 丁氧基鉀,和類似之物;有機鹼,諸如吡啶、三乙胺、二乙胺、二甲胺、甲胺、咪唑、苯并咪唑、二異丙基乙胺、4-二甲基胺吡啶、哌啶,和類似之物;以及較佳地吡啶。這些鹼的任何分開的一者或者它們的二或更多類型的一組合可被使用。The base used in the above reaction is not particularly limited. As for the base, a conventionally known base can be widely used, and examples of the base include: alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and the like; Alkali metal hydroxides, such as sodium hydroxide, potassium hydroxide, and the like; inorganic bases, including alkali metal hydrides, such as sodium hydride and potassium hydride, and the like; alkali metal alkoxides, such as methoxy sodium, sodium ethoxide, three - butoxide, and the like of the composition; an organic base, such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisobutyl Propylethylamine, 4-dimethylaminepyridine, piperidine, and the like; and preferably pyridine. Any separate one of these bases or a combination of two or more types thereof may be used.

要被使用的鹼的量通常是每1莫耳的該化合物(V) 1.0至5.0莫耳,較佳地1.0至1.1莫耳,有時候,當一有機鹼被使用時,它亦可作為一溶劑。The amount of the base to be used is usually 1.0 to 5.0 moles per 1 mole of the compound (V), preferably 1.0 to 1.1 moles, and sometimes, when an organic base is used, it can also be used as a Solvent.

要被使用的化合物(XI)的量通常是每1莫耳的該化合物(V) 1.0至5.0莫耳,較佳地1.0至2.0莫耳。The amount of the compound (XI) to be used is usually 1.0 to 5.0 moles, preferably 1.0 to 2.0 moles per 1 mole of the compound (V).

反應溫度變化視起始化合物、試劑、溶劑和類似之物而定,但是它一般而言是自-10℃至該溶劑的沸點。The reaction temperature varies depending on the starting compound, reagents, solvent and the like, but it is generally from -10°C to the boiling point of the solvent.

反應時間變化視化合物、試劑、溶劑和反應溫度以及類似之物而定,但是通常是自10分鐘至48小時,較佳地自1小時至12小時。The reaction time varies depending on the compound, reagents, solvent, reaction temperature and the like, but it is usually from 10 minutes to 48 hours, preferably from 1 hour to 12 hours.

途徑 -1 中所表示的各個化合物,在反應完成後可容易地從反應混合物而被分離並且藉由已知的分離和純化技術(諸如過濾、溶劑萃取、蒸餾、再結晶以及管柱層析法)而被純化。Each compound represented in Route -1 can be easily separated from the reaction mixture after completion of the reaction and by known separation and purification techniques (such as filtration, solvent extraction, distillation, recrystallization, and column chromatography) Method).

本揭示的化合物(1)可被使用作為一害蟲控制劑的一活性成分。害蟲控制劑的實例包括用於控制在農業和園藝領域中所有引起問題的害蟲、蟎(mites)、線蟲(nematode)或土壤害蟲的試劑(農業和園藝的殺蟲劑、殺蟎劑(miticides)、殺線蟲劑(nematicides),或土壤殺蟲劑);動物-外寄生蟲(ectoparasite)-控制劑(例如,滅蚤劑(pulicide)、殺蜱劑(ixodicide),和殺蝨劑(pedivulicide)),以及類似之物。The compound (1) of the present disclosure can be used as an active ingredient of a pest control agent. Examples of pest control agents include reagents for controlling all pests, mites, nematode or soil pests that cause problems in the agricultural and horticultural fields (agricultural and horticultural insecticides, miticides) , Nematicides, or soil insecticides); animal-ectoparasite-controlling agents (eg, pulicide, ixodicide, and pedivulicide) ), and the like.

為了使用作為一害蟲-控制劑的一活性成分,有可能使用本揭示的化合物(1)如現狀而沒有額外的組分。然而,通常較佳的是使用該化合物藉由它組合以一固體載體、液體載體或氣體載體(推進劑(propellant)),以及選擇性地與一表面活性劑和其它佐劑(adjuvant)用於藥物製劑,並且依據已知的製備方法配方所形成的混合物成為各種不同的形式,諸如油溶液、乳劑、可濕性粉末、可流動的製劑、顆粒、粉劑(dusts)、氣溶膠、燻蒸劑(fumigants),或類似之物。In order to use an active ingredient as a pest-controlling agent, it is possible to use the compound (1) of the present disclosure as it is without additional components. However, it is generally preferred to use the compound by combining it with a solid carrier, liquid carrier or gas carrier (propellant), and optionally with a surfactant and other adjuvant (adjuvant) Pharmaceutical preparations, and the mixtures formed according to the known preparation methods into various forms, such as oil solutions, emulsions, wettable powders, flowable preparations, granules, dusts, aerosols, fumigants ( fumigants), or similar.

本揭示的化合物(1)通常呈一為0.01至95 wt%,以及較佳地0.1至50 wt%的比例而被包含在這些配方中。The compound (1) of the present disclosure is generally included in these formulations in a ratio of 0.01 to 95 wt%, and preferably 0.1 to 50 wt%.

固體載體的實例包括礦物載體,諸如葉蠟石黏土(pyrophyllite clay)、高嶺土(kaolin clay)、矽岩黏土(Silicastone clay)、滑石(talc)、矽藻土(diatomaceous earth)、沸石(zeolite)、膨土(bentonite)、酸性黏土、活性黏土、凹凸棒黏土(Attapulgus Clay)、蛭石(vermiculite)、珍珠岩(perlite)、浮石(pumice)、白碳(white Carbon)(例如合成的矽酸或合成的矽酸鹽)、二氧化鈦和類似之物;蔬菜載體,諸如木粉、玉米稈、胡桃殼、果核、稻殼、鋸屑、麥麩、大豆粉、粉末纖維素、澱粉、糊精、醣和類似之物;無機鹽載體,諸如碳酸鈣、硫酸銨、硫酸鈉、氯化鉀和類似之物;以及聚合物載體,諸如聚乙烯、聚丙烯、聚氯乙烯、聚乙酸乙烯酯、乙烯-乙酸乙烯酯共聚物、脲-醛樹脂和類似之物。Examples of solid supports include mineral supports such as pyrophyllite clay, kaolin clay, Silicastone clay, talc, diatomaceous earth, zeolite, Bentonite, acid clay, activated clay, attapulgus clay, vermiculite, perlite, pumice, white carbon (e.g. synthetic silicic acid or Synthetic silicate), titanium dioxide and the like; vegetable carriers such as wood flour, corn stalks, walnut shells, cores, rice husks, sawdust, wheat bran, soybean flour, powdered cellulose, starch, dextrin, sugar And the like; inorganic salt carriers such as calcium carbonate, ammonium sulfate, sodium sulfate, potassium chloride and the like; and polymer carriers such as polyethylene, polypropylene, polyvinyl chloride, polyvinyl acetate, ethylene- Vinyl acetate copolymers, urea-aldehyde resins and the like.

液體載體的實例包括一元醇,諸如甲醇、乙醇、丙醇、異丙醇、丁醇、環己醇和類似之物;多元醇,諸如乙二醇、二伸乙甘醇(diethylene glycol)、丙二醇、己二醇,聚乙二醇、聚丙二醇、甘油和類似之物;多元醇衍生物,諸如丙烯型甘醇醚(propylene type glycol ether)和類似之物;酮,諸如丙酮、甲基乙基酮、甲基異丁基酮、二異丁基酮、環己酮、異佛酮(isophorone)和類似之物;醚,諸如乙醚、1,4-二㗁烷、賽珞蘇(cellosolve)、二丙醚、四氫呋喃和類似之物;脂族烴,諸如正烷烴(normal paraffin)、環烷(naphthene)、異烷烴(isoparaffin)、煤油(kerosene)、礦物油和類似之物;芳族烴,諸如甲苯、C9 -C10 烷基苯、二甲苯、溶劑石腦油(solvent naphtha)、烷基萘(alkylnaphthalene)、高沸點芳族烴和類似之物;鹵化烴,諸如1,2-二氯乙烷、氯仿、四氯化碳和類似之物;酯,諸如乙酸乙酯、鄰苯二甲酸二異丙酯(diisopropyl phthalate)、鄰苯二甲酸二丁酯(dibutyl phthalate)、鄰苯二甲酸二辛酯(dioctyl phthalate)、己二酸二甲酯(dimethyl adipate)和類似之物;內酯(lactones),諸如γ-丁內酯(γ-butyrolactone)和類似之物;醯胺,諸如二甲基甲醯胺、二乙基甲醯胺、二甲基乙醯胺、N -烷基吡咯啶酮和類似之物;腈,諸如乙腈和類似之物;硫化合物,諸如二甲亞碸和類似之物;植物油,諸如大豆油、菜籽油、棉籽油、椰子油、蓖麻油和類似之物;以及水。Examples of liquid carriers include monohydric alcohols such as methanol, ethanol, propanol, isopropanol, butanol, cyclohexanol, and the like; polyhydric alcohols such as ethylene glycol, diethylene glycol, propylene glycol, Hexanediol, polyethylene glycol, polypropylene glycol, glycerin, and the like; polyol derivatives, such as propylene type glycol ether and the like; ketones, such as acetone, methyl ethyl ketone , Methyl isobutyl ketone, diisobutyl ketone, cyclohexanone, isophorone (isophorone) and the like; ethers, such as diethyl ether, 1,4-dioxane, cellosolve, di Propyl ether, tetrahydrofuran and the like; aliphatic hydrocarbons such as normal paraffin, naphthene, isoparaffin, kerosene, mineral oil and the like; aromatic hydrocarbons such as Toluene, C 9 -C 10 alkylbenzene, xylene, solvent naphtha, alkylnaphthalene, high-boiling aromatic hydrocarbons and the like; halogenated hydrocarbons such as 1,2-dichloro Ethane, chloroform, carbon tetrachloride and the like; esters such as ethyl acetate, diisopropyl phthalate, dibutyl phthalate, phthalic acid Dioctyl phthalate, dimethyl adipate and the like; lactones such as γ-butyrolactone and the like; amides such as di Methylformamide, diethylformamide, dimethylacetamide, N -alkylpyrrolidone, and the like; nitriles, such as acetonitrile and the like; sulfur compounds, such as dimethylsulfoxide and Analogues; vegetable oils such as soybean oil, rapeseed oil, cottonseed oil, coconut oil, castor oil, and the like; and water.

至於表面活性劑,沒有特別的限制。然而,該表面活性劑較佳地在水中凝膠化或膨脹。實例包括非-離子表面活性劑,諸如去水山梨醇脂肪酸酯(sorbitan fatty acid ester)、聚氧乙烯去水山梨醇脂肪酸酯(polyoxyethylene sorbitan fatty acid ester)、蔗糖脂肪酸酯、聚氧乙烯脂肪酸酯、聚氧乙烯樹脂酸酯、聚氧乙烯脂肪酸二酯、聚氧乙烯烷基醚、聚氧乙烯烷基苯基醚、聚氧乙烯二烷基苯基醚、聚氧乙烯烷基苯基醚-福馬林縮合物(polyoxyethylene alkylphenyl ether-formalin condensate)、聚氧乙烯聚氧丙烯嵌段聚合物(polyoxyethylene polyoxypropylene block polymer)、烷基聚氧乙烯聚丙烯嵌段聚合物醚、聚氧乙烯烷基胺、聚氧乙烯脂肪酸醯胺、聚氧乙烯脂肪酸二苯醚、聚亞烷基芐基苯基醚、聚氧化烯苯乙烯基苯基醚、乙炔二醇、聚氧化烯-加成乙炔二醇、聚氧乙烯醚型矽、酯型矽、含氟表面活性劑、聚氧乙烯蓖麻油、聚氧乙烯硬化蓖麻油和類似之物;陰離子表面活性劑,諸如烷基硫酸鹽、聚氧乙烯烷基醚硫酸鹽、聚氧乙烯烷基苯基醚硫酸鹽、聚氧乙烯苯乙烯基苯基醚硫酸鹽、烷基苯磺酸鹽、木質素磺酸鹽、烷基磺基琥珀酸鹽、萘磺酸鹽、烷基萘磺酸鹽、萘磺酸-福馬林縮合物鹽、烷基萘磺酸-福馬林縮合物鹽、脂肪酸鹽、多羧酸鹽、N -甲基-脂肪酸肌胺酸鹽、樹脂酸鹽、聚氧乙烯烷基醚磷酸鹽、聚氧乙烯烷基苯基醚磷酸鹽和類似之物;陽離子表面活性劑包括烷基胺鹽,諸如月桂胺鹽酸鹽、硬脂胺鹽酸鹽、油胺鹽酸鹽、硬脂胺乙酸鹽、硬脂基胺基丙胺乙酸鹽、烷基三甲基氯化銨、烷基二甲基苯扎氯銨(alkyl dimethyl benzalkonium chloride)和類似之物;以及兩性表面活性劑,諸如甜菜鹼型(betaine type)(例如二烷基二胺基乙基甜菜鹼或烷基二甲基芐基甜菜鹼)、胺基酸型(例如二烷基胺基乙基甘胺酸或烷基二甲基芐基甘胺酸)以及類似之物。As for the surfactant, there is no particular limitation. However, the surfactant preferably gels or swells in water. Examples include non-ionic surfactants such as sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyethylene Fatty acid ester, polyoxyethylene resin acid ester, polyoxyethylene fatty acid diester, polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene dialkyl phenyl ether, polyoxyethylene alkyl benzene Ether-formalin condensate (polyoxyethylene alkylphenyl ether-formalin condensate), polyoxyethylene polyoxypropylene block polymer (polyoxyethylene polyoxypropylene block polymer), alkyl polyoxyethylene polypropylene block polymer ether, polyoxyethylene alkyl Amine, polyoxyethylene fatty acid amide, polyoxyethylene fatty acid diphenyl ether, polyalkylene benzyl phenyl ether, polyoxyalkylene styryl phenyl ether, acetylene glycol, polyoxyalkylene-addition acetylene di Alcohol, polyoxyethylene ether type silicon, ester type silicon, fluorosurfactant, polyoxyethylene castor oil, polyoxyethylene hardened castor oil and the like; anionic surfactants such as alkyl sulfate, polyoxyethylene Alkyl ether sulfate, polyoxyethylene alkyl phenyl ether sulfate, polyoxyethylene styryl phenyl ether sulfate, alkyl benzene sulfonate, lignin sulfonate, alkyl sulfosuccinate, Naphthalenesulfonate, alkylnaphthalenesulfonate, naphthalenesulfonate-formalin condensate salt, alkylnaphthalenesulfonate-formalin condensate salt, fatty acid salt, polycarboxylate, N -methyl-fatty acid sarcosine Acid salt, resinate, polyoxyethylene alkyl ether phosphate, polyoxyethylene alkyl phenyl ether phosphate and the like; cationic surfactants include alkylamine salts, such as laurylamine hydrochloride, stearin Amine hydrochloride, oleylamine hydrochloride, stearylamine acetate, stearylaminopropylamine acetate, alkyl trimethyl ammonium chloride, alkyl dimethyl benzalkonium chloride And the like; and amphoteric surfactants, such as betaine type (betaine type) (e.g. dialkyldiaminoethyl betaine or alkyl dimethylbenzyl betaine), amino acid type (e.g. di (Alkylaminoethylglycine or alkyldimethylbenzylglycine) and the like.

至於黏合劑(binder)和增黏劑(tackifier),實例包括羧甲基纖維素或它的一鹽類、糊精、水溶性澱粉、三仙膠(xanthane gum)、瓜爾膠(guar gum)、蔗糖、聚乙烯吡咯啶酮、阿拉伯膠(gum arabic)、聚乙烯醇、聚乙酸乙烯酯、聚丙烯酸鈉、具有一為6,000至20,000的平均分子量的聚乙二醇、具有一為100,000至5,000,000的平均分子量的聚氧化乙烯,以及天然磷脂(例如腦磷脂酸(cephalinic acid)或卵磷脂)。As for binders and tackifiers, examples include carboxymethyl cellulose or one of its salts, dextrin, water-soluble starch, xanthane gum, guar gum , Sucrose, polyvinylpyrrolidone, gum arabic, polyvinyl alcohol, polyvinyl acetate, sodium polyacrylate, polyethylene glycol having an average molecular weight of 6,000 to 20,000, having a molecular weight of 100,000 to 5,000,000 The average molecular weight of polyethylene oxide, and natural phospholipids (such as cephalinic acid (cephalinic acid) or lecithin).

至於增稠劑(thickening agent),實例包括水-溶性聚合物,諸如三仙膠、瓜爾膠 、羧甲基纖維素、聚乙烯吡咯啶酮、羧基乙烯基聚合物、丙烯酸聚合物、澱粉衍生物、多醣和類似之物;以及無機細粉,諸如高純度膨土、白碳和類似之物。As for the thickening agent, examples include water-soluble polymers, such as three gums, guar gum, carboxymethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic polymer, starch derivative Substances, polysaccharides, and the like; and fine inorganic powders, such as high-purity bentonite, white carbon, and the like.

至於著色劑,實例包括,無機顏料,諸如氧化鐵、氧化鈦、普魯士藍(Prussian Blue)和類似之物;以及有機染料,諸如茜素染料(Alizarine dye)、偶氮染料(azo dye)、金屬酞青染料(metal phthalocyanine dye)和類似之物。As for the colorant, examples include, inorganic pigments such as iron oxide, titanium oxide, Prussian Blue and the like; and organic dyes such as Alizarine dye, azo dye, metal Metal phthalocyanine dye and the like.

至於展開劑(spreader),實例包括矽-為基礎的表面活性劑(silicone-based surfactant)、纖維素粉末、糊精、加工澱粉、聚胺基羧酸螯合化合物、交聯的聚乙烯吡咯啶酮、馬來酸和苯乙烯、甲基丙烯酸共聚物、在多元醇聚合物與二羧酸酐之間的半酯,以及聚苯乙烯磺酸的水溶性鹽類。As for the spreader, examples include silicon-based surfactants, cellulose powder, dextrin, processed starch, polyaminocarboxylic acid chelating compounds, cross-linked polyvinylpyrrolidine Ketones, maleic acid and styrene, methacrylic acid copolymers, half esters between polyol polymers and dicarboxylic anhydrides, and water-soluble salts of polystyrene sulfonic acid.

至於黏著劑(sticker),實例包括表面活性劑(例如二烷基磺基琥珀酸鈉、聚氧乙烯烷基醚、聚氧乙烯烷基苯基醚,或聚氧乙烯脂肪酸酯)、石蠟、萜烯、聚醯胺樹脂、聚丙烯酸鹽、聚氧乙烯、蠟、聚乙烯基烷基醚、烷基酚-福馬林縮合物,以及合成的樹脂乳劑。As for the adhesive, examples include surfactants (such as sodium dialkyl sulfosuccinate, polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, or polyoxyethylene fatty acid ester), paraffin, Terpenes, polyamide resins, polyacrylates, polyoxyethylene, waxes, polyvinyl alkyl ethers, alkylphenol-formalin condensates, and synthetic resin emulsions.

至於防凍劑(anti-freeze),實例包括多元醇(例如乙二醇、二甘醇、丙二醇或甘油)。As for anti-freeze, examples include polyhydric alcohols (such as ethylene glycol, diethylene glycol, propylene glycol, or glycerin).

至於固化抑制劑,實例包括多醣(例如澱粉、海藻酸、甘露糖或半乳糖)、聚乙烯吡咯啶酮、白碳、酯膠和石油樹脂。As for the curing inhibitor, examples include polysaccharides (for example, starch, alginic acid, mannose, or galactose), polyvinylpyrrolidone, white carbon, ester gum, and petroleum resin.

關於崩解劑(disintegrator),實例包括三聚磷酸鈉、六偏磷酸鈉、硬脂酸金屬鹽、纖維素粉末、糊精、甲基丙烯酸酯共聚物、聚乙烯吡咯啶酮、聚胺基羧酸螯合化合物、磺化苯乙烯-異丁烯-馬來酸酐共聚物以及澱粉聚丙烯腈接枝共聚物。Regarding disintegrator, examples include sodium tripolyphosphate, sodium hexametaphosphate, metal stearate, cellulose powder, dextrin, methacrylate copolymer, polyvinylpyrrolidone, polyamino carboxyl Acid chelating compound, sulfonated styrene-isobutylene-maleic anhydride copolymer and starch polyacrylonitrile graft copolymer.

至於分解抑制劑,實例包括,乾燥劑,諸如沸石、生石灰、氧化鎂和類似之物;抗氧化劑,諸如酚型、胺型、硫型、磷酸型和類似之物;以及紫外線吸收劑,諸如水楊酸型、二苯甲酮型以及類似之物。As for decomposition inhibitors, examples include, desiccants such as zeolite, quicklime, magnesium oxide and the like; antioxidants such as phenol type, amine type, sulfur type, phosphoric acid type and the like; and ultraviolet absorbers such as water Salicylic acid type, benzophenone type and the like.

當本害蟲控制劑含有上述的添加劑組分時,它們的含量(根據質量)被選擇在載體(例如固體載體或液體載體)的例子中在一通常地5至95%、較佳地20至90%的範圍內,在表面活性劑的例子中通常地0.1至30%、較佳地0.5至10%,以及在其它添加劑的例子中通常地0.1至30%、較佳地0.5至10%。When the present pest control agent contains the above-mentioned additive components, their content (according to quality) is selected in the case of a carrier (such as a solid carrier or a liquid carrier) at a usual 5 to 95%, preferably 20 to 90 Within the range of %, in the case of surfactants, it is usually 0.1 to 30%, preferably 0.5 to 10%, and in the case of other additives, it is usually 0.1 to 30%, preferably 0.5 to 10%.

本害蟲控制劑被使用在選自於下列的任何配方:粉劑配方、粉劑-顆粒混合物、顆粒、可濕性粉末、水溶性濃縮物、水分散性顆粒、錠劑、大粒劑(Jumbo)、可乳化濃縮物(emulsifiable concentrate)、油配方、溶液、可流動濃縮物、乳劑、微乳劑、懸乳劑(suspoemulsion)、超低容量配方、微膠囊、發煙劑(smoking agent)、氣溶膠、餌劑、糊劑等等。The pest control agent is used in any formulation selected from the group consisting of powder formulations, powder-granule mixtures, granules, wettable powders, water-soluble concentrates, water-dispersible granules, lozenges, large granules (Jumbo), and Emulsifiable concentrate, oil formula, solution, flowable concentrate, emulsion, microemulsion, suspoemulsion, ultra-low volume formula, microcapsule, smoking agent, aerosol, bait , Paste, etc.

在配方的實際使用中,配方可以本身或者在以一呈一給定濃度的稀釋劑(例如水)稀釋後而被使用。含有本化合物或它的稀釋產物的配方的施加可以藉由一慣常地被使用的方法而被進行,諸如分散(例如噴灑、噴霧、霧化、粉末分散、顆粒分散、在水面上分散,或者箱內分散(inbox dispersion))、土壤施加(例如混合或浸濕)、表面施加(例如塗布、粉劑塗布或覆蓋)、浸沒、毒餌、發煙以及類似之方法。為了預防有害的害蟲(特別是在家畜的排泄物中的有害昆蟲)的侵擾和生長,亦可能混合上述的活性成分與一家畜飼料。In the actual use of the formula, the formula may be used by itself or after being diluted with a diluent (such as water) at a given concentration. The application of the formulation containing the compound or its diluted product can be carried out by a conventionally used method, such as dispersion (for example, spraying, spraying, atomizing, powder dispersion, particle dispersion, dispersion on water surface, or tank) Inbox dispersion), soil application (such as mixing or wetting), surface application (such as coating, powder coating or covering), immersion, poison bait, smoke and similar methods. In order to prevent the infestation and growth of harmful pests (especially harmful insects in the excrement of livestock), it is also possible to mix the above-mentioned active ingredients with a family animal feed.

在本害蟲控制劑中的有效成分的比例(質量%)被適當地選擇藉此滿足需要。活性成分被適當地選擇,例如,在下列範圍: 在粉劑配方中,粉劑-顆粒混合物等等:0.01至20%,較佳地0.05至10%。在顆粒等等:0.1至30%,較佳地0.5至20%。在可濕性粉末、水-可分散的顆粒等等:1至70%,較佳地5至50%。在水-可溶性濃縮物、溶液等等:1-95%,較佳地10至80%。在可乳化濃縮物等等:5至90%,較佳地10至80%。在油配方等等:1至50%,較佳地5至30%。在可流動濃縮物等等:5至60%,較佳地10至50%。在乳劑、微乳劑、懸乳劑等等:5至70%,較佳地10至60%。在錠劑、餌、糊劑等等:1至80%,較佳地5至50%。在發煙劑等等:0.1至50%,較佳地1至30%。在氣溶膠等等:0.05至20%,較佳地0.1至10%。The ratio (mass %) of the active ingredient in this pest control agent is appropriately selected to satisfy the need. The active ingredient is appropriately selected, for example, in the following range: In powder formulations, powder-particle mixtures, etc.: 0.01 to 20%, preferably 0.05 to 10%. In particles and the like: 0.1 to 30%, preferably 0.5 to 20%. In wettable powders, water-dispersible particles, etc.: 1 to 70%, preferably 5 to 50%. In water-soluble concentrates, solutions, etc.: 1-95%, preferably 10 to 80%. In emulsifiable concentrates, etc.: 5 to 90%, preferably 10 to 80%. In oil formulations, etc.: 1 to 50%, preferably 5 to 30%. In flowable concentrates, etc.: 5 to 60%, preferably 10 to 50%. In emulsion, microemulsion, suspoemulsion, etc.: 5 to 70%, preferably 10 to 60%. In lozenges, baits, pastes, etc.: 1 to 80%, preferably 5 to 50%. In smoking agents and the like: 0.1 to 50%, preferably 1 to 30%. In aerosols and the like: 0.05 to 20%, preferably 0.1 to 10%.

該配方在稀釋後呈一適當濃度被噴灑,或者直接地被施加。The formulation is sprayed at an appropriate concentration after dilution, or applied directly.

當本害蟲控制劑在以一稀釋劑稀釋之後而被使用時,活性成分的濃度一般而言是0.1至5,000 ppm。當該配方本身被使用時,其每單位面積的施加量就活性成分化合物而言是每1 ha 0.1至5,000 g;然而,施加量不限於此。When the pest control agent is used after being diluted with a diluent, the concentration of the active ingredient is generally 0.1 to 5,000 ppm. When the formulation itself is used, its application amount per unit area is 0.1 to 5,000 g per 1 ha for the active ingredient compound; however, the application amount is not limited to this.

附帶地,當單獨使用本化合物作為一活性成分時,本害蟲控制劑是足夠地有效的。然而,本害蟲控制劑如需要可被混合或使用組合以肥料和農業化學品,諸如殺蟲劑、殺蟎劑、殺線蟲劑、增效劑、殺真菌劑、抗病毒劑、引誘劑、除草劑、植物生長-控制劑以及類似之物。在這個例子中,一更高的效用被展現。Incidentally, when the present compound is used alone as an active ingredient, the present pest control agent is sufficiently effective. However, the pest control agent may be mixed or used in combination with fertilizers and agricultural chemicals such as insecticides, acaricides, nematicides, synergists, fungicides, antiviral agents, attractants, herbicides if necessary Agents, plant growth-controlling agents and the like. In this example, a higher utility is shown.

本揭示的化合物(1)被有效地使用作為一農業和園藝的殺蟲劑、殺蟎劑、殺線蟲劑,或者一土壤殺蟲劑。特別地,本揭示的化合物(1)對於控制害蟲是有效的:例如,蚜蟲(aphids),諸如綠桃蚜蟲(green peach aphids)、棉蚜蟲(cotton aphids) 和類似者;小菜蛾(diamondback moths)、斜紋夜盜蛾(Spodoptera litura)、甘藍夜蛾(cabbage armyworms)、蕪菁夜蛾(common cutworms)、蘋果蠹蛾(codling moths)、棉鈴蟲(bollworms)、菸青蟲(tobacco budworms)、舞蛾(gypsy moths)、稻縱捲葉蟲(rice leafrollers)、茶小捲葉蛾(smaller tea tortrix moths)、科羅拉多馬鈴薯甲蟲(Colorado potato beetles)、葫蘆葉甲蟲(cucurbit leaf beetles)、棉鈴象鼻蟲(boll weevils)、蠟蟬(plant hoppers)、葉蟬(leafhoppers)、介殼蟲(scales)、蟲子(bugs)、粉蝨(whiteflies)、薊馬(thrips)、蚱蜢(grasshoppers)、花蠅(anthomyiid flies)金龜子(scarabs)、球菜夜蛾(black cutworms)、切根蟲(cutworms)、螞蟻和農業害蟲;腹足綱(gastropods),諸如蛞蝓(slugs)、蝸牛,和類似者;衛生-危害的昆蟲(hygiene-harming insects),諸如鼠蟎、蟑螂、家蠅、家蚊和類似者;儲糧昆蟲(stored-grain insects),諸如麥蛾(angoumois grain moths)、小豆象鼻蟲(adzuki bean weevil)、紅麵粉甲蟲(red flour beetles)、粉蜱(mealworms),和類似者;衣服-危害昆蟲(clothes-harming insects)以及家庭-和家用-危害昆蟲(house- and household-harming insects),諸如穀巢衣蛾(casemaking clothes moths)、黑地毯甲蟲(black carpet beetles)、地下白蟻(subterranean termites),和類似者;蟎,包括植物-寄生性蟎(plant-parasitic mites),諸如二點葉蟎(two-spotted spider mite)、胭脂红蜘蛛蟎(carmine spider mites)、柑橘紅蟎(citrus red mites)、Kanzawa蜘蛛蟎(Kanzawa spider mites)、歐洲紅蟎(European red mites)、茶細蟎(broad mites)、粉紅柑橘銹蟎(pink citrus rust mites)、根蟎(bulb mites),和類似者,和家塵蟎(house dust mites),諸如腐食酪蟎(Tyrophagus putrescentiae)、美洲室塵蟎(Dermatophagoides farina)、南爪蟎(Chelacaropsis moorei),和類似者;土壤害蟲,包括植物寄生線蟲,諸如根瘤線蟲(root-knot nematodes)、胞囊線蟲(cyst nematodes)、根腐線蟲(root-lesion nematodes)、白尖線蟲(white-tip nematodes)、草莓芽線蟲(strawberry bud nematodes)、松材線蟲(pine wood nematodes),和類似者,以及等足類(isopods),諸如球潮蟲(pill bugs)、蛜蛾(sow bugs),和類似者;以及類似者。The compound (1) of the present disclosure is effectively used as an agricultural and horticultural insecticide, acaricide, nematicide, or a soil insecticide. In particular, the disclosed compound (1) is effective for controlling pests: for example, aphids, such as green peach aphids, cotton aphids, and the like; diamondback moths , Spodoptera litura, cabbage armyworms, common cutworms, codling moths, bollworms, tobacco budworms, and dance moths (gypsy moths), rice leafrollers, smaller tea tortrix moths, Colorado potato beetles, cucurbit leaf beetles, boll weevils ), plant hoppers, leafhoppers, scales, bugs, whiteflies, thrips, grasshoppers, anthoyiid flies scarabs (scarabs), black cutworms, cutworms, ants and agricultural pests; gastropods, such as slugs, snails, and the like; sanitary-hazardous insects ( hygiene-harming insects), such as rat mites, cockroaches, house flies, house mosquitoes and the like; stored-grain insects, such as wheat moths (angoumois grain moths), adzuki bean weevil, Red flour beetles, mealworms, and the like; clothes-harming insects and house- and household-harming insects, such as valley nests Casemaking clothes moths, black carpet beetles, subterranean termites, and the like; mites, including plant-parasitic mites, such as Two-spotted spider mite, carmine spider mites, citrus red mites, Kanzawa spider mites, European red mites, tea Broad mites, pink citrus rust mites, bulb mites, and the like, and house dust mites, such as Tyrophagus putrescentiae, American room Dermatophagoides farina, Chelacaropsis moorei, and the like; soil pests, including plant parasitic nematodes, such as root-knot nematodes, cyst nematodes, and root rot nematodes -lesion nematodes, white-tip nematodes, strawberry bud nematodes, pine wood nematodes, and the like, as well as isopods, such as coccidia pill bugs, sow bugs, and the like; and the like.

本揭示的化合物(1)特徵在於具有一特別優異的殺真菌活性和一廣效的活性。該化合物可被使用於控制歸因於各種不同的真菌病原體或抗性真菌病原體的植物病害。此等真菌病原體的實例包括那些引起黃瓜灰黴病(cucumber gray mold)、稻植物熱病(rice plant blast)(灰梨孢黴(Pyricularia grisea),栗(millet))、稻植物紋枯病(rice plant sheath blight)、蘋果白粉病(apple powdery mildew)、蘋果斑點落葉病(apple Alternaria blotch)、柿白粉病(persimmon powdery mildew)、葡萄白粉病(grape powdery mildew)、大麥白粉病(barley powdery mildew)、小麥白粉病(wheat powdery mildew)、黃瓜白粉病(cucumber powdery mildew)、黃瓜灰黴病、番茄晚疫病(tomato late blight)、草莓白粉病(strawberry powdery mildew)、煙草白粉病(tobacco powdery mildew),以及類似者。實施例 The compound (1) of the present disclosure is characterized by having a particularly excellent fungicidal activity and a broad-spectrum activity. The compound can be used to control plant diseases attributed to various fungal pathogens or resistant fungal pathogens. Examples of such fungal pathogens include those that cause cucumber gray mold, rice plant blast (Rice plant blast (Pyricularia grisea, millet)), rice plant sheath blight (rice plant sheath blight, apple powdery mildew, apple Alternaria blotch, persimmon powdery mildew, grape powdery mildew, barley powdery mildew , Wheat powdery mildew, cucumber powdery mildew, cucumber gray mold, tomato late blight, tomato powdery mildew, strawberry powdery mildew, and tobacco powdery mildew , And the like. Examples

本揭示參考下列製備實施例、配方實施例和試驗實施例而被更詳細地描述。然而,本揭示不限於這些實施例。製備實施例 1 The present disclosure is described in more detail with reference to the following preparation examples, formulation examples, and test examples. However, the present disclosure is not limited to these embodiments. Preparation Example 1

2,3-二甲基-6-((1-(p -甲苯基)-1H -吡唑-3-基)氧基)喹啉-4-基甲基碳酸鹽(2,3-dimethyl-6-((1-(p -tolyl)-1H -pyrazol-3-yl)oxy)quinolin-4-yl methyl carbonate)(化合物 1A-156 )的製備 (1) 1-(p -甲苯基)-1H -吡唑2,3-dimethyl-6-((1-( p -tolyl)-1 H -pyrazol-3-yl)oxy)quinolin-4-ylmethyl carbonate (2,3-dimethyl- Preparation of 6-((1-( p -tolyl)- 1H -pyrazol-3-yl)oxy)quinolin-4-yl methyl carbonate) ( Compound 1A-156 ) (1) 1-( p -tolyl)- 1H -pyrazole

1,1,3,3-四甲氧基丙烷(24.90 g, 151.84 mmol, 1.2 equiv.)在室溫下被添加至配於乙醇(300 mL)的p -甲苯基肼鹽酸鹽(p -tolylhydrazine hydrochloride)(20.0 g, 126.53 mmol)並且反應混合物被回流歷時10 h ("h"意指小時(們)。)。所有揮發物藉由蒸餾而被移除。反應混合物以蒸餾水(100 mL)稀釋並且以二氯甲烷(3 x 100 mL)予以萃取。合併的有機層以蒸餾水清洗,在硫酸鈉上予以乾燥、過濾以及在減壓下濃縮俾以提供有如一淡黃色油的1-(p -甲苯基)-1H -吡唑(18.1 g,粗糙的)。這個粗產物被使用例如在下一個步驟中而沒有任何進一步純化。1,1,3,3-Tetramethoxypropane (24.90 g, 151.84 mmol, 1.2 equiv.) was added to p -tolylhydrazine hydrochloride ( p- tolylhydrazine hydrochloride) (20.0 g, 126.53 mmol) and the reaction mixture was refluxed for 10 h ("h" means hour(s).). All volatiles are removed by distillation. The reaction mixture was diluted with distilled water (100 mL) and extracted with dichloromethane (3 x 100 mL). The combined organic layer was washed with distilled water, dried over sodium sulfate be, filtered and concentrated to provide serve like 1- (p - tolyl) - one as a pale yellow oil under reduced pressure 1H - pyrazole (18.1 g, rough ). This crude product is used for example in the next step without any further purification.

1 H NMR (CDCl3 ):7.89 (d,J = 2.0 Hz, 1H), 7.71 (s, 1H), 7.57 (d,J = 8.0 Hz, 2H), 7.24 (bs, 2H), 6.45 (bs, 1H), 2.38 (s, 3H);MS (M+1) 159.17。 (2) 1-(p -甲苯基)-1H -吡唑-4-甲醛 1 H NMR (CDCl 3 ): 7.89 (d, J = 2.0 Hz, 1H), 7.71 (s, 1H), 7.57 (d, J = 8.0 Hz, 2H), 7.24 (bs, 2H), 6.45 (bs, 1H), 2.38 (s, 3H); MS (M+1) 159.17. (2) 1- (p - tolyl) - 1H - pyrazol-4-carbaldehyde

POCl3 (87.29 g, 569.33 mmol, 5.0 equiv.)在0至10℃在氮氛圍下被緩慢地添加至DMF (41.61 g, 569.33 mmol, 5.0 equiv.)。這個接著被攪拌歷時15分鐘。一配於DMF (25 ml)的1-(p -甲苯基)-1H -吡唑(18.0 g, 113.86 mmol, 1.0 equiv.)的溶液被緩慢地添加至這個混合物並且反應混合物接著在0至10℃下被攪拌歷時30分鐘。接著所形成的混合物處於室溫並且被加熱至110℃歷時10 h。在冷卻至室溫以後,反應混合物被緩慢地倒入至蒸餾水內並且該反應混合物的pH藉由添加10% NaOH溶液至它而變成鹼性。產物接著以乙酸乙酯(3 x 100 mL)萃取。合併的有機層以蒸餾水清洗,在硫酸鈉上予以乾燥、過濾以及在減壓下濃縮俾以提供一粗產物。該因此所獲得的粗產物藉由管柱層析法在矽膠上以乙酸乙酯和n -己烷的一混合物作為一洗提液而被純化俾以提供有如一淡黃色固體的1-(p -甲苯基)-1H -吡唑-4-甲醛(16.5 g,產率78%)。POCl 3 (87.29 g, 569.33 mmol, 5.0 equiv.) was slowly added to DMF (41.61 g, 569.33 mmol, 5.0 equiv.) under a nitrogen atmosphere at 0 to 10°C. This was then stirred for 15 minutes. A counterweight in DMF (25 ml) of 1- (p - tolyl) - 1H - pyrazolo (. 18.0 g, 113.86 mmol, 1.0 equiv) solution was slowly added to the mixture and the reaction mixture followed by 0-10 Stirred at ℃ for 30 minutes. The resulting mixture was then at room temperature and heated to 110°C for 10 h. After cooling to room temperature, the reaction mixture was slowly poured into distilled water and the pH of the reaction mixture became alkaline by adding 10% NaOH solution to it. The product was then extracted with ethyl acetate (3 x 100 mL). The combined organic layer was washed with distilled water, dried over sodium sulfate, filtered and concentrated under reduced pressure to provide a crude product. The crude product thus obtained was purified by column chromatography on silica gel using a mixture of ethyl acetate and n -hexane as an eluent to provide 1-( p as a pale yellow solid - tolyl) - IH - pyrazole-4-carbaldehyde (16.5 g, 78% yield).

1 H NMR (CDCl3 ): 9.96 (s, 1H), 8.39 (s, 1H), 8.15 (s, 1H), 7.59 (d,J = 8.4 Hz, 2H), 7.30-7.29 (m, 2H), 2.41 (s, 3H);MS (M+1) 187.13。 (3) 1-(p -甲苯基)-1H -吡唑-4-醇 1 H NMR (CDCl 3 ): 9.96 (s, 1H), 8.39 (s, 1H), 8.15 (s, 1H), 7.59 (d, J = 8.4 Hz, 2H), 7.30-7.29 (m, 2H), 2.41 (s, 3H); MS (M+1) 187.13. (3) 1- (p - tolyl) - 1H - pyrazol-4-ol

m -氯過氧苯甲酸(m -Chloroperbenzoic acid)(8.34 g, 48.36 mmol, 0.9 equiv.)在室溫在氮氛圍下被添加至一配於氯仿(500 mL)的1-(p -甲苯基)-1H -吡唑-4-甲醛(10.0 g, 53.74 mmol, 1.0 equiv.)的溶液中。所形成的混合物被回流歷時4h。反應混合物接著被冷卻至室溫,以DCM (100 mL)予以稀釋,以碳酸氫鈉溶液(3 x 100 mL)繼而蒸餾水(3 x 100 mL)予以清洗,在硫酸鈉上予以乾燥、過濾以及在減壓下濃縮俾以提供一粗產物。甲醇(50 mL)、蒸餾水(25 mL)繼而濃縮的HCl (50 mL)被添加至該粗產物並且接著反應混合物被回流歷時10h。在冷卻至室溫以後,所有揮發物在減壓下被蒸餾出。該反應混合物的pH接著藉由添加碳酸氫鈉溶液而成為中性並且以乙酸乙酯(3 x 100 mL)予以萃取。合併的有機層以蒸餾水清洗,在硫酸鈉上予以乾燥、過濾以及在減壓下濃縮俾以提供一粗產物。該因此所獲得的粗產物藉由管柱層析法在矽膠上以乙酸乙酯和n -己烷的一混合物作為一洗提液而被純化俾以提供有如一淺褐色固體的1-(p -甲苯基)-1H -吡唑-4-醇(7.0 g,產率75%)。 m - chloroperoxybenzoic acid (m -Chloroperbenzoic acid) (. 8.34 g, 48.36 mmol, 0.9 equiv) was added at room temperature under a nitrogen atmosphere to a ligand in chloroform (500 mL) of 1- (p - tolyl ) -1H -pyrazole-4-carbaldehyde (10.0 g, 53.74 mmol, 1.0 equiv.) in solution. The resulting mixture was refluxed for 4h. The reaction mixture was then cooled to room temperature, diluted with DCM (100 mL), washed with sodium bicarbonate solution (3 x 100 mL) followed by distilled water (3 x 100 mL), dried over sodium sulfate, filtered and Concentrate under reduced pressure to provide a crude product. Methanol (50 mL), distilled water (25 mL) and then concentrated HCl (50 mL) were added to the crude product and then the reaction mixture was refluxed for 10 h. After cooling to room temperature, all volatiles were distilled off under reduced pressure. The pH of the reaction mixture was then neutralized by adding sodium bicarbonate solution and extracted with ethyl acetate (3 x 100 mL). The combined organic layer was washed with distilled water, dried over sodium sulfate, filtered and concentrated under reduced pressure to provide a crude product. The crude product thus obtained was purified by column chromatography on silica gel using a mixture of ethyl acetate and n -hexane as an eluent to provide 1-( p as a light brown solid - tolyl) - IH - pyrazol-4-ol (7.0 g, 75% yield).

1 H NMR (CDCl3 ):7.56 (s, 1H), 7.46 (d,J = 8.4 Hz, 2H), 7.41 (s, 1H), 7.22 (d,J = 8.4 Hz, 2H), 4.86 (bs, 1H), 2.36 (s, 3H);MS (M+1) 175.13。 (4) 4-(4-硝基苯氧基)-1-(p -甲苯基)-1H -吡唑 1 H NMR (CDCl 3 ): 7.56 (s, 1H), 7.46 (d, J = 8.4 Hz, 2H), 7.41 (s, 1H), 7.22 (d, J = 8.4 Hz, 2H), 4.86 (bs, 1H), 2.36 (s, 3H); MS (M+1) 175.13. (4) 4- (4-nitrophenoxy) -1- (p - tolyl) - 1H - pyrazol

碳酸銫(4.21 g, 12.92 mmol, 1.5 equiv.)和1-氟-4-硝基苯(1.21 g, 8.61 mmol, 1.0 equiv.)在室溫在氮氛圍下被依序地添加至一配於DMF (50 mL)的1-(p -甲苯基)-1H -吡唑-4-醇(1.5 g, 8.61 mmol, 1.0 equiv.)的溶液中。所形成的混合物接著被加熱至70℃歷時10 h。反應混合物被冷卻至室溫,予以倒入至蒸餾水(100 mL)內並且以乙酸乙酯(3 x 80 mL)萃取。合併的有機層以蒸餾水清洗,在硫酸鈉上予以乾燥和過濾。這個接著在減壓下被濃縮俾以提供有如一黃色固體的4-(4-硝基苯氧基)-1-(p -甲苯基)-1H-吡唑(1.65 g,粗糙的)。這個粗產物被使用例如在下一個步驟中而沒有任何進一步純化。Cesium carbonate (4.21 g, 12.92 mmol, 1.5 equiv.) and 1-fluoro-4-nitrobenzene (1.21 g, 8.61 mmol, 1.0 equiv.) were added sequentially to a mixture at room temperature under a nitrogen atmosphere. DMF (50 mL) of 1- (p - tolyl) - 1H - pyrazol-4-ol (. 1.5 g, 8.61 mmol, 1.0 equiv) was. The resulting mixture was then heated to 70°C for 10 h. The reaction mixture was cooled to room temperature, poured into distilled water (100 mL) and extracted with ethyl acetate (3 x 80 mL). The combined organic layer was washed with distilled water, dried over sodium sulfate and filtered. This was then concentrated under reduced pressure to provide 4-(4-nitrophenoxy)-1-( p -tolyl)-1H-pyrazole (1.65 g, rough) as a yellow solid. This crude product is used for example in the next step without any further purification.

1 H NMR (CDCl3 ):8.23 (d.J = 9.2 Hz, 2H), 7.86 (s, 1H), 7.61 (s, 1H), 7.55 (d,J = 8.4 Hz, 2H), 7.28 (d,J = 8.4 Hz, 2H), 7.15 (d,J = 9.2 Hz, 2H), 2.40 (s, 3H);MS (M+1) 296.16。 (5) 4-((1-(p-甲苯基)-1H -吡唑-4-基)氧基)苯胺 1 H NMR (CDCl 3 ): 8.23 (d. J = 9.2 Hz, 2H), 7.86 (s, 1H), 7.61 (s, 1H), 7.55 (d, J = 8.4 Hz, 2H), 7.28 (d, J = 8.4 Hz, 2H), 7.15 (d, J = 9.2 Hz, 2H), 2.40 (s, 3H); MS (M+1) 296.16. (5) 4 - ((1- (p- tolyl) - 1H - pyrazol-4-yl) oxy) aniline

氯化銨(2.72 g, 50.83 mmol, 10.0 equiv.)被添加至一配於THF:甲醇(1:1, 50 mL)和蒸餾水(5 mL)的4-(4-硝基苯氧基)-1-(p-甲苯基)-1H-吡唑(1.50 g, 5.08 mmol)的溶液中,繼而在室溫下分批添加鋅粉(3.32 g, 50.83 mmol, 10 equiv.)。所形成的混合物在室溫下被攪拌歷時2h。反應混合物接著以乙酸乙酯(100 ml)稀釋並且經由矽藻土床而被過濾。濾液以蒸餾水清洗,在硫酸鈉上予以乾燥、過濾。這個接著在減壓下被濃縮俾以提供有如一米白色固體的4-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)苯胺(1.34 g,粗糙的)。這個粗產物被使用例如在下一個步驟中而沒有任何進一步純化。Ammonium chloride (2.72 g, 50.83 mmol, 10.0 equiv.) was added to a mixture of 4-(4-nitrophenoxy) in THF: methanol (1:1, 50 mL) and distilled water (5 mL). To a solution of 1-(p-tolyl)-1H-pyrazole (1.50 g, 5.08 mmol), zinc powder (3.32 g, 50.83 mmol, 10 equiv.) was added in portions at room temperature. The resulting mixture was stirred at room temperature for 2h. The reaction mixture was then diluted with ethyl acetate (100 ml) and filtered through a bed of diatomaceous earth. The filtrate was washed with distilled water, dried over sodium sulfate, and filtered. This then was concentrated under reduced pressure to provide serve like one meter white solid 4 - ((1- (p - tolyl) - 1H - pyrazol-4-yl) oxy) aniline (1.34 g, rough) . This crude product is used for example in the next step without any further purification.

1 H NMR (CDCl3 ):7.64 (s, 1H), 7.51-7.49 (m, 3H), 7.27 (d,J = 8.4 Hz, 2H), 6.94 (d,J = 8.8 Hz, 2H), 6.66 (d,J = 8.8 Hz, 2H), 4.63 (bs, 2H), 2.37 (s, 3H);MS (M+1) 266.22。 (6) 2,3-二甲基-6-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)-喹啉-4(1H)-酮 1 H NMR (CDCl 3 ): 7.64 (s, 1H), 7.51-7.49 (m, 3H), 7.27 (d, J = 8.4 Hz, 2H), 6.94 (d, J = 8.8 Hz, 2H), 6.66 ( d, J = 8.8 Hz, 2H), 4.63 (bs, 2H), 2.37 (s, 3H); MS (M+1) 266.22. (6) 2,3-dimethyl -6 - ((1- (p - tolyl) - IH - pyrazol-4-yl) oxy) - quinolin -4 (1H) - one

2-甲基-3-氧丁酸乙酯(Ethyl 2-methyl-3-oxobutanoate)(0.74 g, 5.14 mmol, 1.1 equiv.)和p -甲苯磺酸(催化量)在氮氛圍下被依序地添加至一配於二甲苯(30 mL)的4-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)苯胺(1.24 g, 4.67 mmol, 1.0 equiv.)的溶液中。所形成的混合物使用一迪安-斯塔克裝置(Dean-Stark apparatus)裝置而被回流歷時16h。所有揮發物在減壓下被蒸餾出俾以提供一粗產物。該因此所獲得的粗產物藉由管柱層析法在矽膠上以甲醇和二氯甲烷的一混合物作為一洗提液而被純化俾以提供有如一褐色固體的2,3-二甲基-6-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)喹啉-4(1H )-酮(0.7 g,產率43%)。Ethyl 2-methyl-3-oxobutanoate (0.74 g, 5.14 mmol, 1.1 equiv.) and p -toluenesulfonic acid (catalytic amount) are sequentially provided under a nitrogen atmosphere added to a counterweight 4 in xylene (30 mL) is - ((1- (p - tolyl) - 1H - pyrazol-4-yl) oxy) aniline (1.24 g, 4.67 mmol, 1.0 equiv.) In solution. The resulting mixture was refluxed for 16h using a Dean-Stark apparatus. All volatiles were distilled off under reduced pressure to provide a crude product. The crude product thus obtained was purified by column chromatography on silica gel using a mixture of methanol and dichloromethane as an eluent to provide 2,3-dimethyl- as a brown solid 6 - ((1- (p - tolyl) - 1H - pyrazol-4-yl) oxy) quinolin -4 (1H) - one (0.7 g, 43% yield).

1 H NMR (DMSO-d6 ):δ 11.52 (bs, 1H), 8.59 (s, 1H), 7.73-7.71 (m, 3H), 7.54-7.52 (m, 1H), 7.47-7.43 (m, 1H), 7.31 (d, J = 8.0 Hz, 2H), 7.11 (d, J = 7.6 Hz, 1H), 2.37 (s, 3H), 2.34 (s, 3H), 1.94 (s, 3H);MS (M+1) 346.20。 (7) 2,3-二甲基-6-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)喹啉-4-基甲基碳酸鹽(1A-156 ) 1 H NMR (DMSO- d 6 ): δ 11.52 (bs, 1H), 8.59 (s, 1H), 7.73-7.71 (m, 3H), 7.54-7.52 (m, 1H), 7.47-7.43 (m, 1H ), 7.31 (d, J = 8.0 Hz, 2H), 7.11 (d, J = 7.6 Hz, 1H), 2.37 (s, 3H), 2.34 (s, 3H), 1.94 (s, 3H); MS (M +1) 346.20. (7) 2,3-dimethyl -6 - ((1- (p - tolyl) - 1H - pyrazol-4-yl) oxy) quinolin-4-yl methyl carbonate (1A-156 )

三級-丁氧基鉀(16 mg, 0.14 mmol, 1.0 equiv.)在室溫在氮氛圍下被添加至一配於THF(10 ml)的2,3-二甲基-6-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)喹啉-4(1H )-酮(50 mg, 0.14 mmol)的混合物中並且被攪拌歷時15分鐘。氯甲酸甲酯(13 mg, 0.14 mmol, 1.0 equiv.)被添加至這個溶液並且反應混合物接著在室溫下被攪拌歷時10 h。該反應混合物接著以乙酸乙酯(20 mL)稀釋並且有機層以碳酸氫鈉溶液繼而蒸餾水清洗。該有機層在硫酸鈉上被乾燥、予以過濾並且在減壓下濃縮俾以提供一粗產物。該因此所獲得的粗產物藉由管柱層析法在矽膠上以乙酸乙酯和n -己烷的一混合物作為一洗提液而被純化俾以提供有如一米白色固體的2,3-二甲基-6-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)喹啉-4-基甲基碳酸鹽(40 mg,產率68.5%)。Tertiary-butoxy potassium (16 mg, 0.14 mmol, 1.0 equiv.) was added to a 2,3-dimethyl-6-((1 - (p - tolyl) - 1H - (1H) pyrazol-4-yl) oxy) quinoline -4-- -one (50 mg, 0.14 mmol) and stirred in for 15 minutes. Methyl chloroformate (13 mg, 0.14 mmol, 1.0 equiv.) was added to this solution and the reaction mixture was then stirred at room temperature for 10 h. The reaction mixture was then diluted with ethyl acetate (20 mL) and the organic layer was washed with sodium bicarbonate solution followed by distilled water. The organic layer was dried over sodium sulfate, filtered and concentrated under reduced pressure to provide a crude product. The crude product thus obtained was purified by column chromatography on silica gel using a mixture of ethyl acetate and n -hexane as an eluent to provide 2,3-like a beige solid dimethyl -6 - ((1- (p - tolyl) - 1H - pyrazol-4-yl) oxy) methyl-quinolin-4-yl carbonate (40 mg, 68.5% yield).

1 H NMR (CDCl3 ):δ 7.99 (d,J = 9.2 Hz, 1H), 7.81 (s, 1H), 7.62 (s, 1H), 7.55 (d,J = 8.4 Hz, 2H), 7.49-7.46 (dd, J = 9.2, 2.8 Hz, 1H), 7.32 (d,J = 2.4 Hz, 1H), 7.27 (s, 1H), 7.25 (s, 1H), 3.91 (s, 3H), 2.71 (s, 3H), 2.39 (s, 3H), 2.30 (s, 3H);MS (M+1) 404.51。製備實施例 2 1 H NMR (CDCl 3 ): δ 7.99 (d, J = 9.2 Hz, 1H), 7.81 (s, 1H), 7.62 (s, 1H), 7.55 (d, J = 8.4 Hz, 2H), 7.49-7.46 (dd, J = 9.2, 2.8 Hz, 1H), 7.32 (d, J = 2.4 Hz, 1H), 7.27 (s, 1H), 7.25 (s, 1H), 3.91 (s, 3H), 2.71 (s, 3H), 2.39 (s, 3H), 2.30 (s, 3H); MS (M+1) 404.51. Preparation Example 2

2,3-二甲基-6-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)喹啉-4-基乙基碳酸鹽(2,3-dimethyl-6-((1-(p -tolyl)-1H -pyrazol-4-yl)oxy)quinolin-4-yl ethyl carbonate)(化合物 1A-157 )的製備 三級-丁氧基鉀(16 mg, 0.14 mmol, 1.0 equiv.)在室溫在氮氛圍下被添加至一配於THF(10 ml)的2,3-二甲基-6-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)喹啉-4(1H )-酮(50 mg, 0.14 mmol)的混合物中並且攪拌歷時15分鐘。氯甲酸乙酯(15 mg, 0.14 mmol, 1.0 equiv.)被添加至這個溶液並且反應混合物接著在室溫下被攪拌歷時10 h。該反應混合物以乙酸乙酯(20 mL)稀釋並且有機層以碳酸氫鈉溶液繼而蒸餾水清洗。該有機層在硫酸鈉上被乾燥、予以過濾並且在減壓下濃縮俾以提供一粗產物。該因此所獲得的粗產物藉由管柱層析法在矽膠上以乙酸乙酯和n -己烷的一混合物作為一洗提液而被純化俾以提供有如一米白色固體的2,3-二甲基-6-((1-(p -甲苯基)-1H -吡唑-4-基)氧基)喹啉-4-基乙基碳酸鹽(40 mg,產率66.2%)。2,3-dimethyl-6-((1-( p -tolyl)-1 H -pyrazol-4-yl)oxy)quinolin-4-ylethyl carbonate (2,3-dimethyl- Preparation of 6-((1-( p -tolyl)- 1H -pyrazol-4-yl)oxy)quinolin-4-yl ethyl carbonate) ( Compound 1A-157 ) Tertiary-butoxy potassium (16 mg, 0.14 . mmol, 1.0 equiv) was added at room temperature under a nitrogen atmosphere to a ligand in THF (10 ml) of 2,3-dimethyl -6 - ((1- (p - tolyl) - 1H - pyrazol -4-yl)oxy)quinolin-4( 1H )-one (50 mg, 0.14 mmol) in a mixture and stirred for 15 minutes. Ethyl chloroformate (15 mg, 0.14 mmol, 1.0 equiv.) was added to this solution and the reaction mixture was then stirred at room temperature for 10 h. The reaction mixture was diluted with ethyl acetate (20 mL) and the organic layer was washed with sodium bicarbonate solution followed by distilled water. The organic layer was dried over sodium sulfate, filtered and concentrated under reduced pressure to provide a crude product. The crude product thus obtained was purified by column chromatography on silica gel using a mixture of ethyl acetate and n -hexane as an eluent to provide 2,3-like a beige solid dimethyl -6 - ((1- (p - tolyl) - 1H - pyrazol-4-yl) oxy) quinolin-4-yl ethyl carbonate (40 mg, 66.2% yield).

1 H NMR (CDCl3 ):δ 7.99 (d, J = 9.2 Hz, 1H), 7.82 (s, 1H), 7.62 (s, 1H), 7.55 (d,J = 8.4 Hz, 2H), 7.49-7.46 (dd,J = 9.2, 2.8 Hz, 1H), 7.30 (d,J = 2.8 Hz, 1H), 7.27 (s, 1H), 7.25 (s, 1H), 4.33-4.28 (q,J = 7.2 Hz, 2H), 2.71 (s, 3H), 2.39 (s, 3H), 2.30 (s, 3H), 1.32 (t,J = 7.2 Hz, 3H);MS (M+1)418.86。 1 H NMR (CDCl 3 ): δ 7.99 (d, J = 9.2 Hz, 1H), 7.82 (s, 1H), 7.62 (s, 1H), 7.55 (d, J = 8.4 Hz, 2H), 7.49-7.46 (dd, J = 9.2, 2.8 Hz, 1H), 7.30 (d, J = 2.8 Hz, 1H), 7.27 (s, 1H), 7.25 (s, 1H), 4.33-4.28 (q, J = 7.2 Hz, 2H), 2.71 (s, 3H), 2.39 (s, 3H), 2.30 (s, 3H), 1.32 (t, J = 7.2 Hz, 3H); MS (M+1)418.86.

本揭示的代表性化合物被例示在下列 1 4 ,但是本揭示不限於這些化合物。Representative compounds of the present disclosure is illustrated in the following Tables 1 to 4, but the present disclosure is not limited to these compounds.

1 4 中所顯示的化合物(不是在製備實施例12 所獲得的化合物)藉由相似於在製備實施例12 所描述的方法或在說明書中所描述的方法而被生產。 在 1 4 的縮寫被指示如下:The compounds shown in Tables 1 to 4 (not the compounds obtained in Preparation Examples 1 to 2 ) were produced by a method similar to that described in Preparation Examples 1 to 2 or the method described in the specification . The abbreviations in Tables 1 to 4 are indicated as follows:

F:氟,Cl:氯,Br:溴,Me:甲基,Et:乙基,n-Pr:n -丙基,n-Bu:n -丁基,t Bu:三級 - 丁基,Ph:苯基,C6 H11 :環己基,CF3 :三氟甲基,C3 F7 :七氟異丙基,OCF3 :三氟甲氧基,OMe:甲氧基,COMe:甲基羰基,OPh:苯氧基,CO2 Me:甲氧基羰基,CO2 Et:乙氧基羰基,CO2 Ph:苯氧基羰基,Cy-pr:環丙基,Cy-pent:環戊基,F2 -Ph:二氟苯基,Cl2 -Ph:二氯苯基,Cl3 -Ph:三氯苯基,SO2 Me:甲基磺醯基,SO2 Et:乙基磺醯基,SO2 CF3 :三氟甲基磺醯基,CN:氰基,NO2 :硝基。F: fluorine, Cl: chlorine, Br: bromine, Me: methyl, Et: ethyl, n-Pr: n -propyl, n-Bu: n -butyl, t Bu: tertiary - butyl, Ph : Phenyl, C 6 H 11 : cyclohexyl, CF 3 : trifluoromethyl, C 3 F 7 : heptafluoroisopropyl, OCF 3 : trifluoromethoxy, OMe: methoxy, COMe: methyl Carbonyl, OPh: phenoxy, CO 2 Me: methoxycarbonyl, CO 2 Et: ethoxycarbonyl, CO 2 Ph: phenoxycarbonyl, Cy-pr: cyclopropyl, Cy-pent: cyclopentyl , F 2 -Ph: difluorophenyl, Cl 2 -Ph: dichlorophenyl, Cl 3 -Ph: trichlorophenyl, SO 2 Me: methylsulfonyl, SO 2 Et: ethylsulfonyl , SO 2 CF 3 : trifluoromethylsulfonyl, CN: cyano, NO 2 : nitro.

1:

Figure 02_image017
Figure 108122910-A0304-0001
*這兩者異構物藉由管柱層析法是不可分離的 Table 1:
Figure 02_image017
Figure 108122910-A0304-0001
*The two isomers are inseparable by column chromatography

2

Figure 02_image019
Figure 108122910-A0304-0002
Table 2 :
Figure 02_image019
Figure 108122910-A0304-0002

3

Figure 02_image021
Figure 108122910-A0304-0003
*這兩者異構物藉由管柱層析法是不可分離的。 Table 3 :
Figure 02_image021
Figure 108122910-A0304-0003
*The two isomers are inseparable by column chromatography.

4 屬於本揭示的結構(1A、1B & 1C)的合成的化合物的1 H NMR和LC-MS的細節:

Figure 108122910-A0304-0004
配方實施例 1 :乳劑 Table 4 : Details of 1 H NMR and LC-MS of the synthesized compounds belonging to the structure (1A, 1B & 1C) of the present disclosure:
Figure 108122910-A0304-0004
Formulation Example 1 : Emulsion

10部分的本揭示的各個化合物被溶解在45部分的Solvesso 150和35部分的N -甲基吡咯啶酮中。10部分的一乳化劑(商標名:Sorpol 3005X,由Toho Chemical Industry Co., Ltd.所生產)被添加於此。混合物藉由攪拌而被混合俾以提供10%乳劑。配方實施例 2 :可濕性粉末 Part 10 of each disclosed compound was dissolved in 45 parts of Solvesso 150 and 35 parts of N -methylpyrrolidone. Part 10 of an emulsifier (trade name: Sorpol 3005X, manufactured by Toho Chemical Industry Co., Ltd.) was added here. The mixture is mixed by stirring to provide a 10% emulsion. Formulation Example 2 : Wettable powder

20部分的本揭示的各個化合物被添加至2部分的十二烷基硫酸鈉、4部分的木質素磺酸鈉、20部分的合成的水合二氧化矽的細粉末和54部分的黏土的一混合物。混合物藉由在一果汁混合器中摻合而被混合俾以提供20%可濕性粉末。配方實施例 3 :顆粒 Part 20 of each compound of the present disclosure is added to a mixture of 2 parts of sodium lauryl sulfate, 4 parts of sodium lignosulfonate, 20 parts of fine powder of synthetic hydrated silica, and 54 parts of clay . The mixture is mixed by blending in a juice mixer to provide a 20% wettable powder. Formulation Example 3 : Granules

2部分的十二烷基苯磺酸鈉、10部分的膨土和83部分的黏土被添加至5部分的本揭示的各個化合物,並且各個混合物藉由攪拌而被充分地混合。一適當量的水被添加於此。所形成的混合物進一步被攪拌並且以一造粒機而被粒化。顆粒被風乾俾以提供5%顆粒。配方實施例 4 :粉劑 2 parts of sodium dodecylbenzenesulfonate, 10 parts of bentonite and 83 parts of clay were added to 5 parts of each compound of the present disclosure, and each mixture was sufficiently mixed by stirring. An appropriate amount of water is added here. The resulting mixture is further stirred and granulated with a granulator. The particles were air dried to provide 5% particles. Formulation Example 4 : Powder

1部分的本揭示的各個化合物被溶解在一適當量的丙酮中。5部分的合成的水合二氧化矽的細粉末、0.3部分的酸性磷酸異丙酯(acidic isopropyl phosphate, PAP)和93.7部分的黏土被添加於此。混合物藉由在一果汁混合器中摻和而被混合,以及丙酮藉由蒸發而被移除俾以提供1%粉劑。配方實施例 5 :可流動製劑 Part 1 of each compound of the present disclosure is dissolved in an appropriate amount of acetone. 5 parts of fine powder of synthetic hydrated silica, 0.3 parts of acidic isopropyl phosphate (PAP) and 93.7 parts of clay were added here. The mixture was mixed by blending in a juice mixer, and acetone was removed by evaporation to provide 1% powder. Formulation Example 5 : Flowable formulation

20部分的本揭示的各個化合物被混合以20部分的含有3部分的聚氧乙烯三苯乙烯基苯基醚磷酸酯三乙醇胺和0.2部分的Rhodorsil 426R的水。混合物以一DYNO-Mill進行濕式粉碎,並且被混合以60部分的含有8部分的丙二醇和0.32部分的三仙膠的水俾以提供配於水的20%懸浮液。Part 20 of each compound of the present disclosure was mixed with 20 parts of water containing 3 parts of polyoxyethylene tristyrylphenyl ether phosphate triethanolamine and 0.2 parts of Rhodorsil 426R. The mixture was wet pulverized with a DYNO-Mill and was mixed with 60 parts of water containing 8 parts of propylene glycol and 0.32 parts of Sanxian gum to provide a 20% suspension formulated in water.

一些試驗實施例被提供在下面俾以證明:本揭示的化合物作為一用於殺蟲劑、殺蟎劑和殺真菌劑的活性成分是有用的。化合物 A化合物 BFlometoquin 是在WO2006/013896A1、WO2007/088978A1的說明書中所提到的代表性化合物。

Figure 02_image023
試驗實施例 1 ( 棉蚜蟲的殺蚜蟲試驗 ) Some test examples are provided below to prove that the disclosed compounds are useful as an active ingredient for insecticides, acaricides and fungicides. Compound A , Compound B and Flometoquin are representative compounds mentioned in the specification of WO2006/013896A1, WO2007/088978A1.
Figure 02_image023
Test Example 1 ( Aphid-killing test of cotton aphids )

一片非織物(4.5 x 5.5 cm)經由一在塑膠杯的蓋子所做出的切口而被懸置在一塑膠杯內。在水被倒入至杯內以後,杯子被覆蓋以蓋子。一黃瓜葉(約3.5 x 4.5Cm)接著被放置在經充分地浸泡的非織物上。另一個帶有棉蚜蟲(約30個蚜蟲樣品)的黃瓜葉被放置在第一片葉子的頂部,並且織物和葉子被放置在一具有一為25±2℃的溫度和一為40%的溼度的恆溫室中過夜。第二天早上,當蚜蟲族群已經移至下部葉子時,頂部葉子被移除。A piece of non-woven fabric (4.5 x 5.5 cm) was suspended in a plastic cup through a cut made in the lid of the plastic cup. After the water is poured into the cup, the cup is covered with a lid. A cucumber leaf (approximately 3.5 x 4.5 cm) was then placed on a fully immersed non-woven fabric. Another cucumber leaf with cotton aphids (about 30 aphids samples) was placed on top of the first leaf, and the fabric and leaves were placed at a temperature of 25±2°C and a humidity of 40% Overnight in the constant temperature room. The next morning, when the aphid population had moved to the lower leaves, the top leaves were removed.

含有本揭示的化合物(100 ppm)的殺蟲配方藉由添加Sorpol 355 (由TOHO Chemical Industry Co., Ltd.所製造)的一水性溶液(100 ppm)至本揭示的化合物的一甲醇溶液而被製備。Insecticide formulations containing the disclosed compound (100 ppm) were added by adding an aqueous solution (100 ppm) of Sorpol 355 (manufactured by TOHO Chemical Industry Co., Ltd.) to a methanol solution of the disclosed compound. preparation.

這些殺蟲配方被噴灑在葉子上,並且葉子被風乾和放置在一恆溫室(25±2℃和一為50%的濕度)中。棉蚜蟲的死亡率在3天後被計算。化合物1A-10 1A-11 1A-12 1A-18 1A-19 1A-21 1A-100 1A-115 1A-117 1A-156 1A-159 1A-172 1A-180 1A-181 1A-183 1A-252 1A-254 1A-264 1A-266 1A-314 1B-3 1B-35 1B-36 1B-38 1B-46 1B-47 1B-59 1B-62 1B-64 1B-66 1B-69 顯示80%或更多的死亡率,而參考化合物(化合物 A化合物 BFlometoquin )各個顯示100%死亡率。試驗實施例 2( 在斜紋夜盜蛾上的殺蟲試驗 ) These insecticidal formulas are sprayed on the leaves, and the leaves are air-dried and placed in a constant temperature room (25±2°C and a humidity of 50%). The mortality of cotton aphids was calculated after 3 days. Compounds 1A-10 , 1A-11 , 1A-12 , 1A-18 , 1A-19 , 1A-21 , 1A-100 , 1A-115 , 1A-117 , 1A-156 , 1A-159 , 1A-172 , 1A -180 , 1A-181 , 1A-183 , 1A-252 , 1A-254 , 1A-264 , 1A-266 , 1A-314 , 1B-3 , 1B-35 , 1B-36 , 1B-38 , 1B-46 , 1B-47 , 1B-59 , 1B-62 , 1B-64 , 1B-66, and 1B-69 show 80% or more mortality, while the reference compounds ( Compound A , Compound B, and Flometoquin ) each show 100% mortality rate. Test Example 2 ( Insecticidal test on Spodoptera litura )

含有本揭示的化合物(100 ppm和20 ppm)的殺蟲配方以如在試驗實施例1的相同方式而製備。這些殺蟲配方被噴灑在蓖麻葉(4 x 4 cm)上,葉子被風乾並且被放置在濕紙上的一塑膠杯中。4天齡的夜盜蛾屬(Spodoptera )幼蟲(12-15 Nos.)被釋放,以及杯子被關閉並且被放置在一恆溫室(25±2℃和一為50%的濕度)中。夜盜蛾屬的死亡率在3天後被計算。化合物1A-5 1A-6 1A-7 1A-8 1A-9 1A-10 1A-32 1A-33 1A-81 1A-84 1A-85 1A-86 1A-87 1A-88 1A-91 1A-92 1A-93 1A-94 1A-96 1A-97 1A-134 1A-160 1A-161 1A-175 1A-185 1A-186 1A-188 1A-190 1A-193 1A-194 1A-195 1A-202 1A-240 1A-241 1A-255 1A-258 1A-267 1A-269 1A-292 1A-293 1A-294 1A-295 1A-296 1A-297 1A-298 1A-299 1A-300 1A-301 1A-306 1A-315 1A-321 1A-324 1A-348 1A-349 1A-352 1A-353 1A-360 1A-361 1A-362 1A-363, 1A-364 1A-367 1A-369 1A-370 1A-371 1A-373 1A-374 1A-375 1A-376 1A-377 1A-378 1A-379 1A-383 1A-384 1A-385 1A-386 1A-387 1A-388 1A-389 1A-390 1A-391 1A-392 1A-393 1A-394 1A-395 1A-396 1A-397 1A-398 1A-406 1A-407 1A-408 1A-409 1A-410 1A-411 1A-412 1A-413 1A-414 1A-415 1A-416 1A-417 1A-418 1A-419 1A-420 1A-428 1A-429 1A-430 1A-432 1A-434 1A-435 1A-436 1A-437 1A-449 1A-452 1A-453 1A-454 1A-455 1A-456 1A-457 1A-458 1A-459 1A-460 1A-463 1A-464 1A-465 1A-466 1A-467 1A-468 1A-469 1A-470 1A-471 1A-472 1A-473 1A-477 1A-478 1A-480 1A-481 1A-484 1A-485 1A-486 1A-487 1A-489 1A-490, 1A-491 1A-492 1B-11 1B-48 1B-49 1B-55 1B-57 1B-77 1B-78 1B-80 1B-81 1B-82 1B-83 1B-84 1B-85 1B-86 1B-87 1B-88 1C-4 1C-6 1C-13 1C-34 1C-37 1C-40 1C-41 1C-43 1C-49 以及 1C-50 在100 ppm下顯示80%或更多的死亡率,而參考化合物 A 在100 ppm下顯示0%死亡率,以及參考化合物 BFlometoquin 各個在500 ppm下對抗斜紋夜盜蛾顯示小於30%死亡率。化合物1A-84 1A-85 1A-87 1A-88 1A-91 1A-92 1A-93 1A-94 1A-96 1A-97 1A-175 1A-185 1A-186 1A-188 1A-190 1A-193 1A-194 1A-195 1A-240 1A-241 1A-255 1A-292 1A-293 1A-295 1A-296 1A-297 1A-299 1A-300 1A-301 1A-348 1A-353 1A-361 1A-362 1A-363 1A-364 1A-373 1A-374 1A-376 1A-377 1A-378 1A-379 1A-387 1A-388 1A-389 1A-394 1A-395 1A-396 1A-397 1A-398 1A-406 1A-407 1A-408 1A-409 1A-411 1A-412 1A-414 1A-415 1A-416 1A-417 1A-418 1A-419 1A-420 1A-428 1A-429 1A-430 1A-434 1A-435 1A-436 1A-437 1A-452 1A-453 1A-454 1A-455 1A-456 1A-457 1A-458 1A-459 1A-463 1A-465 1A-466 1A-467 1A-468 1A-469 1A-470 1A-471 1A-472 1A-484 1A-487 1A-490 1B-48 1B-55 1B-80 1B-81 1B-83 1C-4 以及 1C-13 在20 ppm下顯示80%或更多的死亡率。試驗實施例 3 ( 在二點葉蟎 上的殺蟎試驗 ) Insecticidal formulations containing the compounds of the present disclosure (100 ppm and 20 ppm) were prepared in the same manner as in Test Example 1. These insecticidal formulas were sprayed on castor leaves (4 x 4 cm), and the leaves were air-dried and placed in a plastic cup on wet paper. The 4-day-old Spodoptera larvae (12-15 Nos.) were released, and the cup was closed and placed in a constant temperature room (25±2°C and a humidity of 50%). The death rate of Spodoptera was calculated after 3 days. Compounds 1A-5 , 1A-6 , 1A-7 , 1A-8 , 1A-9 , 1A-10 , 1A-32 , 1A-33 , 1A-81 , 1A-84 , 1A-85 , 1A-86 , 1A -87 , 1A-88 , 1A-91 , 1A-92 , 1A-93 , 1A-94 , 1A-96 , 1A-97 , 1A-134 , 1A-160 , 1A-161 , 1A-175 , 1A-185 , 1A-186 , 1A-188 , 1A-190 , 1A-193 , 1A-194 , 1A-195 , 1A-202 , 1A-240 , 1A-241 , 1A-255 , 1A-258 , 1A-267 , 1A -269 , 1A-292 , 1A-293 , 1A-294 , 1A-295 , 1A-296 , 1A-297 , 1A-298 , 1A-299 , 1A-300 , 1A-301 , 1A-306 , 1A-315 , 1A-321 , 1A-324 , 1A-348 , 1A-349 , 1A-352 , 1A-353 , 1A-360 , 1A-361 , 1A-362 , 1A-363, 1A-364 , 1A-367 , 1A -369 , 1A-370 , 1A-371 , 1A-373 , 1A-374 , 1A-375 , 1A-376 , 1A-377 , 1A-378 , 1A-379 , 1A-383 , 1A-384 , 1A-385 , 1A-386 , 1A-387 , 1A-388 , 1A-389 , 1A-390 , 1A-391 , 1A-392 , 1A-393 , 1A-394 , 1A-395 , 1A-396 , 1A-397 , 1A -398 , 1A-406 , 1A-407 , 1A-408 , 1A-409 , 1A-410 , 1A-411 , 1A-412 , 1A-413 , 1A-414 , 1A-415 , 1A-416 , 1A-417 , 1A-418 , 1A-419 , 1A-420 , 1A-428 , 1A-429 , 1A-430 , 1A-432 , 1A-434 , 1A-435 , 1A-436 , 1A-437 , 1A-449 , 1A -452 , 1A-453 , 1A-454 , 1A-455 , 1A-456 , 1A-457 , 1A-458 , 1A-459 , 1A-460 , 1A-463 , 1A-464 , 1A-465 , 1A-466 , 1A-467 , 1A -468 , 1A-469 , 1A-470 , 1A-471 , 1A-472 , 1A-473 , 1A-477 , 1A-478 , 1A-480 , 1A-481 , 1A-484 , 1A-485 , 1A-486 , 1A-487 , 1A-489 , 1A-490, 1A-491 , 1A-492 , 1B-11 , 1B-48 , 1B-49 , 1B-55 , 1B-57 , 1B-77 , 1B-78 , 1B -80 , 1B-81 , 1B-82 , 1B-83 , 1B-84 , 1B-85 , 1B-86 , 1B-87 , 1B-88 , 1C-4 , 1C-6 , 1C-13 , 1C-34 , 1C-37 , 1C-40 , 1C-41 , 1C-43 , 1C-49, and 1C-50 showed 80% or more mortality at 100 ppm, while Reference Compound A showed 0% death at 100 ppm The rates, as well as the reference compounds B and Flometoquin each showed less than 30% mortality at 500 ppm against Spodoptera litura . Compounds 1A-84 , 1A-85 , 1A-87 , 1A-88 , 1A-91 , 1A-92 , 1A-93 , 1A-94 , 1A-96 , 1A-97 , 1A-175 , 1A-185 , 1A -186 , 1A-188 , 1A-190 , 1A-193 , 1A-194 , 1A-195 , 1A-240 , 1A-241 , 1A-255 , 1A-292 , 1A-293 , 1A-295 , 1A-296 , 1A-297 , 1A-299 , 1A-300 , 1A-301 , 1A-348 , 1A-353 , 1A-361 , 1A-362 , 1A-363 , 1A-364 , 1A-373 , 1A-374 , 1A -376 , 1A-377 , 1A-378 , 1A-379 , 1A-387 , 1A-388 , 1A-389 , 1A-394 , 1A-395 , 1A-396 , 1A-397 , 1A-398 , 1A-406 , 1A-407 , 1A-408 , 1A-409 , 1A-411 , 1A-412 , 1A-414 , 1A-415 , 1A-416 , 1A-417 , 1A-418 , 1A-419 , 1A-420 , 1A -428 , 1A-429 , 1A-430 , 1A-434 , 1A-435 , 1A-436 , 1A-437 , 1A-452 , 1A-453 , 1A-454 , 1A-455 , 1A-456 , 1A-457 , 1A-458 , 1A-459 , 1A-463 , 1A-465 , 1A-466 , 1A-467 , 1A-468 , 1A-469 , 1A-470 , 1A-471 , 1A-472 , 1A-484 , 1A -487 , 1A-490 , 1B-48 , 1B-55 , 1B-80 , 1B-81 , 1B-83 , 1C-4 and 1C-13 showed 80% or more mortality at 20 ppm. Test Example 3 ( Acaricidal test on Tetranychus urticae )

一片非織物(4.5 x 5.5Cm)經由一在塑膠杯的蓋子所做出的切口而被懸置在一塑膠杯內。在水被倒入至杯中以後,杯子被覆蓋以蓋子。一菜豆葉(約3.5 x 4.5Cm)接著被放置在經充分浸泡的非織物上。另一個帶有二點葉蟎(約30個蟎樣品)的菜豆葉被放置在第一片葉子的頂部,並且織物和葉子被放置在一具有一為25±2℃的溫度和一為40%的溼度的恆溫室中過夜。第二天早上,當蟎族群已經移至下部葉子時,頂部葉子被移除。A piece of non-woven fabric (4.5 x 5.5 cm) was suspended in a plastic cup through a cut made in the lid of the plastic cup. After the water is poured into the cup, the cup is covered with a lid. One kidney bean leaf (approximately 3.5 x 4.5 cm) is then placed on a fully-soaked non-woven fabric. Another kidney bean leaf with Tetranychus urticae (about 30 mite samples) was placed on top of the first leaf, and the fabric and leaves were placed at a temperature of 25±2°C and 40% Overnight in a constant temperature room with humidity. The next morning, when the mite population had moved to the lower leaves, the top leaves were removed.

含有本揭示的化合物(100 ppm)的殺蟎配方以如在試驗實施例1的相同方式而製備。這些殺蟎配方被噴灑在葉子上,並且葉子被風乾和放置在一恆溫室(25±2℃和一為50%的濕度)中。二點葉蟎的死亡率在2天後被計算。化合物1B-251B-381B-391B-411B-461B-471B-611B-621B-63 1B-64 1B-66 1B-69 1B-73 1B-75 1B-76 1B-78 1B-82 1B-831B-89 顯示80%或更多的死亡率,而參考化合物 A 在100 ppm下顯示0%死亡率,以及 參考化合物 BFlometoquin 各個在500 ppm下對抗二點葉蟎顯示小於30%死亡率。試驗實施例 4 ( 在二點葉蟎上的殺卵試驗 ) The acaricidal formulation containing the compound of the present disclosure (100 ppm) was prepared in the same manner as in Test Example 1. These acaricidal formulations are sprayed on the leaves, and the leaves are air dried and placed in a constant temperature room (25±2°C and a humidity of 50%). The mortality of Tetranychus urticae was calculated after 2 days. Compounds 1B-25 , 1B-38 , 1B-39 , 1B-41 , 1B-46 , 1B-47 , 1B-61 , 1B-62 , 1B-63 , 1B-64 , 1B-66 , 1B-69 , 1B -73 , 1B-75 , 1B-76 , 1B-78 , 1B-82 , 1B-83, and 1B-89 show 80% or more mortality, while Reference Compound A shows 0% mortality at 100 ppm, And Reference Compound B and Flometoquin each showed less than 30% mortality at 500 ppm against Tetranychus urticae. Test Example 4 ( Eggicide test on Tetranychus urticae )

一片非織物(4.5 x 5.5 cm)經由一在塑膠杯的蓋子所做出的切口而被懸置在一塑膠杯內。在水被倒入至杯內以後,杯子被覆蓋以蓋子。一菜豆葉(約3.5 x 4.5 cm)接著被放置在經充分地浸泡的非織物上。20隻二點葉蟎的雌性成體被放置在葉子的頂部,並且織物和葉子被放置在一具有一為25±2℃的溫度和一為40%的溼度以及16L8D的恆溫室中。A piece of non-woven fabric (4.5 x 5.5 cm) was suspended in a plastic cup through a cut made in the lid of the plastic cup. After the water is poured into the cup, the cup is covered with a lid. One kidney bean leaf (approximately 3.5 x 4.5 cm) is then placed on a fully immersed non-woven fabric. 20 female adults of Tetranychus urticae were placed on top of the leaves, and the fabric and leaves were placed in a constant temperature room with a temperature of 25±2°C and a humidity of 40% and 16L8D.

第二天,在雌性成體的數目再次被調整至20後,以如在試驗實施例1的相同方式所製備的含有本揭示的化合物(500 ppm和100 ppm)的殺蟎配方被噴灑在葉子上,並且葉子被風乾和放置在一恆溫室(25±2℃和一為50%的濕度)中。二點葉蟎的殺卵率在噴灑該殺蟎配方之後6天被計算。化合物1B-38 1B-39 1B-41 1B-46 1B-47 1B-59 1B-61 1B-62 1B-63 1B-64 1B-66 1B-69 1B-70 1B-73 1B-75 1B-78 以及1B-83 在100 ppm下顯示80%或更多的死亡率,而參考化合物化合物 A 顯示在500 ppm下顯示40%死亡率以及在100 ppm下0%死亡率,並且 參考化合物 BFlometoquin 各個顯示在500 ppm下小於30%死亡率。化合物1B-3 1B-6 1B-7 1B-8 1B-10 1B-38 1B-39 1B-41 1B-42 1B-46 1B-47 1B-59 1B-60 1B-61 1B-62 1B-63 1B-64 1B-65 1B-66 1B-69 1B-70 1B-71 1B-73 1B-74 1B-75 1B-76 1B-78 1B-82 1B-83 1B-85 1B-87 1B-88 1B-89 以及 1B-91 在500 ppm下顯示80%或更多的死亡率。試驗實施例 5 ( 在栗的灰梨孢黴上的殺真菌試驗 ) The next day, after the number of female adults was adjusted to 20 again, the acaricidal formula containing the compounds of the present disclosure (500 ppm and 100 ppm) prepared in the same manner as in Test Example 1 was sprayed on the leaves The leaves were dried and placed in a constant temperature room (25±2°C and a humidity of 50%). The egg kill rate of Tetranychus urticae was calculated 6 days after spraying the acaricidal formula. Compounds 1B-38 , 1B-39 , 1B-41 , 1B-46 , 1B-47 , 1B-59 , 1B-61 , 1B-62 , 1B-63 , 1B-64 , 1B-66 , 1B-69 , 1B -70 , 1B-73 , 1B-75 , 1B-78 and 1B-83 showed 80% or more mortality at 100 ppm, while the reference compound Compound A showed 40% mortality at 500 ppm and 100% 0% mortality at ppm, and each of Reference Compound B and Flometoquin showed less than 30% mortality at 500 ppm. Compounds 1B-3 , 1B-6 , 1B-7 , 1B-8 , 1B-10 , 1B-38 , 1B-39 , 1B-41 , 1B-42 , 1B-46 , 1B-47 , 1B-59 , 1B -60 , 1B-61 , 1B-62 , 1B-63 , 1B-64 , 1B-65 , 1B-66 , 1B-69 , 1B-70 , 1B-71 , 1B-73 , 1B-74 , 1B-75 , 1B-76 , 1B-78 , 1B-82 , 1B-83 , 1B-85 , 1B-87 , 1B-88 , 1B-89, and 1B-91 showed 80% or more mortality at 500 ppm. Test Example 5 ( Fungicidal test on P. grisea on chestnut )

小塊的灰梨孢黴的菌絲體被取自培養管並且無菌地被轉移在mathur培養基平板上。被接種的平板在25℃下被保持歷時7天。接著平板在暴露至黑光藍(black light blue) 16L8D下在25℃被培育歷時5天。在5天後,平板完全地被覆蓋以真菌的孢子。孢子以0.01% Tween 20溶液而從平板被清洗並且通過薄紙。接著濾液以0.01% Tween 20溶液而被稀釋俾以獲得每ml 2 x 105 cfu孢子。The small pieces of Mycelia of Grifola frondosa were taken from the culture tube and aseptically transferred to mathur medium plate. The inoculated plate was kept at 25°C for 7 days. The plate was then incubated at 25°C for 5 days under exposure to black light blue 16L8D. After 5 days, the plates were completely covered with fungal spores. The spores were washed from the plate with 0.01% Tween 20 solution and passed through tissue paper. The filtrate was then diluted with 0.01% Tween 20 solution to obtain 2 x 10 5 cfu spores per ml.

以如在試驗實施例1的相同方式所製備的本揭示的化合物(500 ppm)的溶液被噴灑在新鮮健康的2週齡栗植物。該等植物被風乾並且被接種以新鮮地製備的孢子懸浮液。該等被接種的植物接著被放置在一露室(25℃和一為100%的濕度)中。在接種之後1天,植物被轉移至恆溫室(25℃、一為80%的濕度,以及16L8D)。相較於對照,疾病控制百分比在5-7天後從葉疾病區域被評估。化合物1A-276 1A-325 1B-71B-33 顯示80%或更多的控制,而參考化合物(化合物 A化合物 BFlometoquin )在500 ppm下分別顯示小於 50%小於 30% 以及小於 30 %控制。試驗實施例 6 ( 在黃瓜的蒼耳單絲殼 ( Sphaerotheca fuliginea ) 上的殺真菌試驗 ) A solution of the disclosed compound (500 ppm) prepared in the same manner as in Test Example 1 was sprayed on fresh and healthy 2-week-old chestnut plants. The plants were air-dried and inoculated with a freshly prepared spore suspension. The inoculated plants were then placed in a dew room (25°C and a humidity of 100%). One day after inoculation, the plants were transferred to a constant temperature room (25°C, a humidity of 80%, and 16L8D). Compared to the control, the percentage of disease control was evaluated from the leaf disease area after 5-7 days. Compounds 1A-276 , 1A-325 , 1B-7, and 1B-33 showed 80% or more control, while reference compounds ( Compound A , Compound B, and Flometoquin ) showed less than 50% and less than 30% at 500 ppm, respectively And less than 30 % control. Test Example 6 (fungicidal test on Sphaerotheca fuliginea of cucumber cocklebur (Sphaerotheca fuliginea) a)

蒼耳單絲殼被培養在完整的黃瓜植物上。帶有孢子的感染葉子以0.01% Tween 20溶液而被清洗並且通過薄紙。接著濾液以0.01% Tween 20溶液而被稀釋俾以獲得每ml 2 x 105 cfu孢子。Xanthium monofilaments are cultivated on whole cucumber plants. Infected leaves with spores were washed with 0.01% Tween 20 solution and passed through tissue paper. The filtrate was then diluted with 0.01% Tween 20 solution to obtain 2 x 10 5 cfu spores per ml.

以如在試驗實施例1的相同方式所製備的本揭示的化合物(500 ppm)的溶液被噴灑在新鮮健康的2週齡黃瓜植物。該等植物被風乾並且被接種以新鮮地製備的孢子懸浮液。該等被接種的植物接著被放置在溫室(25℃、一為60%的濕度,以及16L8D)中。相較於對照,疾病控制百分比在12天後從葉疾病區域被評估。化合物1A-172 1A-181 1A-254 1A-262 1A-264 1A-266 1A-325 1A-431 1B-33 1B-57 1B-60 1B-661C-10 顯示80%或更多的控制,而參考化合物 A 500ppm 下顯示如此強的植物毒性在黃瓜上以致評估是不可能的,以及 參考化合物 B Flometoquin 500ppm 下分別地顯示 100% 和小於 70% 控制。 產業利用性 A solution of the compound of the present disclosure (500 ppm) prepared in the same manner as in Test Example 1 was sprayed on fresh and healthy 2-week-old cucumber plants. The plants were air-dried and inoculated with a freshly prepared spore suspension. The inoculated plants were then placed in a greenhouse (25°C, a humidity of 60%, and 16L8D). Compared to the control, the percentage of disease control was assessed from the leaf disease area after 12 days. Compounds 1A-172 , 1A-181 , 1A-254 , 1A-262 , 1A-264 , 1A-266 , 1A-325 , 1A-431 , 1B-33 , 1B-57 , 1B-60 , 1B-66 and 1C -10 80% or more display control, and reference compound a exhibits a strong phytotoxicity so that evaluation is not possible on cucumber, and reference compound B are displayed and Flometoquin less than 100% at 500ppm and at 500ppm 70% control. Industrial availability

本揭示的經取代的吡唑化合物或它們的一鹽類顯示一對抗一廣泛範圍的害蟲(諸如蚜蟲、夜盜蛾屬、蟎等等)的優異控制效用,並且作為一用於農業和園藝用途的殺害蟲劑是有用的。 (註釋)The substituted pyrazole compounds of the present disclosure or one of their salts show an excellent control effect against a wide range of pests (such as aphids, budworm, mites, etc.), and are used as an agricultural and horticultural use Of pesticides are useful. (Note)

如上面所描述的,本揭示藉由本揭示的較佳具體例而被例示說明。然而,將被瞭解的是:本揭示的範圍應該僅藉由申請專利範圍而被解釋。被瞭解的是:在此所引述的專利、專利申請案和文獻在此被併入本案以做為參考資料,猶如其內容在此被具體地描述。本申請案主張於2018年6月29日向印度專利局(印度智慧財產權)所提申的印度專利申請案第201811024217號的優先權,它的全部內容在此被併入本案以做為參考資料。As described above, the present disclosure is exemplified by preferred specific examples of the present disclosure. However, it will be understood that the scope of the present disclosure should be interpreted only by applying for a patent. It is understood that the patents, patent applications and documents cited herein are incorporated into this case as a reference material as if their contents were specifically described here. This application claims the priority of Indian Patent Application No. 201811024217 filed with the Indian Patent Office (Indian Intellectual Property Rights) on June 29, 2018, and its entire contents are incorporated into this case for reference.

(無)(no)

Claims (24)

一種由下列化學式(1 )所代表的經取代的吡唑化合物、或它的一鹽類:
Figure 03_image006
其中, Q代表一氧原子、一硫原子、CR6 R7 或直接鍵; R6 和R7 各個獨立地代表氫、鹵素、氰基、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C1 -C12 烷基硫基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 烯基氧基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C2 -C12 炔基氧基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的C3 -C12 環烷基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的C1 -C12 烷基羰基胺基、經取代的或未經取代的C1 -C12 烷基磺醯基氧基、經取代的或未經取代的C1 -C12 烷基亞磺醯基氧基、經取代的或未經取代的芳基、經取代的或未經取代的雜芳基或者經取代的或未經取代的飽和雜環; R代表氫、經取代的或未經取代的芳基、經取代的或未經取代的雜芳基、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的C3 -C12 環烷基,或者經取代的或未經取代的飽和雜環; R1 代表氫、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C3 -C12 環烷基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C2 -C12 烯基羰基、經取代的或未經取代的C2 -C12 炔基羰基、經取代的或未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的芳基氧基羰基、經取代的或未經取代的雜芳基氧基羰基、經取代的或未經取代的芳基羰基、經取代的或未經取代的雜芳基羰基、經取代的或未經取代的雜環羰基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的芳基亞磺醯基、經取代的或未經取代的雜芳基亞磺醯基、經取代的或未經取代的芳基磺醯基、經取代的或未經取代的雜芳基磺醯基; R2 和R3 各個獨立地代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C3 -C12 環烷基、經取代的或未經取代的芳基、經取代的或未經取代的雜芳基,或者經取代的或未經取代的雜環; R4 和R5 各個獨立地代表氫、鹵素、氰基、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C1 -C12 烷基硫基或者經取代的或未經取代的芳基; X1 代表C-R8 或N, X2 代表C-R9 或N,和 X3 代表C-R10 或N, 有條件的是:當X1 代表一氮原子時,X2 和X3 分別地代表C-R9 和C-R10 ,當X2 代表一氮原子時,X1 和X3 分別地代表C-R8 和C-R10 ,和當X3 代表一氮原子時,X1 和X2 分別地代表C-R8 和C-R9 ;以及 R8 、R9 和R10 各個獨立地代表氫、鹵素、經取代的或未經取代的C1 -C12 烷基、經取代的或未經取代的C1 -C12 烷氧基、經取代的或未經取代的C1 -C12 烷基硫基、經取代的或未經取代的C1 -C12 烷氧基羰基、氰基、硝基,或者經取代的或未經取代的胺基。
A substituted pyrazole compound represented by the following chemical formula ( 1 ), or a salt thereof:
Figure 03_image006
Where Q represents an oxygen atom, a sulfur atom, CR 6 R 7 or a direct bond; R 6 and R 7 each independently represent hydrogen, halogen, cyano, substituted or unsubstituted C 1 -C 12 alkane Group, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, substituted or unsubstituted C 2 -C 12 Alkenyl, substituted or unsubstituted C 2 -C 12 alkenyloxy, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 2 -C 12 Alkynyloxy, substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted Substituted C 3 -C 12 cycloalkyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or Unsubstituted C 1 -C 12 alkylcarbonylamino, substituted or unsubstituted C 1 -C 12 alkylsulfonyloxy, substituted or unsubstituted C 1 -C 12 alkyl Sulfenyloxy, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted saturated heterocyclic ring; R represents hydrogen, substituted Or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 2 -C 12 alkene Group, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, or substituted or unsubstituted saturated heterocycle; R 1 represents hydrogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 2 -C 12 alkenylcarbonyl, substituted or unsubstituted C 2 -C 12 alkynylcarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted aryloxycarbonyl, substituted or unsubstituted Heteroaryloxycarbonyl, substituted or unsubstituted arylcarbonyl, substituted or unsubstituted heteroarylcarbonyl, substituted or unsubstituted heterocyclic carbonyl, Substituted or unsubstituted C 1 -C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted arylsulfinyl Sulfonyl, substituted or unsubstituted heteroarylsulfinyl, substituted or unsubstituted arylsulfonyl, substituted or unsubstituted heteroarylsulfonyl; R 2 and R 3 each independently represent hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted Substituted C 2 -C 12 alkenyl, substituted or unsubstituted C 2 -C 12 alkynyl, substituted or unsubstituted C 3 -C 12 cycloalkyl, substituted or unsubstituted Substituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted heterocycle; R 4 and R 5 each independently represent hydrogen, halogen, cyano, substituted or unsubstituted Substituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, or substituted or Unsubstituted aryl; X 1 represents CR 8 or N, X 2 represents CR 9 or N, and X 3 represents CR 10 or N, conditionally: when X 1 represents a nitrogen atom, X 2 and X 3 represents CR 9 and CR 10 respectively , when X 2 represents a nitrogen atom, X 1 and X 3 represent CR 8 and CR 10 respectively , and when X 3 represents a nitrogen atom, X 1 and X 2 respectively Stands for CR 8 and CR 9 ; and R 8 , R 9 and R 10 each independently represent hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 12 alkoxy, substituted or unsubstituted C 1 -C 12 alkylthio, substituted or unsubstituted C 1 -C 12 alkoxycarbonyl, cyano, nitro, or Substituted or unsubstituted amine groups.
如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中Q代表一氧原子,或者一硫原子。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein Q represents an oxygen atom or a sulfur atom. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R代表經取代的或未經取代的芳基、經取代的或未經取代的雜芳基,或者經取代的或未經取代的C1 -C12 烷基。A substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R represents a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, or Substituted or unsubstituted C 1 -C 12 alkyl. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R代表經取代的或未經取代的C6 -C10 芳基,或者未經取代的C1 -C12 烷基。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R represents a substituted or unsubstituted C 6 -C 10 aryl group, or an unsubstituted C 1 -C 12 alkyl. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R1 代表氫、經取代的或未經取代的C2 -C12 烯基、經取代的或未經取代的C2 -C12 炔基、經取代的或未經取代的C1 -C12 烷基羰基、經取代的或未經取代的C3 -C12 環烷基羰基、經取代的或未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的芳基羰基、經取代的或未經取代的芳基氧基羰基、經取代的或未經取代的C1 -C12 烷基亞磺醯基、經取代的或未經取代的C1 -C12 烷基磺醯基、經取代的或未經取代的芳基亞磺醯基,或者經取代的或未經取代的芳基磺醯基。A substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 1 represents hydrogen, substituted or unsubstituted C 2 -C 12 alkenyl, substituted or unsubstituted Substituted C 2 -C 12 alkynyl, substituted or unsubstituted C 1 -C 12 alkylcarbonyl, substituted or unsubstituted C 3 -C 12 cycloalkylcarbonyl, substituted or unsubstituted Substituted C 1 -C 12 alkoxycarbonyl, substituted or unsubstituted arylcarbonyl, substituted or unsubstituted aryloxycarbonyl, substituted or unsubstituted C 1- C 12 alkylsulfinyl, substituted or unsubstituted C 1 -C 12 alkylsulfonyl, substituted or unsubstituted arylsulfinyl, or substituted or unsubstituted Substituted arylsulfonyl. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R1 代表氫、經取代的或未經取代的C2 -C12 烯基、未經取代的C2 -C12 炔基、未經取代的C1 -C12 烷基羰基、未經取代的C3 -C12 環烷基羰基、未經取代的C1 -C12 烷氧基羰基、經取代的或未經取代的C6 -C10 芳基羰基、未經取代的C6 -C10 芳基氧基羰基,或者未經取代的C6 -C10 芳基磺醯基。A substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 1 represents hydrogen, substituted or unsubstituted C 2 -C 12 alkenyl, unsubstituted C 2 -C 12 alkynyl, unsubstituted C 1 -C 12 alkylcarbonyl, unsubstituted C 3 -C 12 cycloalkylcarbonyl, unsubstituted C 1 -C 12 alkoxycarbonyl, substituted Or unsubstituted C 6 -C 10 arylcarbonyl, unsubstituted C 6 -C 10 aryloxycarbonyl, or unsubstituted C 6 -C 10 arylsulfonyl. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R2 代表氫、鹵素,或者經取代的或未經取代的C1 -C12 烷基。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 2 represents hydrogen, halogen, or a substituted or unsubstituted C 1 -C 12 alkyl group. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R2 代表氫,或者未經取代的C1 -C12 烷基。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 2 represents hydrogen, or an unsubstituted C 1 -C 12 alkyl group. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R3 代表經取代的或未經取代的C1 -C12 烷基。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 3 represents a substituted or unsubstituted C 1 -C 12 alkyl group. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R4 和R5 各個獨立地代表氫、鹵素,或者經取代的或未經取代的C1 -C12 烷基。A substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 4 and R 5 each independently represent hydrogen, halogen, or substituted or unsubstituted C 1 -C 12 alkyl. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R4 和R5 各個獨立地代表氫,或者未經取代的C1 -C12 烷基。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 4 and R 5 each independently represent hydrogen, or an unsubstituted C 1 -C 12 alkyl group. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中X1 代表C-R8 ,X2 代表C-R9 ,X3 代表C-R10 ,以及R8 、R9 和R10 彼此獨立地是氫、鹵素、經取代的或未經取代的C1 -C12 烷基,或者經取代的或未經取代的C1 -C12 烷氧基。A substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein X 1 represents CR 8 , X 2 represents CR 9 , X 3 represents CR 10 , and R 8 , R 9 and R 10 Independent of each other are hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, or substituted or unsubstituted C 1 -C 12 alkoxy. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中X1 代表C-R8 ,X2 代表C-R9 ,X3 代表C-R10 ,以及R8 、R9 和R10 彼此獨立地是氫、鹵素、經取代的或未經取代的C1 -C12 烷基,或者未經取代的C1 -C12 烷氧基。A substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein X 1 represents CR 8 , X 2 represents CR 9 , X 3 represents CR 10 , and R 8 , R 9 and R 10 Independent of each other are hydrogen, halogen, substituted or unsubstituted C 1 -C 12 alkyl, or unsubstituted C 1 -C 12 alkoxy. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中Q代表一氧原子。A substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein Q represents an oxygen atom. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R代表經取代的或未經取代的C6 芳基。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R represents a substituted or unsubstituted C 6 aryl group. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R1 代表氫、未經取代的C1 -C12 烷基羰基、未經取代的C3 -C12 環烷基羰基、未經取代的C1 -C12 烷氧基羰基,或者經取代的或未經取代的C6 芳基羰基。A substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 1 represents hydrogen, unsubstituted C 1 -C 12 alkylcarbonyl, unsubstituted C 3 -C 12 Cycloalkylcarbonyl, unsubstituted C 1 -C 12 alkoxycarbonyl, or substituted or unsubstituted C 6 arylcarbonyl. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R2 代表未經取代的C1 -C6 烷基。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 2 represents an unsubstituted C 1 -C 6 alkyl group. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R3 代表未經取代的C1 -C6 烷基。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 3 represents an unsubstituted C 1 -C 6 alkyl group. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中R4 和R5 各個獨立地代表氫,或者未經取代的C1 -C6 烷基。The substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein R 4 and R 5 each independently represent hydrogen, or an unsubstituted C 1 -C 6 alkyl group. 如前述請求項中任一項的經取代的吡唑化合物或它的一鹽類,其中X1 代表C-R8 ,X2 代表C-R9 ,X3 代表C-R10 ,以及R8 、R9 和R10 彼此獨立地是氫、鹵素、未經取代的C1 -C6 烷基,或者未經取代的C1 -C6 烷氧基。A substituted pyrazole compound or a salt thereof according to any one of the preceding claims, wherein X 1 represents CR 8 , X 2 represents CR 9 , X 3 represents CR 10 , and R 8 , R 9 and R 10 Independent of each other is hydrogen, halogen, unsubstituted C 1 -C 6 alkyl, or unsubstituted C 1 -C 6 alkoxy. 一種害蟲控制劑,其包含有如請求項1至20中任一項的經取代的吡唑化合物或它的一鹽類作為一活性成分。A pest control agent comprising the substituted pyrazole compound according to any one of claims 1 to 20 or a salt thereof as an active ingredient. 一種使用如請求項1至20中任一項的經取代的吡唑化合物或它的一鹽類的方法,其用於控制害蟲。A method of using the substituted pyrazole compound according to any one of claims 1 to 20 or a salt thereof for controlling pests. 一種用於控制害蟲的方法,其包含有施加如請求項1至20中任一項的經取代的吡唑化合物或它的一鹽類至一植物或它的附近,或者一植物被栽培的土壤。A method for controlling pests, which comprises applying a substituted pyrazole compound or a salt thereof according to any one of claims 1 to 20 to a plant or its vicinity, or a soil where a plant is cultivated . 一種用於控制害蟲的方法,其包含有施加一有效量的如請求項1至20的任一項的經取代的吡唑化合物或它的一鹽類至害蟲、害蟲的一棲地,或者一預測棲息的地點。A method for controlling pests, which comprises applying an effective amount of the substituted pyrazole compound according to any one of claims 1 to 20 or a salt thereof to the pest, the pest's habitat, or a Predict where to live.
TW108122910A 2018-06-29 2019-06-28 Novel substituted pyrazole derivatives TW202012390A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201811024217 2018-06-29
IN201811024217 2018-06-29

Publications (1)

Publication Number Publication Date
TW202012390A true TW202012390A (en) 2020-04-01

Family

ID=67551583

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108122910A TW202012390A (en) 2018-06-29 2019-06-28 Novel substituted pyrazole derivatives

Country Status (2)

Country Link
TW (1) TW202012390A (en)
WO (1) WO2020003219A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168311A (en) 1973-12-10 1979-09-18 Hoechst Aktiengesellschaft Hydroxyquinoline carbamates and n-oxide hydroxyquinoline carbamates and their use as insecticides
US5190952A (en) 1989-07-07 1993-03-02 Meiji Seika Kabushiki Kaisha 4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing same
US7074801B1 (en) * 2001-04-26 2006-07-11 Eisai Co., Ltd. Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
BR0314302A (en) * 2002-09-18 2005-07-05 Pfizer Producs Inc Pyrazole Compounds as Transforming Growth Factor (TGF) Inhibitors
CN1993328B (en) * 2004-08-04 2010-12-22 明治制果株式会社 Quinoline derivative and insecticide containing same as active constituent
JP5112083B2 (en) 2006-02-03 2013-01-09 Meiji Seikaファルマ株式会社 Novel quinoline derivatives and agricultural and horticultural fungicides containing the same as active ingredients
EP1996196A2 (en) * 2006-03-13 2008-12-03 Merck & Co., Inc. Somatostatin agonists
JP5047588B2 (en) 2006-10-31 2012-10-10 Meiji Seikaファルマ株式会社 Quinoline derivatives and agricultural and horticultural insecticides comprising the same
JP2009073776A (en) * 2007-09-21 2009-04-09 Sumitomo Chemical Co Ltd Heterocyclic compound and harmful arthropod controller
BR112016012129A8 (en) * 2013-12-11 2020-05-12 Pfizer Ltd methods for the production, expansion and purification of retinal pigment epithelial cells, pharmaceutical composition and use of cells
WO2016092559A1 (en) * 2014-12-12 2016-06-16 Oat & Iil India Laboratories Private Limited Substituted pyrazole derivatives having activity as fungicides

Also Published As

Publication number Publication date
WO2020003219A1 (en) 2020-01-02

Similar Documents

Publication Publication Date Title
KR101397792B1 (en) Tetrazoyloxime derivative and plant disease control agent
JP6321042B2 (en) New halogen-substituted compounds
WO2006013896A1 (en) Quinoline derivative and insecticide containing same as active constituent
CZ20022244A3 (en) Trifluoromethyl pyrrolecarboxamides and trifluoromethyl pyrrolethioamides, process of their preparation and microbicidal preparation containing thereof
JP2012082186A (en) Insecticidal arylpyrrolidines
JP2012017289A (en) Pesticidal pyrroline derivative
ES2689956T3 (en) Compound of ethinylphenylamine or salt thereof, procedure to produce the same and fungicide for agricultural and horticultural use
BRPI0714572A2 (en) compounds, process for preparing compounds, agricultural composition, process for treating harmful phytopathogenic fungi, use of compounds, methods to combat arthropod pests, to protect crops from attack or infestation by arthropod pests, to protect seed from pest infestation arthropods and from infestation of shoots and seedling roots by arthropod pests, and to protect non-living materials from attack or infestation by arthropod and seed pests
JP2013510080A (en) Insecticidal arylpyrroline compounds
JP2011219431A (en) New aryl nitroalkane derivative
KR102348155B1 (en) Novel benzylamide compounds, methods for their preparation, and acaricides
JP2012062267A (en) Pesticidal pyrroline n-oxide derivative
WO2018051252A2 (en) Novel amide compound, method for producing the same, and miticide
JP2012041325A (en) Oxadiazolinone derivative and controlling application of pest
CN113045561B (en) Diarylamine derivatives as fungicides
JP2021502402A (en) Tetrazolylpropyl derivatives and their use as fungicides
CN112142621A (en) Meta-diamide compound and preparation method and application thereof
TW202012390A (en) Novel substituted pyrazole derivatives
ES2274553T3 (en) DERIVATIVES OF ACID PIRAZOLIL ACRILICO AND ACID PIRAZOLIL OXIMINO-ACETICO, ITS PREPARATION AND ITS USE AS FUNGICIDES.
CN105777640B (en) Pyrazole cyclohexanediol ether compound and application thereof
JP2005060255A (en) Carboxamide compounds and pest control agent containing the same as active ingredient
JP2006232814A (en) Anthranilamide-based compound, method for producing the same and pest control agent containing the same
TW201617322A (en) Novel 2-substituted imidazole compound and use thereof
JP2020203883A (en) 2,4-dioxo-1,4-dihydro thieno pyrimidine compound and bactericide for agricultural and horticultural use
WO2018015797A1 (en) Novel benzylamide compound, method for producing the same, and miticide